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 The growth of the multibillion dollar bionanoparticle industry has spurred the 
development of new physical characterization methods. One such metod, electrospray-
differential mobility analysis (ES-DMA) constitutes an electrospray for aerosolization of 
bionanoparticles (such as viruses, gold-nanoparticles, proteins, nanoparticle-protein complexes) 
and an ion mobility method that operates at atmospheric conditions, and separates 
bionanoparticles spatially. This dissertation identifies some relevant “problem” areas for ES-
DMA by reviewing selected applications.  
Some such problems are: proteins while passing through ES capillaries are found to 
interact with it and thus produce time dependent size distributions. Further, it is thought that 
adsorbed proteins may subsequently desorb and influence size distributions with the ES-DMA 
which may concomitantly affect quantification of aggregates. These artifacts are studied 
systematically and it is demonstrated that ES-DMA can quantify adsorption-desorption of 
complex protein mixtures at high shear rates. Further, it is shown that desorbing proteins do not 





aersolization process. Two units (called monomers) of a bionanoparticle may get encapsulated in 
the same ES droplet and upon drying of the droplet create artificial dimers thus affecting 
quantification with ES-DMA. Assuming Poisson distribution, this thesis provides a systematic 
approach that can be undertaken to eliminate this artifact. A third art fact arises from the low 
sensitivity of the DMA to size increase. When a ligand (for e.g. protein) adsorbs to a 
bionanoparticle it creates an increase in the size of the later, which can be used to quantify the 
amount of  ligand adsorbed per bionanoparticle. As ligands can change conformations upon 
adsorption, using ES-DMA for such applications may be flawed. This issue has been identified 
and a solution has been provided by integrating a mass analyzer after the ES-DMA. 
After correcting for these artifacts, this dissertation delves into characterization of 
different types of bionanoparticles and demonstrates that ES-DMA has several advantages over 
other traditional techniques such as transmission electron microscopy, size exclusion 
chromatography, analytical ultracentrifugation, dynamic light scattering and plaque assay and 
thus has immense potential to become a process analytical technique i  biomanufacturing 
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Chapter 1: INTRODUCTION 
 1.1 Growth trends of the bionanoparticle industry 
The nanoparticle industry is growing at a steady rate as evident from Figure 1.1 
(primary Y-axis) below [1]. Curiously, the biopharmaceutical industry, a giant by its 
own right (Figure 1.1, secondary Y-axis), although presumably unrelated to the 
nanoparticle industry is also showing a steady growth [2]. As the barriers between 
conventional fields of science and engineering break down it becomes difficult to 
segregate these two areas. For example, the most important products of the biopharma 
industry are different drugs, such as proteins. These proteins themelv s are roughly 
several nanometers in size and thus strictly speaking are nanoparticles or 
nanomaterials. In this dissertation the pharma and nanomaterial industry together will 
be considered as the bionanoparticle industry. In this context, bionanoparticles are 
being defined as nano-sized particles that are either biologically or synthetically-
derived (examples, viruses and proteins) or are functionalized to integrate into a 
biological context (example, nanoparticle-protein complexes). Although such a 
definition should include non-functionalized (also referred to as unconjugated) 
inorganic nanoparticles such as gold, silver, etc, this dissertation avoids the discussion 
of such particles. Also, the words particles, nanoparticles and bionanoparticles are 







Figure 1.1: Global growth trends of the nanomaterial and pharmaceutical industry. 
Given the growth potential of the bionanoparticle industry, it is imperativ  that 
it would be perhaps the most sought after and researched area for decades to come. 
The growth of this industry also has spurred the development of several analytical 
tools that can characterize bionanoparticles. This is because analytical tools act as the 
“eyes” necessary for efficient development and production of bionanoparticles.  
1.2 Necessity of multiple analytical tools 
Broadly speaking, bionanoparticle characterization can be either physical or 
chemical. Of the different physical properties of interest, particle size is perhaps of 
foremost importance. The need for better characterization of bionanoparticles in the 
last decade has either seen a resurgence of old techniques modified for addressing the 
nano-size regime or the development of completely new techniques. It is beyond the 
































only a few of the most routinely used tools are shown in Figure 1.2. Most of these 
techniques provide a relative measure of size such as electrophoresis, size exclusion 
chromatography (SEC), analytical ultracentrifugation (AUC), Coulter counter (CC), 
laser diffraction (LD) etc. Some, such as transmission electron microscopy (TEM) 
and scanning electron microscopy (SEM) on the other hand can provide a dir ct 
measure of size and more importantly provide visual images. Although eac
technique has its own pros and cons almost all techniques have some or many 
operational disadvantages. For example, SEC is the workhorse of the pharmaceutical 
industry for protein characterization [3] but does not provide a direct m asure of size. 
Inside a SEC a heterogeneous mixture of protein is passed through a column and as 
the extent of interaction for different proteins with the column is different, hence they 
elute at different times. Usually, the smaller species elute fast st and the bigger ones 
elute later, thus providing a measure of the different types of proteins in solution. 
Another cheap-easy-to-use popular technique, dynamic light scattering (DLS) is 
regularly used by the nanomaterial industry for obtaining the hydrodnamic size of 
nanoparticles and correlates it with the hydrodynamic diameter of the particle. 
Although it is accurate for monodispersed systems, for a polydispersed sy tem size 
distributions are skewed towards larger sizes because of the strong dependence of the 
scattered light on size [4]. Alhough TEM provides high resolution images, it i  
expensive, relatively slow, and artifacts can be introduced from electron beam 
damage, sample preparation, and biases in particle selection for quantitative analysis. 
Some more discussion about the disadvantages of other analytical techniques is also 
discussed briefly in chapter 3. It is evident that one analytical tool cannot give all the 
answers and thus there is a need for characterization of bionanoparticles using 







Figure 1.2: A list of techniques used for determining nanoparticle size. 
 Perhaps driven by the necessity to develop new techniques to characterize 
bionanoparticles, Stanley Kaufman, a scientist at TSI Inc., attemp ed to put together 
electrosprays (ESs) with a special type of ion mobility spectrometers called 
differential mobility analyzer (DMA) in the 1990s. In this regard, ESs were used in 
1960s and 1970s for applications involving surface coatings, agricultural treatments, 
emulsions and as colloid micro-thrusters [6]. In the 1980s it was discovered that ES 
could also be used for aerosolizing bio-macromolecules allowing their analysis with 
mass spectrometers (MS) [7]. On the other hand, DMA is just one of the several ion 
mobility techniques and its conceptualization can be traced to the late 19th – early 20th 
century [8]. In general, all ion mobility techniques measure how fast an ion moves in 
a viscous medium under the influence of an electrical field, and depending on the 
design can probe particle sizes from sub-nanometer to several hundred mic ometers. 
The predecessor of present day DMA was developed in 1957 to investigat charging 













commercialized [8]. Although, exploratory experiments were underway even in 1994 
[9], Kaufman et al. published a seminal paper integrating the ES and DMA in 1996, 
when he used this technique to determine the size of globular proteins [10]. 
Subsequently, researchers have used ES-DMA to characterize other bi nanoparticles 
including polymers, viruses, bacteriophages, nanoparticles-bionanoparticle and 
bionanoparticle-bionanoparticle conjugates, leading to an exponential increase in the 
number of publications reporting the use of ES-DMA. A detailed review of the 
bionanoparticles characterized using ES-DMA will appear in Chapter 3. 
1.3 Growth of ES-DMA 
 Although relatively new, ES-DMA is showing an increasing growth mainly 
for research purposes as evident from Figure 1.3 below. These plots have been 
generated using the key words “Electrospray” and “Differential Mobility analysis” in 
Web of Knowledge (version 5.3). As mentioned in the previous section, the first 
reported application of ES-DMA to biological molecules was by Kaufman et al in 
1996 for characterizing proteins. This work was followed over the next decade by 
several reports from Allmaier et al [11], Wick et al. [12] and de la Mora et al. [13] 
related to characterization of several other proteins, viruses and polymers. Starting in 
2006 as seen in Figures 1.3A and 1.3B a dramatic increase in the number of 
publications and citations related to ES-DMA occurred with contributions from 
Biswas et al. [14], Zachariah et al. [15], Loo et al [16], Hogan et al [17], Pergantis et 






Figure 1.3: (A) Published articles on ES-DMA from 1996 to 2010. (B) Number of 
citations (including self-citations) from 1996 to 2010.  
 
Although developed primarily for size determination, with an increasing pool of 
users, several orthogonal utilities have been found for this technique a detailed 
discussion of which will be appear later in Chapter 3. 
 1.4 Structure and organization of this dissertation 
Having introduced the necessity of ES-DMA in this chapter its different 
components will be reviewed in the next chapter (chapter 2). In chapter 3, a 
comprehensive literature survey of applications of ES-DMA (in the context of 
bionanoparticles) is going to be performed. Based on this survey it will become 
evident that this technique has certain artifacts and issues. Chapter 4, 5 and 6 will 
delve into these artifacts and try to eliminate and/or understand them. Subsequently, 
in chapter 7, 8 and 9 several applications of the ES-DMA are going t be discussed 
after accounting for the above mentioned artifacts. Chapter 10 will conclude by 
identifying the areas where further research can be carried out.  It should be pointed 
out that non-spherical bionanoparticles with high values of length to diameter ratios 




















































Chapter 2: ES-DMA: PRINCIPLES AND OPERATION 
The ES-DMA constitutes of four components: the ES for aerosolizati n of 
particles, the neutralizer for charge reduction, the DMA for size selection and finally a 
condensation particle counter (CPC) for counting the size selected particles.  
2.1 Electrospray  
The first unit of ES-DMA is the electrospray. Usually the analyte solution is 
housed inside a chamber under pressure (Figure 2.1), which enables the analyt
solution to be pushed through a silica capillary. For reliable and stable operation of 
the ES the solution needs to be conductive. The flow inside the ES capillary can be 
changed by changing the pressure drop (∆ capillary) that can be manually controlled 
externally and is given by the equation below: 
4









      (2.1)
 
Here µliquid is the viscosity of the solution passing through the liquid, Lcapillary, Qcapillary 
and Dcapillary are the lengths, flow rates and inner diameters of the capillary 
respectively. For simplicity, it is going to be assumed that the viscosity of the buffer 
used in ES is equal to water. The conductive solution disassociates to form positive 
and negative ions. As ammonium acetate is used as the solution in this dissertation the 
respective positive and negative ions formed are ammonium ions and acetate ions. 
When a positive voltage is applied with a Platinum wire, the positively charged ions 
migrate away from the wire. The voltage is then manually modified to create a Taylor 
cone [21, 22] at the tip of the ES capillary. At the tip Columbic repulsion forces the 
liquid out to form multiple charged droplets. The governing equations fr the droplet 







Figure 2.1: A schematic of the section of the ES that aerosolize the analytes into the 
gas phase. 
 
 After an ES droplet is emitted from the ES silica capillary tip, it holds a charge 
that is 0.4 – 0.5 times the Rayleigh limit and thus does not disintegrate immediately 




max 8 ( )oq Rπ γε=         (2.2) 
where γ is the surface tension of the solvent and εo= 8.854×10
-12 C2/Nm2 is the 
permittivity of free space. Although for cone stability ammonium acet te is added in 
small proportions with water for ES operations, for simplicity, let it be assumed that 
the properties of the resultant solution are same as that of pure water and thus  γ = 














 Typically the droplet size at the moment of formation under the op rating 
conditions of the ES used here is 150 nm. A detailed discussion about the operating 
conditions that produces this droplet size is provided later in section 2.6. The ES 
droplet moves away from the capillary towards the orifice plate as shown in Figure 
2.2 because of the electric field as well as a source of air (and or CO2). The later also 
aids in the evaporation of the ES droplet. Further based on force balance on an ES 
droplet of mass mR (= 4/3πρR
3where ρ is the density of water and is equal to 1000 
kg/m3) one could write: 
R E Dm a F F= +         (2.3) 
Here FE = qE where q=0.5qmax=2×10
-16 C and E=V/h where h is the distance from the 
ES capillary tip to the orifice plate and FD is the drag force. This is a simplistic 
assumption as the electrical field, denoted by the blue bold line in Figure 2.2 would 
vary in the direction perpendicular to the direction of the movement of the ES droplet. 
Further assuming the equation of drag force to follow Stokes Law [24] for such small 
objects, one can write, 6D airF vRπµ= . Here v is the velocity of the ES droplet and µair
is the viscosity of air. The voltage V is assumed to be 2 kV and is reasonable as the 












       (2.4)
 
For simplicity assuming that the acceleration on the ES droplet is equal to zero 
and the ES radius is not changing as a function of time the velocity of the ES droplet 
can be determined to be ~ 16 m/s from equation 2.4 above. Given that the distance 
where the neutralization chamber begins and the ES tip is located is ~ 1 mm, it takes a 





On the other hand, the time taken for the ES droplet to vaporate to the size 
such that it reaches the Rayleigh limit can also be independently ascertained. 
Considering solvent evaporation it can be shown that the time taken to reach a droplet 











        (2.5)
 
Where α´ is assumed to be ~ 0.04 and is a measure of condensation and is assumed to 
be almost equal to water, v´ is the thermal velocity and is assumed to be 4.5×102 m/s, 
po is the partial vapor pressure =  2.3 kPa at T = 293 K, M = 0.018 kg/mol and Rg= 
8.314 J/mol/K.  
The ES droplet would continue to evaporate till the Rayleigh limit is reached 
at which point it will disintegrate into smaller droplets. Thus, 
1 1
3 32 2
28 ( ) 0.5 8 ( )o oR Rπ γε π γε= ×       (2.6)  
Thus for a 150 nm ES droplet, 2R2 = ~ 95 nm. Now substituting this value of R2 in 
equation 2.5 above, one will get t = 362 µs. As it takes 62 µs for an ES to reach the 
orifice plate, it implies that a droplet will reach t e orifice plate and enter the 
neutralization chamber much before it starts to disintegrate by Columbic repulsion. In 
this regard, the 150 nm droplet becomes ~ 140 nm droplet in 62 µs (obtained by 






Figure 2.2: The journey of the ES droplet from the tip of the ES capillary to the orifice 
plate. 
 
 This analysis has a very important consequence. It implies that from the time 
of formation of the ES droplet to the time it reaches the neutralizer, the nanoparticle 
residing inside the ES droplet will stay intact and unperturbed by the electro-
hydrodynamic forces. In the context of this discussion certain operational parameters 
of the ES are discussed for clarity. A more detailed discussion about the ES 
operational conditions is further provided in section 2.6 and a detailed descriptions of 
the mechanism of how ES droplets evaporate and charge is transferred to the analyte 
are provided elsewhere [23, 26]. 
2.2 Neutralization chamber 
The neutralizer is the second component of the ES-DMA and is the primary 
way of charging the analytes in ES-DMA unlike mass spectrometry (MS) [23, 26]. 
















t = ~ 62 µs Neutralization Chamber
Air and or CO2

















the the N2, O2and CO2 to create a bipolar atmosphere of ions as shown in Figure 
2.3(A). The alpha particles at first collide with te individual gas molecules to 
generate positive ions. The electrons emitted from these positive ions then may 
generate negative ions thus creating a bipolar atmosphere. These ions themselves can 
collide with each other and create more ions or may agglomerate presumably by 
electrostatic interactions and form very large ions too. As the 140 nm electrospray 
droplet passes through, these ions collide with the ES droplet to reduce the charge on 
the droplets. Thus, the ES droplets can no longer disintegrate by Columbic repulsion.  
Given the flow rate of the air that drives the ES droplets and the neutralizer 
volume, it takes about a few seconds for the ES droplet to transit through the 
neutralizer and thus the droplet continues to evaporate. If it is assumed that there is an 
analyte inside that itself has a diameter of 10 nm,then the minimum R2 is > 5 nm. 
Using, this value in equation 2.5 above, it takes about ~ 1 ms for the ES droplet to 
completely evaporate. As the transition time through the neutralizer for the droplet 
volume is much more, thus one can assume that the ES droplet completely evaporates 
before exiting the neutralizer. It should be pointed out though that some nanoparticles 
may have more affinity towards water and because equation 2.5 above does not take 
into account the interaction of the nanoparticle inside the ES droplet with the solvent 
thus it may be possible that some water may still stay bound to the nanoparticle before 
it reaches the DMA. 
Figure 2.3B shows a few of the several possible ways a nanoparticle can end 
up acquiring a neutral, +2, +1 or -1 charge. In context of this dissertation, the ES-
DMA’s resolution is significantly less compared to a MS and it cannot differentiate 
between the different charges. Say for example, an an lyte acquires a +1 charge either 
through a N2
+ ion or through a NH4





is charged with +1 charge .Further, as ammonium acetate-water as a solvent is not 
very common amongst the ES-MS users, it is not clear what is the most prevalent 
chemical composition of the charges. However, extensiv  studies have been 
conducted on the fraction of charges (irrespective of the chemical nature) [24, 27] 
generated by such a diffusion mechanism and thus one ca  collect either the positive 
or negatively charged particles using a technique discussed in the next section to 
calculate back the actual gas phase concentrations of the particles. 
 
 
Figure 2.3: (A) An alpha source, typically Po-210, is used in commercial ES-DMA 
for neutralizing the charges on the electrospray. (B) The journey of the ES droplet and 
the analyte inside the neutralization chamber.  
 
Combining the neutralizer with the ES opens up a really interesting avenue for 
ES units that are usually not applicable to ES-MS systems. Although it is usually 
believed that an ES does not break up non-covalent bo ds, it is possible that as the 
droplets disintegrate by Columbic repulsion once thRayleigh’s limit is reached 
during evaporation, the stresses on the non-covalent na oparticle systems residing 





































































disintegrated by stresses generated during disintegration of the ES droplet). As the ES 
droplet is not allowed to disintegrate by Columbic forces in a ES-neutralizer system, 
such a unit can potentially sample intrinsic aggregat  populations of different 
nanoparticles more accurately which will become evid nt in chapters 5 and 8.  
The combination of the ES-neutralizer also allows one to measure and monitor 
the ES droplet size. As the ES droplet does not disintegrate, it implies that if known 
concentration of a non-volatile salt is ESed and if the droplet residue size (Dresidue) can 
somehow be measured then the ES droplet size can be extracted from it. Assuming 
Csucrose is a known concentration of sucrose being ESed through such a system and the 









        (2.7)
 
Further, it has been experimentally observed that te residue particle size is strongly 
correlated with the capillary flow rate [28]: 
1
3~residue capillaryD Q         (2.8)
 
Further as the pressure drop through the capillary is correlated with the capillary flow 
rate (equation 2.1), thus, changing the pressure drop in the ES can enable one to 
change the ES droplet volume. The consequence of this demonstration will be 
illustrated later in chapter 5 and 8.  
Figure 2.4A shows the residue size of sucrose at two different capillary 
pressure drops of 3 PSI and 3.7 PSI using 0.67 % volume/volume sucrose 
concentration. Figure 2.4B shows the corresponding ES droplet sizes determined 
using equation 2.7. The sucrose residue size as shown above can be most 







Figure 2.4: (A) Size distribution of the sucrose residue size. (B) Size distribution of 
the ES droplet size for the same sucrose residue size. 
 
2.3 Differential Mobility Analysis 
The DMA which is a mobility analyzer is the third component of the ES-DMA 
system. There are many types of analyzers for mobility c assification, which fall 
broadly into two classes; time-of-flight and differential mobility. While the former 
separates particles temporally, the later separates particles spatially. There are other 
available varieties of mobility classifiers such as, drift tube – ion mobility, high field 
asymmetric ion mobility, and travelling voltage wave ion mobility, but these 
techniques are beyond the scope of this dissertation. F r a brief overview of these 
techniques the reader can refer elsewhere [27].  
Irrespective of the type of classifier the mobility velocity (v) of a charged particle is 
proportional to the electrical field (E): 
v ZE=                (2.9)   
where Z is the proportionality constant and is called the electrical mobility [27]. This 
equation is valid for low electric fields as at higer field strengths charged particles 
may exhibit preferential orientations and thus electrical mobility may not remain 
























































with large values of length to diameter ratios) and s pointed out in chapter 1, these 
particles won’t be dealt with in this dissertation. 
Within the class of DMA’s, the cylindrical configuration is the most 
widespread, primarily because its electrodes can be manufactured with exacting 
spatial specifications, and thus, electric fields are highly uniform and precisely 
controlled. The cylindrical DMA consists of two electrodes, one that is held at a high 
voltage (usually the inner electrode), and another at is grounded (usually the outer 
cylinder) as shown in Figure 2.5.  
Once the analyte enters the DMA, it almost immediatly “relaxes” under the 
new conditions of forces.  The expression for the “relaxation time” of a particle is 









        (2.10)
 
Where, Danalyte is the analyte diameters, µmedium is the viscosity of the medium and Cc
is the Cunningham slip factor that takes into account the variation in the 
experimentally determined values of drag force in the different flow domains (free 
molecular flow, transition flow and continuum flow). The expression for Cc is 
provided later. Further, V is the voltage applied to an electrode and the h is the 
spacing inbetween the two electrodes (assuming rectangular electrode configuration 
for simplicity). Assuming different values of V and Danalyte it can be shown that the 
residence time of an analyte inside the DMA is significantly greater (typically few 






Figure 2.5: Force balance on a charged analyte inside the DMA. 
If a negative voltage is applied to the inner electrode as shown in Figure 2.5, a 
positively charged analyte upon entering the DMA will get attracted towards the inner 
electrode. As a result a drag force also acts on the analyte in the direction opposite to 
its motion. The neutral and negatively charged particles are lost to the electrodes by 







        (2.11)
 
Where manalyte is the mass of the analyte, vr is the velocity of the analyte in the r-
direction and FD and FE are the drag and electrical forces respectively. As the particle 
is non-accelerating, thus dvr/dt = 0 and hence: 
E DF F=          (2.12) 
The equation for electrical force would be same as pre ented for ES droplet i.e:  
EF qE=          (2.13) 
Here q=ne, where n is the number of charges and e is the charge of 1 electron. In this 



























electric field here is inside the DMA and should not be confused with the electric field 
inside the ES. The expression of drag force is slightly complicated. It is developed by 











        (2.14)
 
Cunningham slip correction factor is dependent on the particle size and is given by







= + + − . Here λ is the mean free path of the 
medium used. For air, this is ~ 66 nm at standard temperature and pressure. Although 
strictly speaking, a similar correction should have be n employed for the ES droplets 
in section 2.1, usually Cc becomes constant and ~ 1 for large particles and he ce it 
was not intentionally used in the analysis. In this regard, as discussed before in the 
context of ES droplets, Stokes Law is used here as the Reynolds number of aerosols is 
typically less than 1. 









=         (2.15) 
The variation of this slip factor as a function of particle diameter is well established 
[20]. For particles smaller than the mean free path of gas (~ 66 nm at 293 K and 100 
kPa) it is inversely proportional to Danalyte, and for larger particles it decreases linearly 
with increasing particle diameter. Thus, for very small particles (say 10 nm or 20 nm), 
DMA separates particles based on the difference of pr jected area, while for larger 
particles (say 100 nm or above) it separates based on the difference of diameter.  
As shown in Figure 2.5, a laminar sheath flow (Qsh) also enters the DMA. The 














−         (2.16)
 
Further if the amount of time taken for the analyte to traverse the gap between the 
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and in that same time the analyte traverses a length Ls because of the sheath flow then,  
2 2
2 1( )s s
z
z sheath
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Combining the above two equations such that tr = tz 
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2 2













= −       (2.19) 
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Above equation implies that a particular voltage corresponds to a particular mobility 
of a particle. The bold dotted red line in Figure 2.5 shows the specific trajectory of a 
particular particle for a specific voltage V. Thus by scanning the DMA voltage from 
low to high voltages, mobility of particles from subnanometer size to several hundred 
nanometers can be obtained, depending on DMA design. Then, by substituting 
equation 2.20 in equation 2.15, Danalyte of a particle can be determined. One major 





on the particles is in the radial direction because of the applied electric field and flow 
effects are negligible.  
Usually the analyte flow that enters the DMA is referred to as polydispersed 
flow, and the mobility size selected aerosol flow is referred to as monodispersed flow. 
Typically, the DMA is operated under balanced condition which implies that the 
polydispersed flow is equal to the monodispersed flow and thus the sheath air 
becomes equal to the excess flow. 
2.4 Condensation particle counter (CPC) 
The CPC, the last component of the ES-DMA is the most sensitive detector available, 
and is about a thousand times more sensitive than commercially available 
electrometers. The high counting sensitivity of a CPC is based on condensation of a 
working fluid (alcohol or water) on the particle, which increases in size to form ~ 10 
µm almost uniform droplets (irrespective of the analyte size) so that it can be easily 
counted optically (Figure 2.6). However, while extrmely sensitive, the CPC suffers 
from a lower size limit of detection of ~ 2.5 nm because the droplet activation 
efficiency is size dependent (i.e. smaller analytes are more difficult to activate at a 
given supersaturation of the working fluid). This size dependence is usually accounted 
for by calibrating CPCs against electrometers and is called the CPC collection 
efficiency (ηCPC) [30]. It should be pointed out that modifications, including use of 
different working fluids and operating temperatures can lower the size limit to ~ 1 nm 







Figure 2.6 Schematic of the operating principle of the CPC 
2.5 Data Interpretation 
 The raw data obtained with ES-DMA is corrected with the response of each of 
the intermediate components for obtaining the actual gas phase distribution (Figure 
2.7). For the neutralizer, the charge distribution on the analyte is a function of particle 
size and is an absolutely essential correction. As mentioned earlier, upon applying a 
negative DMA voltage only the positively charged particles are collected. As the 
actual gas phase particles have positive, neutral and negatively charged particles, one 
needs to implement a correction to get back the original concentration. The fraction of 
positive, neutral and negatively charged particles g nerate by diffusion as a function 













=       (2.21) 
where dp represents the diameter of the analyte, do = 1 nm, j is the number of charges 
on a particle, and ao
1 through a5
1 are given by empirically fitted values of -2.3484, 
0.6044, 0.4800, 0.0013, -0.1553, and 0.0320, while ao
2 through a5
2 are given by 
empirically fitted values of -44.4756, 79.3772, -62.8900, 26.4492, -5.7480, and 
0.5049, respectively. 
 The next correction is for the transfer function of the DMA usually 
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the DMA, trajectories of different analyte may vary. This means that particles with 
slightly different trajectory may also enter the CPC for a particular DMA voltage. For 
example, depending on the operating conditions of the DMA, a 10 nm and a 10.2 nm 
particle may get collected by the CPC for a particular DMA voltage. Thus, even 
though these two particle sizes are different an user would think they are the same. 
Qualitatively these two sized particles are then within the resolution of the DMA. 
Thus the ultimate resolution and throughput of the DMA can be described by the 
transfer function and the resolution and transfer function always go hand in hand. 
Under balanced flow conditions, (i.e. when sheath flow equals excess flow and 
analyte or aerosol flow in, equals monodispersed size elected flow out) the ratio of 
the sheath to the analyte flow in provides an ultima e measure of the theoretical 
resolution [20]. The transfer function can be furthe  broadened by Brownian diffusion 
and the equations can get extremely complicated. In this dissertation, the effect of 
diffusion has been neglected for simplicity. For all the bionanoparticles that are 
discussed in this dissertation, the transfer functio  is assumed to be equal to 1 as 
under the operating conditions the influence of transfer function on size distributions 
was found to be insignificant. In other words, the distribution obtained with DMA 
reflects the intrinsic distribution width.  
Finally, the collection efficiency of the CPC is analyte size dependent and thus 
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= . Here Danalyteo is the diameter of an 
analyte for which the collection efficiency is ~ 0 % and Danalyte50 is the diameter of an 





particle sizes of 5 nm with 50 % efficiency and particles of around 7 nm with ~ 90 % 
efficiency. In the context of this dissertation, the collection efficiency of most 
bionanoparticles will be 100 % as they will be larger than or equal to 7 nm. 
Incorporating all the responses from the neutralizer, DMA and the CPC, and 
neglecting the effects of the transfer function it can be shown that the raw data N1(V1) 
from the CPC at a particular voltage V1 (corresponding to mobility Zp1 and diameter 
Dp1) and the size distributions are related by:  
1 1 1 1 1
1
( ) ( ) ( )CPC p c p p
p
dN
N V D f D dD
dD
η=
      (2.23)
 
Where dDp1 is the increment of size from Dp1 to Dp1+ dDp1 under balanced flow 
conditions, i.e. the polydispersed flow equals the monodispersed flow and also 
assuming that the aerosol flow is equal to the flow into the CPC. 
 
Figure 2.7: Steps for converting the raw data to the actual gas phase distribution. 
2.6 Operating parameters of the ES-DMA 
 Twenty mmol/L ammonium acetate buffer is prepared by adding 0.77 g of 
ammonium acetate (Sigma Aldrich, St Louis, MO, #631- 1-8) to 0.5 L of deionized 
water (18 MΩ/cm, Barnestead nanopure UV system) and adjusting to the desired pH 
using ammonium hydroxide (Baker, Phillipsburg, NJ, #9721-01). The concentration 
of acetate buffer used can also be as low as 2 mmol/L or as high as 80 mmol/L. If the 






































unstable ES droplets. On the other hand, if the conductivity is too high then the Taylor 
cone is not stable which results in small droplets but with higher polydispersity. 
Further details about the “window” of operation of the ES can be found elsewhere 
[30]. 
Typically the ES chamber pressure (Figure 2.1 and Figure 2.8A) is maintained 
at 3.7 PSI which for a capillary with 25 µm inner diameter and 24 cm length gives the 
liquid flow rate of ~ 70 nL/min and the Reynolds number for this flow is < 1. These 
capillaries have an outer diameter of 150 µm. The capillaries from TSI Inc also come 
with an inner diameter of 40 µm but for most of thework in this dissertation 25 µm 
capillaries were used unless otherwise stated. Further, it should be pointed out that the 
chamber pressure is also operated at 3.0 PSI the reasons for which will become 
evident in chapter 4 and 8. 
A 5 mCi Po-210 is used as the neutralizer. In Figure 2.8B it is not visible as it 
resides in the enclosed chamber inside the ES unit. The arrowhead in Figure 2.7B is 
barely indicative of its position. Although Po-210 has a half-life of ~ 138 days, it can 
be used upto one year after which the proportion of doubly charged particles even at 
small sizes (say 20 nm) starts to become significant. 
The next component is the DMA (Figure 2.8C). At thehighest sheath flow 
rates (30 L/min) used in this dissertation the Reynolds number inside the DMA is < 
1000 and thus the flow is laminar. For calculating the Reynolds number the hydraulic 
diameter of the concentric cylindrical configuration f the DMA was assumed. In a 
slightly different context, an example calculation is provided in Appendix A. The 
inner diameter of the electrode for the DMA used is ~ .94 cm and the outer diameter 
is ~ 1.905 cm. The model used in this dissertation has length of ~ 5 cm which is 





long-DMA), and is thus often referred to as a nano-DMA (NDMA, Figure 2.8C). The 
polydispersed flow, sheath flow and monodiserpsed flow are shown in Figure 2.8. 
The polydispersed and monodispersed flow connections are made with tygon tubings 
(from ES to DMA and DMA to CPC, respectively) while the sheath flow connection 
(from a high pressure dewar set at 40 PSI to the DMA) is through a plastic tubing. 
The DMA back pressure would vary from ~ 5 mm of H2O (3 L/min) to ~ 30 mm of 
H2O (30 L/min) depending on the sheath flow rate. Theexcess flow outlet is behind 
the NDMA and thus cannot be seen in this picture. The last component used for 
counting the particles size selected by the DMA is the CPC (Figure 2.8D). The model 
used in this dissertation is 3025A. For all cases in this dissertation, it was operated at 
high flow mode (1.5 L/min) to reduce the deposition l sses of the bionanoparticles the 
tubing that connects the DMA size selected monodispersed outlet to the CPC.  
As the operating conditions can slightly vary from experiment to experiment 
hence, each chapter (or section) will provide the op rating conditions of the ES-DMA 
pertaining to that chapter (or section). 
 
Figure 2.8: Actual ES-DMA experimental set up.  
Polydispersed Aerosol Flow (PDAF)
ES Pressure Gauge




















 To summarize the above sections a schematic of the different components of 
the ES-DMA system is provided in Figure 2.9. In theES (Figure 2.9A) the analyte, 
typically dissolved in a volatile buffer solution is passed through a fused silica 
capillary under pressure and then electrosprayed to produce multiply charged droplets 
containing the analyte. The ES in this figure is shown operating in the positive ion 
mode. The analyte containing droplets are then mixed with air (sometimes also 
supplemented with CO2) and are passed through the neutralizer (Figure 2.9B) where 
solvent from droplets continue to evaporate, and a residual charge on the particles 
results from diffusion charging from  positively and egatively charged ions. Only 
positively (or negatively) charged particles are thn classified by applying a negative 
(or positive) bias in the DMA (Figure 2.9C). The rest of the particles with zero or 
negative (or positive) charges will collide with one of the electrodes of the DMA and 
be lost. Finally analyte particles are eventually detected (Figure 2.9D) by either using 
a condensation particle counter or an electrometer and thus a size distribution is 
obtained.  Figure 2.9E below shows the size distributions of human serum albumin 
and MS2 virus (after charge correction) in ammonium acetate buffer. Size 
distributions adapted with permission from [10], copyright 1996 (American Chemical 
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Chapter 3: LITERATURE SURVEY 
Although a few groups of researchers use ES-DMA for characterizing AuNPs, 
silver nanoparticles (AgNPs) routinely the scope of this dissertation is only limited to 
nanoparticles in the biological context and thus in this chapter the most relevant 
examples are discussed. 
3.1 Viruses and bacteriophages  
Over the last decade, ES-DMA has been applied broadly to characterize phage 
and virus-like particles. For example, a number of studies measured the size of both 
large and small viruses as evident from Table 3.1 below. Using ES-DMA size 
distributions Pease, et al. [31] determined the symmetry and number of proteins per 
capsid for PR772 (Family Tectiviridae, Genus Tectivirus), a biosafety level 1 (BSL1) 
simulant of adenovirus.  Lute, t al. [32] extended ES-DMA analyses to viruses of 
particular interest to biomanufacturers and filter firms by characterizing the size 
distributions of several viruses used in virus filtration studies and in the Parenteral 
Drug Association’s (PDA) new nomenclature standards for small and large virus 
retentive filters. Wick, et al., [33] demonstrated that ES-DMA is sufficiently gentl  to 
enveloped viruses such as  alphavirus (Family Togaviridae) although there was some 
loss of structure in murine hepatitis virus (Family Coronaviridae, Genus 
Coronavirus), and sendai rodent virus (Family Paramyxoviridae, Genus 
Respirovirus). Using a novel recombinant virus-like particle as a test article, Pease et 
al., [34] recently compared ES-DMA size distributions to those of TEM and 
asymmetric flow field-flow fractionation and found good agreement among the 
techniques for particle quantitation. Furthermore, it has been shown that icosahedra 





appear to lose structural integrity and infectivity in the electrospray. Overall, this 
technique has the potential to analyze many types of viruses.  Table 3.1 below 
provides a comprehensive list of all viruses that have been studied till date. 
Table 3.1: Summary of reported virus identities and mobility sizes. (Adapted from 
reference [36]) 







Wick 2005 [33] 22.5 Kilham rat virus (KRV) Parvoviridae 
Lute 2008 [37] 23.2 PP7 Leviviridae 
Kuzmanovic 2008 
[38] 
23.3 MS2 Leviviridae 
Wick 2005 [33] 23.3 MS2 Leviviridae 
Cole 2009 [39] 23.4 MS2 Leviviridae 
Thomas 2004 [35]  23.6 MS2 Leviviridae 
Cole 2009 [39] 24.0 PP7 Leviviridae 
Hogan 2006 [14]  24.1 MS2 Leviviridae 
Wick 1999 [12] 25.0 MS2 Leviviridae 
Kaddis 2007 [40] 25.4 
Cowpea chlorotic mottle virus 
(CCMV) 
Bromoviridae 
Thomas 2004 [35] 25.9 Cowpea mosaic virus (CPMV) Comoviridae 
Lute 2008 [41] 26.5 X174 Microviridae 
Wick 2005 [33] 26.9 MVM parvovirus Parvoviridae 
Cole 2009 [39] 27.0 X173 Microviridae 
Wick 2005 [33] 28.0 







Thomas 2004 [35] 28.5 RYMV Sobemovirus 
Wick 2005 [33] 28.9 Sendai Rodent Virus Paramyxoviridae 
Laschober 2008 
[42] 
29.8 Human Rhinovirus (HRV) Picornaviridae 
Bacher 2001 [11] 29.8 HRV Types 2 & 14 Picornaviridae 
Wick 2005 [33] 31.1 GD7 picornavirus Picornaviridae 
Bacher 2001 [11] 31.1 HRV Types 2 & 14 Picornaviridae 
Pease 2009 [34] 38.1 VLP Polyomaviridae 
Hogan 2006 [14] 43.9 -phage Siphoviridae 
Pease 2010 [31] 59.6 PR772 Techtiviridae 
Wick 2005 [33] 70.0 Alpha virus Togaviridae 
Wick 2005 [33] 73.7 Murine hepatitis virus (MHV) Coronaviridae 
Wick 2005 [33] 79.1 Reo-3 (rheovirus) Reoviridae 
Thomas 2004 [35] 79.7 Adenovirus Adenoviridae 
Wick 2005 [33] 82.0 Adenovirus Adenoviridae 
Hogan 2006 [14] 87.0 T2 Myoviridae 
Hogan 2006 [14] 88.3 T4 Myoviridae 





By collecting viruses post-ES [14]  and post-ES-DMA [6] it has been 
established that some viruses (e.g., MS2, λ) remain viable after the ES process while 
some others do not (e.g.,T2, T4, [14] and TMV [6]). The latter also appear at mobility 
diameters smaller than expected, especially if the ES droplet sizes are smaller or 





perturbation during the ES evaporation process may disrupt the integrity of these 
viruses. That some viruses indeed break up during the ES process has also recently 
been corroborated with TMV [6].  
Evaluating the titer (concentration) of viral products as part of a lot release 
protocol is a key quality control step essential to ensuring their efficacy and safety 
[44].  Although the specific tests comprising the lot release protocol are prescribed 
individually for each product as appropriate for each case, the assays and instruments 
used to evaluate the identity, composition and potency of viral products must meet 
standards established by the International Committee on Harmonisation (ICH) (ICH 
Expert Working Group, 2005). Specifically, “ICH Q2 Validation of Analytical 
Procedures: Text and Methodology” indicates that a qu ntitative assay must be 
evaluated based on seven criterion, namely; specificity, linearity, range, accuracy, 
precision, robustness, and system suitability testing [44]. Although routinely used by 
several labs, such a systematic study for viruses i lacking in the literature and thus 
will be systematically studied in chapter 7. 
3.2Polymers and proteins  
Almost all polymers and proteins of interest are amenable to characterization 
by ES-DMA, which offers faster characterization times over size exclusion 
chromatography (SEC), analytical ultracentrifugation (AUC), flow-field fractionation 
(FFF), and gel electrophoresis, in addition to providing a direct measure of size. ES-
MS methods have difficulty measuring high molecular weight proteins and the 
presence of more than one charge state can complicate data interpretation [45].   
The first application of ES-DMA to nucleic acids can be traced back to 1997 
when it was used for determining the mobility diameter of single stranded and double 





in the size range of 4k to 700 kDa were used to establi h that  molecular weight and 
mobility diameter could be correlated by a one-third power law [47] a correlation that 
had already been established for proteins three years prior [11]. Similar behavior has 
been reported for water insoluble polymers [48]. Using this correlation, ES-DMA can 









        (3.1)
 
Here ρ is the density of the polymer (or protein), MW is the molecular weight, Navg is 
the Avagadro’s number and dDMA is the analyte diameter determined by DMA [46, 
50]. It should be pointed out that for a known gas phase density of a particle, equation 
3.1 can conversely also be used to determine the mol cular weight. Such a correlation 
is obvious for any globular particle as it resembles a sphere. However, it arises for any 
non-spherical particle such as a PEG probably becaus  ES droplet evaporation causes 
it to dry up to a near spherical shape. It should be pointed out that unlike proteins, 
equation 4 cannot be used to correlate the molecular weight of viruses with mobility 
diameter most likely because the density of the different internal constituents of 
viruses can vary [11]. 
ES-DMA has been used to determine polydispersity in PEGs, although, in this 
study, the density of PEGs were assumed to be the same as proteins with no 
justification whatsoever [51]. It was also found that 2 kDa PEG monomers are too 
small for analysis by ES-DMA. This result is expected because a CPC’s sensitivity is 
nearly zero at particles sizes of ~ 2 nm to 3 nm [52] and the mobility diameter of 2 
kDa PEG falls in this range. This limitation can however be overcome by using an 
electrometer instead of a CPC. Another group has also ttempted determining the 





groups (0.52 gm/cc to 1.3 gm/cc) [47, 51]. The reason for this variation is discussed 
later.  
ES-DMA has been used to characterize different generations of poly(amido-
)amine dendrimers (G2 to G10) and size distributions btained were found to be in 
reasonable agreement with atomic force microscopy, transmission electron 
microscopy, and small angle X-ray or neutron scattering [53]. In this study, using 
equation 3.1, the densities of the dendrimers were d t rmined to be ~ 0.54 gm/cc. It 
should be pointed out that for some generations of these dendrimers, the density 
values obtained using ES-DMA were about a factor of 2 lesser than rated densities of 
the manufacturer. Silk-elastin-like protein polymers (SELP) are a new class of 
materials that potentially can be used for gene delivery applications. Recently it has 
been demonstrated with the ES-DMA that such polymers can be electrosprayed to 
produce finely-tunable, potentially non-toxic nanoparticles either by changing 
concentration of the SELPs in solution or by changing solution viscosities [54].  
Another potentially valuable application of ES-DMA is characterizing and 
quantifying proteins and protein aggregates, the latter being a common problem 
during therapeutic protein development or storage [55]. ES-DMA possesses some 
distinct advantages relative to other more popular techniques such as SEC, dynamic 
light scattering (DLS) and field-flow fractionation (FFF). Although not demonstrated 
before, it is presumed that ES-DMA has a better resolution than SEC. In DLS the 
intensity of light scattering scales as the sixth power of the hydrodynamic diameter. 
Thus it cannot characterize heterogeneous populations unless the size difference 
between the particles is at least more than 3:1. On the other hand, ES-DMA size 
selects either on the basis of the inverse of projected area (e.g. 10 nm particles) or 





ES-DMA should also have a limit of detection which s about a thousand fold lower 
compared to techniques that use UV detectors such as SEC, AUC and FFF because of 
the sensitivity of CPC [9].  The first reported use of ES-DMA [10] employed several 
different globular proteins from molecular weight of 5.7 kDa (bovine pancreas 
insulin) to 669 kDa (bovine thyroglobulin). It was demonstrated that the monomers of 
different proteins can be differentiated from their respective oligomers (dimers, 
trimers) and that there was a strong correlation betwe n the molecular weight and the 
mobility diameter determined using ES-DMA. Since thn, the molecular weight – 
mobility diameter empirical correlation plotted in Figure 3.1 has been confirmed by 
several groups of researchers for both globular, as well as non-globular proteins 
ranging from a few kDa [11, 19, 56, 57] to several MDa [56]. The actual expression is 
later going to be used in Chapter 8. Recalling thate DMA does not measure mass 
directly, but rather projected area (for very small particles), the validity of this 
correlation implies that the proteins (esp. non globu ar proteins) undergo structural 
changes and become spherical during the evaporation of the ES droplet. A recent 
study with GroEL, a 14-mer complex suggested partial collapse of the structure in the 
gas phase after the ES-DMA thus strengthening this hypothesis although it should be 
pointed out that a “neutralizer” was not used for charge reduction in this study [58].  
ES-DMA has been used to resolve protein aggregates of DNase [59], insulin 
[30], and various immunoglobulins [19]. It has also been used to gain insight into the 
function of a number of protein complexes such as vult proteins [56], 20S 
proteasome [16], ErbB3 [60], hemoglobin (Hb), Hemopure (a crosslinked Hb) [49], 
and for correlating heart disease risks with the size of lipoproteins [61]. A brief 





The quantification of different oligomers of proteins has been reported for 
human antibodies [19], bovine serum albumin [10], hemoglobin [59] and 20-S 
proteasome complex [16]. One potentially confounding factor in these studies is 
adsorption of proteins to the ES capillary which produces time variant size 
distributions. However, since the development of ES-DMA this effect has never been 
systematically studied. Furthermore, studies suggest that proteins aggregate upon 
adsorption to different surfaces [48], thus one may wonder how adsorbed proteins 
may effect size distributions when desorbing.  
Another potentially significant problem is the quantification of aggregates 
using ES-DMA. Two or more monomers of a bionanoparticle may get encapsulated in 
the same ES droplet that upon evaporation of the droplet will be incorrectly measured 
as an intrinsic aggregate in MS or DMA. This artifact can be minimized either by 
conducting measurements of proteins at low concentration or by reducing the ES 
droplet volume [10, 62]. However, no quantitative approach is available to correct this 
artifact. 
 ES-DMA can be used to determine the density of proteins. However, density 
determined using equation 3.1 has been found to vary almost by a factor of two by 
different groups. The earliest findings of 1 – 1.1 g/cm3 were close to values reported 
for the liquid phase density [10, 57]. However, commercial ES-DMAs used later 
yielded densities close to 0.6 g/cm3[11, 49]. To explain this difference, it has been 
hypothesized that the mobility diameters are dependent on the geometric features of 
DMAs [63]. It has been independently seen that the mobility diameter obtained for 
same particles but with different DMAs can vary by about 15% [64]. Using 
uncertainty analysis, it can be shown that a 15% variation in mobility diameter results 





the literature and strengthens the above hypothesis. The same rationale may also 
explain the scatter of densities found in PEGs [47, 51]. Curiously, the lower density in 
all cases have been reported only with TSI Inc designed DMAs and this perhaps is 
because of inaccurate or imprecise DMA geometry design d and manufactured by 
them. 
 
Figure 3.1: Molecular weight and mobility diameter co relation.  
3.3 Nanoparticle-biomolecule conjugates 
Gold nanoparticles (AuNPs) are being intensely studied for bio-sensing and 
health diagnostic applications in part because of the ease with which they can be 
surface functionalized. The adsorption of biomolecular ligands, such as nucleic acids 
and proteins, to AuNPs often leads to an increase in mobility diameter that can be 
measured using ES-DMA. This principle has been demonstrated with several different 
















































and quantify surface coverage of single strand DNA molecules on 10 nm gold 
nanoparticles [65]. Similar studies have been report d for self-assembled alkane thiol 
monolayers (SAMs) on 10 and 60 nm AuNPs [15]. This study found that the coverage 
of SAMs was independent of the size of the AuNPs. BSA was recently used as a 
model protein to study AuNP-protein interactions as a function of concentration and 
pH [20]. To further model the complexity inside human plasma where 
multicomponent species may be present, competitive adsorption – desorption of 
SAMs and PEGs on AuNPs has been successfully studied [66, 67].  
ES-DMA has also been used to characterize a variety of bimolecular 
complexes, such as oligomerization of subunits of ribonucleotide reductase in the 
presence of different functional groups [68] and triphosphates [69], PEGylated-Von 
Willebrand factor (VWF) protein [70], quantification of coverage of antibodies (8F5) 
on human common cold virus [42], and quantum dots (QDs) on bacteriophages [71, 
72].  
Two approaches are used to quantify adsorbed ligand (usually peptides and or 
proteins) on a primary particle (such as AuNP, virus, or protein). One approach for 
quantification is based on the increase in projected surface area due to adsorption of 












=       (3.2)
 
Nligand   is defined as the number of ligands per primary particle, dconjugate and dprimaryare 
the mobility diameters of the conjugates and primary particles, respectively, and 
Aligand is the projected area of the ligand in liquid phase. The above equation has been 





well as QDs on phages. The other approach is to quantify based on the increase in 











       (3.3)
 
where dligand is the mobility diameter of the ligand. This has been used for quantifying 
the number of 8F5 antibodies that bind to human comm n cold virus, and has also 
been corroborated with cryo-miscroscopy [42]. For the same mobility diameter 
increase of a primary particle, each of these approaches gives different ligand 
coverages, with equation 3.3 always yielding higher coverages (for ligand size greater 
than 2 nm or more). This is evident from different examples shown in Table 3.2 
below. Further, these values obtained only rarely appe r to corroborate with other 
independent measurements (column 7, Table 3.2). Thus it is evident that further 
systematic studies and comparison with several other orthogonal techniques is 
required to determine which approach provides more accurate values. It should also 
be pointed out that both equations assume that a ligand, upon adsorption, does not 








Table 3.2 List of bionanoparticle conjugates and the differences in results depending on equations used. 
Complex 
Ligand 




                  Size AB approach VB approach Independent 
HRV2 + mAb-8F5 (1:60)[42] 8.8 30.0 35.8 8 28 30 
MS2 + mAb (1:69) [73] 9.0 23.2 31.8 11 27 NA 
MS2 + pAb (1:35) [73] 9.0 23.2 24.0 0 2 NA 
λ Phage + Strp + QD [71, 72] 14.1 48.4 55.8 5 21 7, 13 
10 nm Au + BSA [20] 7.1 13.0 19.3 12 27 3 
30 nm Au + BSA [20] 7.1 31.1 37.2 52 116 30 
30 nm Au + BSA [20] 7.1 59.0 64.9 161 367 87 
60 nm Au + TNF [74] 6.0 60.0 66.4 161 355 1018 








3.4 Advantages and limitations of ES-DMA 
3.4.1 Advantages 
a) ES-DMA characterization is independent of particle type and thus, no prior 
information about the particle type, is required. The use of charge neutralizers result 
in a reduction of the number of charges states per particle compared to ES-MS, and 
thus makes the data interpretation and the mobility spectra relatively simple to 
analyze.  ES-DMA operates under ambient pressure conditi ns, and does not require 
sophisticated pumping. This latter operational characteristic also makes its interface to 
other instruments (such as counters, substrates and m ss spectrometry) much easier.  
b) ES-DMA’s have been routinely used to characterize particles over a broad size 
range (~ 3 nm to several hundred nanometers), and hs also been validated with 
several independent liquid and gas phase techniques [14, 30, 34, 75]. Indeed ES-DMA 
was one of the primary tools in the recent development of NIST traceable 
nanoparticle size standards [76]. Although the commercialized ES-DMA has been 
used up to several hundred nanometers, it can be used for characterizing particles up 
to ~ 2 µm, and thus its operational size-range is significantly greater than both SEC 
and MS.   It should be pointed out however, that for micron sized particles, multiple 
charging, and a decrease in resolution (at fixed flow rate) can pose difficulties. 
Multiple charging can be deconvoluted by using Tandem-DMA methods, analogous 
to MS-MS studies.  
c) ES-DMA can be operated in a scanning mode [77] such that the total time of 
analysis is 2 - 4 minutes, and significantly shorter compared to several other methods. 





d) ES-DMA requires small sample volumes (a few µLs or less depending on time of 
analysis).  
e) Relative to other methods, ES-DMA has high sensitivity. The lower limit of 
detection of CPC is a thousand fold less than UV-vis based detectors typically used in 
SEC, AUC and FFF [9]. A more detailed study of the lower limit of ES-DMA will 
also be provided in chapter 7 (in context of viruses) and chapter 8 (in context of 
proteins).  
3.4.2 Limitations 
a) Liquid phase techniques such as SEC, AUC, FFF and DLS are widely used by the 
biopharmaceutical industry for characterizing protein stability and aggregate 
formation. Most of these techniques are capable of analyzing high concentrations of 
proteins (10 – 100 mg/mL), in non-volatile buffers and at high ionic strengths (100 – 
1000 mM). In contrast, ES artifacts that are going to be discussed in chapter 4 and 5, 
and instability, limits the solution conditions to concentrations of a few hundred 
µg/mL (protein and ES droplet volume specific), low ionic strength (<100 mM), and 
volatile buffers. Furthermore, characterization of proteins from cell media require 
some preprocessing, such as dialysis, to prevent droplet-induced coagulation of the 
analyte and heterogeneous media and a methodology to overcome it will be provided 
in Chapter 4.4. 
b) The uncertainty in measurements of ES-DMA is typically ± 0.3 nm from a size 
range of a few nanometers to at least ~ 100 nm [75] and appears to be independent of 
resolution [78].  However, this uncertainty sometimes may not be adequate to 
distinguish proteins with slight differences in molecular weight. For example, two 
proteins with molecular weights of 145 kDa and 150 kDa would have predicted 





uncertainty, and thus, ES-DMA cannot distinguish betwe n these two proteins. This 
limitation has been reported for certain cases [79]. On the other hand, a typical ES-
MS can easily distinguish differences in molecular weights of a few Daltons. 
c) A typical commercially available ES-DMA and CPC detection system will cost 
~$100 K (USD) and thus is a greater financial impedim nt relative to gel 
electrophoresis, capillary electrophoresis, SEC, DLS and FFF [55]. However, recent 
developments in DMA technology may potentially reduce the price [80]. 
3.5 Summary and Motivation 
Based on the extensive literature survey in previous sections it is evident that ES-
DMA can be used for several different subclasses of bi nanoparticles. Besides size 
determination it can also be used for i) measuring gas phase concentrations and 
correlating with liquid phase concentrations, ii) measuring the density of proteins and 
polymers, iii) quantifying ligand adsorption and iv) kinetics of aggregation.  
However, there are several outstanding questions and issues. These can broadly be 
divided into two categories: research oriented and industry oriented. The first one 
addresses some of the artifacts of ES-DMA from a fundamental standpoint and tries 
to study them systematically, understand them and if possible eliminate them. Under 
this category questions are as follows: 
1. As proteins can interact with ES capillary walls producing a response that varies 
as a function of time, can this interaction be quantified? 
2. Does the above interaction influence the aggregate dis ribution? 
3. Can quantitative theories be developed for quantifyi g unintentional non-specific 





4. The two models (AB and VB approaches) developed for quantifying ligand 
adsorption to bionanoparticles can vary drastically. Can a more acccurate 
methodology be adapted? 
Questions 1 and 2 are addressed in chapter 4, question 3 is addressed in chapter 5 and 
question 4 is addressed in chapter 6. 
To address the second category, different type of bionanoparticles such as 
viruses (chapter 7), proteins (Chapter 8) and nanoprticle-protein complexes (chapter 
9) are going to be taken up and analyzed with the most routinely used analytical 
methods and then compared to ES-DMA to see how the later fares against these 
techniques. It should also be pointed out that analyzing bionanoparticles often 
requires analysis with several orthogonal methods. Thus, in all subsequent chapters 







Chapter 4: ES ARTIFACTS: ADSORPTION AND 
DESORPTION OF PROTEINS AND ITS EFFECTS 
 Depending on the pH of the solution and the type of the protein being 
electrosprayed, there can be a time variant size distribution obtained with the ES-
DMA. The objective of this chapter is three-fold: i) to demonstrate that this time 
variant size distribution can be harnessed to quantify the adsorption and desorption of 
a) monomeric and b) oligomeric proteins to ES silica capillaries , ii) to study whether 
the adsorption and subsequent desorption of proteins to the capillaries influence 
aggregate distributions and iii) to demonstrate through an exploratory example that 
ES-DMA can be used for characterizing complex heterog neous protein mixtures by 
first adsorbing the mixture to the ES capillary and then characterizing during 
desorption. 
4.1 Monomeric protein adsorption-desorption to ES silica capillaries 
4.1.1 Introduction 
Protein adsorption is important to many fields including biomaterials and 
bioprocessing, which has led to many studies to quantify it. The characterization 
methods employed can be broadly characterized into solution depletion, optical, 
spectroscopic, imaging and surface force measurement techniques [81, 82]. Most of 
these techniques operate at stagnant conditions [83, 84] or at low shear [85, 86] 
(typically 102 sec-1 to 103 sec-1) and have only rarely [87-89] been used for studying 
competitive adsorption of protein oligomers (i.e. monomers, dimers, trimers etc. of 
same protein). An understanding of both the effects of shear and competitive 
adsorption is relatively unexplored problem. It has been reported for example that 





context of the  human circulatory system where shear rates can vary from 1 sec-1 to 
105 sec-1 [90].  However, while protein aggregation has been studied at high shear 
flow rates (106 sec-1) [91, 92] adsorption to surfaces is yet to be probed under these 
conditions. Further, it is generally believed that in multi-component systems, smaller 
proteins adsorb fastest, which are then displaced by larger ones [83, 85]. This effect 
has been observed in both stagnant [83, 84] and low shear flow conditions (≈ 500 sec-
1, 225 sec-1 to 2700 sec-1) [85, 86]. However, with a few exceptions, [87-89] there 
seems to be an overall lack of tools that can study adsorption-desorption of oligomers 
of same protein other than a few exceptions. Furthermore, it is common to label 
proteins while studying multi-protein systems or sequ ntial adsorption [92-94] despite 
the fact that labeling may change conformational stbili y of proteins and also affect 
adsorption patterns [95-97]. 
The objective of this section is to demonstrate that Electrospray-differential 
mobility analysis (ES-DMA) can also be used for studying protein adsorption. As 
mentioned in chapter 3 it was pointed out that sizedistributions of proteins are time 
dependent implying interaction of proteins with the ES capillary. As ES-DMA can 
resolve oligomers of the same protein it offers the possibility to study competitive or 
sequential adsorption of oligomers of the same protein or a mixture of different 
proteins or both (as long as their sizes are different) without the need for labeling. 
Because of the ES, particles (proteins in this context) pass through a silica capillary 
under high shear (typically 105 sec-1) thus offering the possibility of studying the 








4.1.2 Materials and Methods 
4.1.2.1 Sample preparation 
A monoclonal antibody (IgG1) Rituxamab (RmAb), was purified using Protein A 
affinity column (GE Healthcare) and stored at -20 oC in 0.025 mol/L Tris buffer at pH 
7.4 and 1×10-5 mol/L of NaN3 was added as a preservative. To desalt the protein 
sample, a millipore centrifuge filter (30 kDa molecular weight cut off) was used 
immediately prior to ES-DMA analysis at 13,200 rpm for 12 minutes. For ES-DMA 
experiments, RmAb was prepared at a concentration of 1.0 mg/ml as determined by 
UV-vis absorption measurements in 0.020 mol/L ammonium acetate at pH 7, and 
further diluted to 0.01 mg/mL, 0.02 mg/mL, 0.05 mg/L and 0.1 mg/mL.  For the 
“proof of principle” experiment described in section 4.1.2, a solution of 0.001% 
sucrose and 0.01 mg/mL RmAb was prepared at 0.020 mol/L ammonium acetate at 
pH 7.0. 
Bovine IgM (Sigma Aldrich, St Louis, MO, 078K4779) obtained in 
concentrations of 1 mg/mL was desalted as described for RmAb and diluted 10× to a 
concentration of 0.1 mg/mL for use in the ES-DMA. 
Stock gelatin (KNOX, trade name: Gelatine, # 0-41000- 3500-5) solutions 
were prepared by suspending 1 mg to 1.5 mg in 1 mL to 1.5 mL of 20 mmol/L 
ammonium acetate at the desired pH in low protein binding vials (Eppendorf). The 1 
mg/mL solution was heated to ≈50 0C for ≈5 minutes for dissolution. The samples 
were then diluted to 0.1 mg/mL and used to passivated the capillaries. Solutions of 
gelatin were prepared fresh each time the capillaries were passivated.  
The capillaries referred to as unpassivated or bare are those that did not 





underwent surface treatment with gelatin or BSA. The methodology of passivation is 
described in great detail in chapter 4.3. 
4.1.2.2 ES-DMA 
About 1.0 M H2SO4 was made to flow through the 25 µm capillaries for 20-30 
minutes (equivalent to 11-16 capillary volumes, definition of capillary volume 
provided later), followed by nano-pure18 MΩ/cm ultrapure water for another 10 
minutes (5-6 capillary volumes). Prior to ES-DMA exp riments, capillaries were 
cleaned by flowing 0.020 mol/L ammonium acetate buffer solutions at pH 7.0 for 5 – 
10 minutes before introduction of the desired sample.  Capillaries undergoing this 
treatment are referred to as “bare”.   
The ES-DMA was operated with a sheath flow rate of 10 L/min using nitrogen 
and an aerosol flow rate of ≈1.5 L/min using air except for the “proof of principle” 
experiment for which the sheath flow used was 30L/min. Size distributions of RmAb 
were obtained by scanning from 7.2 nm to 15.5 nm. The CPC was operated at a high 
flow mode of 1.5 L/min.   
 A typical adsorption-desorption experiment would constitute the following 
steps: firstly, insertion of the sample was followed by starting of data collection after 
4 minutes, to allow for the sample to elute through the capillary, pass through DMA 
and get counted by the CPC; mobility distributions were obtained every 90 seconds 
(unless otherwise mentioned) till steady-state was achieved (within experimental 
variability) and finally the protein sample was replaced with buffer and further 
mobility distributions obtained. The system was calibr ted for size using 60 nm NIST 
calibrated polystyrene latex particles 32. 
It should be noted that all experiments described after the proof of principle 





corrected and mobility distributions were obtained from 7.37 nm to 15.1 nm using 
commercial TSI Inc. software (Aerosol Instrument Manager) that enables obtaining 
size distributions more frequently (every 90 seconds) compared to the experiment in 
“proof of principle” experiment. Also, because the ES community (especially mass 
spectrometry) uses different capillary diameters and hence the flow volume [28, 53, 
98] can vary significantly time was replaced with equivalent capillary volume, which 
is defined by the product of time with capillary flow rate, and divided by the total 
volume within the capillary. In this regard, the mass-spectrometry community 
typically uses different passivations on silica surfaces to reduce protein adsorption 
which concomitantly reduces the long waiting times b fore protein breakthrough [99]. 
4.1.2.3Shear rate calculation 
 For the 25 µm capillaries and the nominal flow rates used in this study, the 
shear rate is calculated to be ≈104 sec-1 as calculated below.  This value is about one 
order of magnitude higher than techniques previously ed to study protein adsorption 
under shear flow conditions such as total internal reflection fluorescence (TIRF) 
[100], ellipsometer [86]  and surface plasmon resonance [101]. 
In laminar flow the velocity profile inside a tube is given by equation 1, 




= −         (4.1) 
Where U is the velocity at any radius r and Dcapillaryis the capillary inner diameter, 
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   (4.3) 
Using equation 3 the shear rate in a 25 µm capillary at a capillary flow rate of 66 
nL/min comes out to be 10756 sec-1.  
4.1.3 Proof of Principle Experiment 
Sucrose was used as a reference marker in this experiment because it does not 
significantly interact with the silica surface of the capillary at pH 7.  On the other 
hand, any protein that interacts with the capillary will result in a mobility distribution 
that should vary with time.   
Figure 4.1A plots the size distributions from 3 nm to 13 nm obtained at times 
of 0, 99, 128, 137.5, and 175.5 minutes for a mixture of 0.001% sucrose (v/v) and 
0.01 mg/mL RmAb. At t = 0 minutes and t = 99 minutes a peak for sucrose at 4.6 nm 
is clearly observed, while no peak is observed for RmAb. At t = 128 minutes, a peak 
for RmAb at ≈ 9nm is first observed that increases quickly in intensity to a steady-
state value with time. These results show that, sucro e does not bind to the capillary, 
and protein adsorption occurs over a long period of time. The RmAb mobility size 
needs to be corrected for sucrose that coats the RmAb molecule. The equation for this 
correction is given by: 
1
3 33
,RmAb RmAb sucrose sucrosed d d= −        (4.4) 
Where dRmAb is the size of RmAb monomer, dRmAb,sucrose is the RmAb coated with 
sucrose and dsucrose is the diameter of sucrose. The dRmAb value obtained is in excellent 
agreement with mobility diameters of immunoglobulins obtained by others [11].  
Figure 4.1A also shows small quantities of RmAb dimers at 11.2 nm which 





[102, 103] as discussed in the previous chapter. Other time points have not been 
shown for clarity. The data has been normalized w.r.t to the sucrose peak. Figure 4.1B 
includes the adsorption phase (upto ≈ 140 minutes), the steady state phase (upto ≈ 180 
minutes) and the desorption phase (upto  ≈  230 minutes). 
 
 
Figure 4.1: Size distributions of 0.001% sucrose (v/v) mixed with 0.01 mg/mL RmAb 
at pH 7.0 using the ES-DMA as a function of time. 2B shows the integration of the 
sucrose peak and RmAb peak plotted as a function of time.  
 
After the protein signal has reached steady-state (≈ 180 minutes), the protein 
solution is replaced with a 20 mmol/L ammonium acette buffer at pH 7. Upon 
replacing the sample with buffer, the sucrose signal decreases immediately, in 
contrast the RmAb signal decays relatively slowly. This is evident from Figure 4.2B 
that plots the integrated area under the RmAb and sucro e peak as a function of time 
for the entire experiment. These results are summarized and interpreted as follows. 
The presence of sucrose signal together with the abs nce of RmAb signal suggests 
that RmAb adsorbs to the wall of the glass capillary.  From 0 to ≈ 130 minutes RmAb 
adsorbs until the RmAb surface coverage reaches saturation, at which point protein is 
first observed and the signal rapidly reaches steady-state. Upon replacing the 
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decreases rapidly, while the RmAb signal falls more slowly.  The slowly decaying 
RmAb signal suggests slow desorption of RmAb from the glass capillary surface. 
4.1.4 Surface coverage and adsorption kinetics for monomeric and multimeric 
proteins 
 In this section the relationships necessary to extract kinetic parameters and 
surface coverages from the mobility distributions are formulated and then 
demonstrated with a monomer protein (RmAb). The reader is reminded that RmAb 
does not elute from the ES capillary for many minutes (or capillary volumes) for all 
experiments conducted for this work, hence it is not p ssible to determine the 
adsorption rate constants for RmAb using ES-DMA.  
 To determine the surface coverage, Celuting
t(i) is defined as the concentration of 
protein in liquid phase eluting through the ES capill ry, a parameter that varies with 
time where superscript ti denotes time i. The DMA-CPC however measures the gas 
phase concentration, which must be corrected for transport losses and particle 
charging fraction. While the charge fraction is based on well known relationships 
which allows one to make the appropriate quantitative corrections (defined by αcharge), 
the transport losses must be empirically calibrated, through a parameter α which takes 
into account Brownian motion [24] and electrostatic deposition losses and 
electrospray efficiency [104] as shown in equation 4.5.   






α=       (4.5) 
whereα is an unknown at this point since Celutingt(i) is unknown and Qcpc  and Qcapillary 
are the flow rates inside the CPC and capillary respectively. Cgasphase
t(i) is given by 





integrating over the entire size range of observed protein species such as protein 
monomer, dimer, or larger aggregates.   
( )
arg( ) ( )
t i







= ∫       (4.6) 
Where Ncpc
t(i) are the counts obtained by the CPC at a mobility diameter of Dp, dDp is 
the increment in mobility diameter and αcharge accounts for the charge correction 
[105]. For RmAb the monomer and dimer counts were obtained by integrating from 
7.6 nm to 9.6 nm and 9.8 nm to 11.8 nm respectively.  
 When the concentration of eluting protein reaches st ady state (or in other 
words assuming adsorption reaches equilibrium) Celuting
t(ss) can be written as shown 
below: 
Celuting
t(ss) = Csolution        (4.7) 
Where Csolution is the total concentration of the protein in soluti n measured by an 
independent technique such as UV-vis and the superscript t(ss) denotes steady state. 
Then combining equation 4.5 and 4.7,α can be determined at steady state. Using this 
approach  α was ≈ 4-5 for RmAb at all concentrations and pH values; however α is 
dependent on system operating parameters such as the erosol flow and sheath flow as 
well as protein type. The assumption of equilibrium has been addressed in greater 
detail in section 4.2. For now assuming steady state corresponds to equilibrium allows 
one to evaluate the adsorption kinetics under non-equilibrium conditions, because α 
once evaluated at steady state can then be used at other conditions assuming linearity. 
Concomitantly, this also allows the amount of protein adsorbed to the capillary 
surface per unit area Γads to be calculated. Because the amount of protein adsorbed 
varies with time and DMA scans require a finite dwell time ∆t, Γads





over a given time interval and summed over each scan period as given by equation 
4.8.  
( )
( ) ( )
t i
solution eluting capillaryt i
ads ads
capillary capillary
C C Q t
D Lπ
− ∆
Γ = Γ =∑ ∑     (4.8) 
Where Dcapillaryand Lcapillary are the diameter and length of the capillary, and Γads is the 
total coverage obtained. 
 When the protein is replaced with buffer, Γdes
t(i) is the amount of protein 
desorbed  










Γ = Γ =∑ ∑
     (4.9) 
where Γdes is the total amount of desorbed protein. 
Figure 4.2A presents data for 0.01 mg/mL RmAb at pH7 electrosprayed through a 
bare capillary for up to ≈ 100 capillary volumes, while Figure 4.2B shows size 
distributions for RmAb as a function of time when the sample is replaced with buffer. 
In this case, RmAb first appears at ≈ 72 capillary volumes consistent with results 
obtained before when sucrose was used as a “marker”. Figure 4.2C displays the total 
counts of RmAb as a function of time and the plot is d vided into four domains. 
Domain I is characterized by zero signal intensity due to the adsorption of nearly all 
protein to the glass capillary surface. Domain II is characterized by a rapid rise in 
counts following saturation of the RmAb surface coverage. Domain III is where 
RmAb signal reaches steady state.  Domain IV is during buffer rinse where a rapid 
decay in RmAb signal occurs.  It should also be noted that the mobility size of the 
RmAb monomers and dimers obtained during desorption (d main IV) are equivalent 





monomers, although from this measurement one cannot be certain that the desorbed 
monomer is in its native state. Figure 4.2D shows the resulting surface coverage 
(mg/m2) as a function of time, determined from equation 4.8. A maximum steady-
state coverage of ≈ 4 mg/m2 is determined, which only slightly decreases during the 
desorption period. The dotted line in domain I represents no protein eluting and thus 
the intial rate of protein adsorption is unknown. The next section compares the 
coverages with previously reported values.  
 
Figure 4.2: (A) Size distributions of RmAb. (B) Size distribution as a function of 
time. (C) Sum of the monomer and twice the dimer counts as a function of time. (D) 
Surface coverage as a function of time for RmAb.  
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4.1.5 Concentration and pH dependent adsorption-desorption of RmAb 
As the methodology for determining coverage, and adsorption-desorption 
kinetics, is now established these parameters can the be determined at different 
conditions. Experiments like those shown in Figure 4.2 were carried out at four 
different concentrations of RmAb: 0.01 mg/mL, 0.02 mg/mL, 0.05 mg/mL and 0.1 
mg/mL at pH 7.0.  The capillary volume at which RmAb started eluting was found to 
be inversely proportional to solution concentration as shown in Figure 4.3A. For 
example at 0.01 mg/mL the first evidence of RmAb appears at ≈ 72 capillary volumes 
as shown in Figure 4.2C before, likewise, RmAb start  eluting after ≈ 38 capillary 
volumes, ≈ 13 capillary volumes and ≈ 7 capillary volumes for 0.02 mg/mL, 0.05 
mg/mL and 0.1 mg/mL respectively. It is also evident from Figure 4.3A that the total 
gas phase counts is linearly correlated with the liquid phase concentration, i.e. the gas 
phase density of 0.02 mg/mL, 0.05 mg/mL and 0.1 mg/mL solutions after steady state 
are about two times, five times and ten times that of the steady state gas phase density 
of 0.01 mg/mL solution implying that the recovery in all these cases are the same and 
that the ES-DMA is linear in this concentration range. Size distributions were 
obtained for 15 to 20 capillary volumes after steady state had been attained for each of 
the above cases after which, the RmAb samples were replaced with buffer and size 
distributions obtained for ≈ 15 capillary volumes, to determine the desorption rate.  
The same methodology was adopted for the pH study. For clarity only one set of 
experiments have been shown in Figure 4.3A.  
Using equation 4.5 and 4.6, the surface coverage of RmAb on the glass 
capillary surface and the amount desorbed are plotted as a function of RmAb solution 





2-3 experiments. Within experimental uncertainty, the amounts of both absorbed and 
desorbed RmAb appear to be relatively independent of protein concentration.   
 
Figure 4.3: (A) The total gas phase density of RmAb as a function of time expressed 
in equivalent capillary volumes at four different con entrations at pH 7.0. (B) 
Adsorbed (open square) and desorbed amounts (open triangle, dotted line) of RmAb 
per unit area as a function of concentration.  
 Other groups have reported that protein adsorption increases as a function of 
concentration at both stagnant to high shear flow cnditions [106-109] which is in 
direct contrast to what is shown in Figure 4.3B.  Nonetheless, the coverages of 3.5 – 
4.3 mg/m2 determined here for concentrations ranging from 0.01 mg/mL to 0.1 
mg/mL fall within the range of 2 – 18 mg/m2 reported in the literature for silica 
surfaces [106-115]. The reasons for the breadth of values may be attributed to 
differences in surface properties [116], ionic strength [106, 107, 117, 118] , pH [113, 
114, 117, 119] and different immunoglobulins [113] .   
Using simple structural models for RmAb one can estimate if adsorption is 
monolayered or multilayered. For a typical IgG, the projected side (53 nm2) and 
frontal areas (94 nm2) [19]  give corresponding coverages of 4.6 mg/m2 and 2.6 
mg/m2,respectively. The experimental values of 3.5 – 4.3 mg/m2 in Figure 4.3B fall 





























































glass capillary surface; however, one cannot exclude the possibilities of mixed 
orientations or coverages, or surface induced aggregation or conformation changes 
that would change the adsorbed area of the protein [106, 119-122]. Many studies have 
proposed monolayer adsorption even for coverages up to 18 mg/m2 for IgG [119, 123, 
124], although multilayer adsorption has been report d by many others [117, 121, 
125-127].  
 The effect of pH on adsorption of RmAb was also examined. Figure 4.4 shows 
the amount of RmAb adsorbed (primary axis) and desorbed per unit area (secondary 
axis) of the capillary as a function of pH at a cone tration of 0.1 mg/mL and error 
bars are obtained by obtaining data at least in duplicate.  The highest surface coverage 
was observed near the isoelectric point (pI) of the protein. These results are consistent 
with the domed shaped profile commonly reported by others [114, 118] suggesting 
that intermolecular electrostatic repulsion effects may be important in influencing 
protein surface coverage. It should be pointed out that the pH study was limited to pH 
9.0 since buffers at ≈ pH 10 start etching of the silica capillaries that produced 







Figure 4.4: Adsorbed and desorbed RmAb per unit area s a function of pH at 
concentration of 0.1 mg/mL.  
 
The amount of  RmAb desorbed was also quantified at pH 4.75, 7.0, 8.5 and 
9.0 to be 0.11 ± 0.02 mg/m2, 0.48 ± 0.26 mg/m2, 0.44 ± 0.13 mg/m2 and 1.35 ± 0.16 
mg/m2 respectively which translates to 5.5 %, 15.3%, 11.1 % and 47% of the amounts 
adsorbed. Buijs et al [113] using reflectrometry found ≈ 10% desorption of IgG from 
silica consistent with the findings in this section. 
4.1.6 Desorption rate constants 
Based on the desorption data, one can also extract kine ic rate constants. 
Assuming that desorption over the 90 sec scan time is constant, one can determine the 
number of particles that desorb, Ndesorb,gas
t(i), by integrating  the area  under the 
monomer peak. Then the number of particles desorbing is Ndesorb,liquid
t(i) , such that  
( ) ( )
, ,
t i t i






































At any time t(i), the amount of particles remaining on the surface, d noted by 
Nsurface
t(i) is,  
( ) ( )
,
t i total t i
surface surface desorb liquidN N N= −       (4.11) 
where the total number of particles on the surface Nsurface
total is calculated from  the 
size distribution as determined by the DMA, the area of the capillary, and assuming 
monolayer coverage.  
The desorption rate is the change of surface concentration with time, which is 
assumed to be a first order process, and is integrated to give: 
( )








= − −        (4.12) 
Where Kdesorption is the desorption rate constant 
Using equation 4.12, the rate constants of desorption for the concentrations 
studied are found to be ≈ 10-5 sec-1 and invariant of concentration. The desorption rate
constants at pH 4.75, 7.0 and 8.5 were determined to be≈ 10-5 sec-1, whereas for pH 9 
it was ≈ 10-4 sec-1. The higher desorption rate at pH 9.0 may be caused by electrostatic 
repulsion between the silica and adsorbed protein. The desorption rate constants are 
listed in Table 4.1. Using X-ray photoelectron spectroscopy, Ball et al [120] found 
desorption rate constant for IgG to be ≈ 10-5 sec-1, consistent with above results. 
Because the experiments by Ball et al. were performed under stagnant conditions, the 
reasonable agreement of results implies that shear does not considerably affect 









Table 4.1. Desorption rate constants at different co centrations and pH.  
Concentration 









0.01 1.8×10-5±7.1×10-6 4.5 2.2×10-5±2.5×10-6 
0.02 1.9×10-5±1.0×10-5 7.0 2.7×10-5±4.2×10-6 
0.05 1.9×10-5±3.5×10-6 8.5 2.7×10-5±1.4×10-6 
0.1 1.7×10-5±2.4×10-6 9.0 1.2×10-4±5.8×10-6 
 
4.1.7 Summary 
The ES-DMA method offers the possibility to study ‘label-free’ competitive as 
well as sequential adsorption of oligomers of the same proteins and or multiple 
proteins under high shear (≈104 sec-1). pH (4.75 to 9.0) and concentration based 
studies were performed for RmAb (0.01 mg/mL to 0.1 mg/mL), on silica at pH 7.0. 
Concentration does not seem to have an effect on the amount of protein adsorbed at 
high shear flow conditions for RmAb. The pH studies show maximum adsorption 
around the pI of RmAb consistent with literature. The desorption rate constants were 
found to be consistent with other studies at static conditions implying that shear may 
not have a significant effect on desorption kinetics. It should be mentioned that this 
methodology can also, in principle, be adapted by the mass spectrometry community 
for studying protein adsorption-desorption on and from silica capillaries although 
because the number of charges on proteins would be solution pH specific, quantitation 
of adsorption-desorption would be more complicated. Such an issue does not arise for 
the ES-DMA since a Po-210 charge neutralizer is used. It should also be pointed out 





adsorption process and the reader would have to refer elsewhere for understanding it 
better [112, 128-130]. 
4.2 Oligomeric protein adsorption-desorption to ES silica capillaries 
4.2.1 Introduction 
As already pointed out in chapter 4.1, protein adsorption to surfaces is 
ubiquitous and is of great importance to the bio-pharma industry and food processing. 
Often times, to emulate the complexity inside human plasma, the adsorption of 
multiple protein systems are studied on to different surfaces. For identifying different 
proteins from such a system it is common to use radio, fluorescent or gold labeling 
[85, 93, 131]. However, labeling may change the conformation stability of proteins, 
and affect their adsorption behavior or even promote aggregation in proteins [87, 95, 
96]. To avoid the adverse effects of labeling, other “label-free” tools have been 
employed such as size exclusion chromatography [87, 95, 96], electrophoresis [128], 
ellipsometry [132, 133], spectroscopy [134], surface plasmon resonance [101], quartz 
crystal microbalance [135], tensiometry [132], reflectrometry [136], shear rheology 
[125], surface force apparatus [137] and imaging techniques [138]. However, there 
are only a few reports where these tools have been employed on oligomers 
(monomers, dimers etc) of the same protein [87-89]. The objective of this section is to 
demonstrate that ES-DMA is one such tool that can be employed for routinely 
studying adsorption-desorption of heterogenous protein mixtures. This is 






4.2.2 Sample preparation 
4.2.2.1 Protein sample preparation 
Bovine IgM (Sigma Aldrich, St Louis, MO, 078K4779) obtained in 
concentrations of 1 mg/mL was desalted using 10 kDamolecular weight cut off 
centrifuge filter from Amicon using the same methodol gy as adapted for RmAb and 
described in Chapter 4.1. It was then diluted 10 times to concentrations of 0.1 mg/mL 
for use in the ES-DMA.  
4.2.2.2 Capillary surface preparation and passivation 
For the electrospray source and adsorption studies, 24 cm long and 25 µm 
internal diameter fused silica capillaries were used. Capillaries were treated with ~ 1.0 
M H2SO4 for 20-30 minutes, and then rinsed with deionized (18 MΩ/cm) ultrapure 
water for another 10 minutes. Prior to ES-DMA experim nts, capillaries were cleaned 
by electrospraying with 20 mmol/L ammonium acetate buffer solutions for 5 – 10 
minutes before insertion of the desired sample.  Capillaries undergoing this treatment 
are referred to as “bare”. 
Stock gelatin (Knox, trade name: Gelatine, # 0-41000- 3500-5) solutions were 
prepared by suspending 1 – 1.5 mg in 1 – 1.5 mL of buffer of 20 mmol/L ammonium 
acetate at the pH 7.0 in low protein binding vials (Eppendorf). The 1 mg/mL solution 
was then heated to about 500 C for approximately 5 minutes to dissolve the protein in 
solution. The samples were then diluted to 0.1 mg/mL solution, and used to coat the 
capillaries. Further details of the protocol for coating the capillaries will be provided 







The experimental conditions were same as the previous section and thus are not 
discussed here. 
4.2.3 Results and Discussion 
The mathematic modeling for determination of the coverage of IgM onto ES 
surface would essentially remain the same as before (Chapter 4.1) with slight 
modifications arising from the heterogeneity of thesample. For example, expression 
for Celuting in equation 4.5 above needs to be slightly modifie or such an oligomeric 
system. Defining Csol
M and Csol
D as the measured monomer and dimer solution 
concentration respectively such that the total concentration Ctot is given by (assuming 
higher order oligomers are negligible in concentration): 
2M Dsol sol totC C C+ =         (4.13) 





Dusing αMand αD in equation 4.5, 4.6, 
4.7. Further, different oligomers can have different projected areas upon adsorption 
depending on their orientation while approaching the surface as shown in Figure 4.5. 
One needs to especially take this into account for estimating whether the coverage is 
monolayered or multilayered. Although this aspect is not addressed in this 
dissertation, the possible orientations are shown in Figure 4.5, nevertheless. 
As the surface is a heterogenous mixture of the mono ers and dimers, 
assuming that the heterogeneity is proportional to the maximum coverages of 
monomers and dimers, the total monomer on the surface Nsurf
M, total can be written as 
below 
,M total pl av












Figure 4.5: (A) Two simplest possible configurations of dimers attaching to the 
surface of ES capillary. (B) Projected area occupied by dimers assuming equal 
probability of both configurations. 
Where ΓM
pl is the maximum (plateau) monomer coverage, dM
 is the diameter of the 
monomer determined by ES-DMA, dcapillary and Lcapillary are the diameters and lengths 
of the capillary, respectively and Nav is Avagadro’s number and MWmonomer is the 
molecular weight of the monomers. 
As the number of dimers on the surface is irrespectiv  of the orientation, hence 
the total number of dimers on the surface can be determined using: 
,
dim
D total pl av





π= Γ × ×          (4.15) 
Where ΓD
pl is the maximum dimer coverage and MWdimer is the molecular weight of 
the dimers.  
Then, following the same methodology as outlined in section 4.1.6, the rate 
constant for the monomers Kdes
M and dimers, Kdes
D can be determined by replacing 
Configuration 1 Configuration 2A
B








4 dimers, 2 with 
configuration 1 &
2 with configuration 2
4 dimers create a projected area 
equivalent to 6 monomers, i.e. the 
number of dimers is 2/3 times that 















D,total in equations 4.10 to 4.12. 
Figure 4.6A shows mobility size distributions of 100 µgm/mL of IgM in 20 
mmol/L ammonium acetate buffer at pH 7.0 while Figure 4.6B shows mobility 
distributions for desorbing IgM when the protein soluti n was replaced with buffer 
after about 50 capillary volumes. Both Figure 4.6A and 4.6B consists of two major 
peaks that can be identified as monomers and dimers of IgM based on an empirical 
correlation between mobility size and molecular weight. It will be demonstrated in 
chapter 5 that the size distribution of IgM is intri sic solution distribution. For now 
the reader needs to just accept this information. As it is clear from Figure 4.6A that 
IgM has significant dimers along with monomers hence it is used as an example of a 
polymeric protein in this section. In Figure 4.6A, the monomers and dimers of IgM 
increased monotonically immediately after insertion of sample, and the mobility of 
the monomers and dimers stayed constant at 15.6 nm and 19.2 nm throughout the 
experiment. Using reasonable numbers for diffusivity (1011 m2/s) for IgM monomers, 
the characteristic diffusion time can be determined to be ~ 16 s to traverse the radius 
of the capillary. This is approximately a factor of8 smaller than the capillary 
residence time, which in this regard is ≈ 2 min.  This implies that the time dependent 
mobility distributions cannot be ascribed to mass transfer effects, and must be 
associated with the intrinsic kinetics of adsorption.  
The area under the monomer and dimer peaks from each mobility size 
distribution are integrated and presented in Figure 4.6C as a function of time.  Domain 
I represents the initial phase of adsorption, followed by a step change represented by 
domain II (capillary volumes 15 onwards), and domain III which is the steady state 





replaced with the buffer (capillary volume 52 onwards). From this data, the coverage 
of protein adsorbed onto ES capillary can also be det rmined as was demonstrated 
with RmAb (using CsolM and CsolDwith CgasM and CgasDusing αMand αD in equations 4.4 to 
4.9). Applying this approach the coverage of IgM monomers and dimers to bare Silica 
is shown in Figure 4.6D.    
Further, by dividing the initial coverage with the initial time (first ~ 20 mins) 
the initial rate of adsorption was determined to be 0.1 ± 0.02 mg/m2/min and 0.18 ± 
0.05 mg/m2/min for monomers and dimers respectively. The initial rate of adsorption 
of IgM dimers is thus about 1.8 times that of IgM monomers. Buijs et al  [113] found 
the initial rate of adsorption to be ≈ 1 - 2 mg/m2/min for IgG at near stagnant 
conditions using reflectometry, implying that IgM has a much lower affinity to silica 
than IgG.  
The maximum monomer and dimer coverage at steady stte were 2.15 ± 0.50 
mg/m2 and 3.75 ± 0.32 mg/m2 respectively. Tengvall et al determined IgM adsorption 
to hydrophobic silica to be as much as 15 mg/m2 [139]. On the other hand Lea et al 
found submonolayer (34 %) coverage of murine IgM onto mica surface using AFM 
[140]. As already described in chapter 4.1, this broad variation in literature could be 
because of several reasons, such as, different IgMsused, the surfaces, characters of 
the surfaces, buffers used, ionic strength of solutions, pH etc. Nevertheless, the results 
obtained here with ES-DMA are well within this broad range of values found in 
literature. 
The desorbed amounts of monomer and dimer per unit area were calculated to be 
0.49 ± 0.3 mg/m2 and 0.08 ± 0.02 mg/m2, respectively, i.e. 22.8% of monomers 





when flushed with buffer. This is also evident qualitatively by comparing Figure 4.6A 
and Figure 4.6B. The dimer/monomer ratio in desorpti n is significantly smaller than 
during adsorption that implies that the primary species coming off the surface is 
monomers. This could be attributed to the larger number of binding sites for IgM 






Figure 4.6: (A) Size distributions of monomers and dimers of IgM as a function of capillary volumes during adsorption. (B) Size 
distributions of monomers and dimers of IgM as a function of capillary volumes during desorption. (C) Integration of the monomer and 
dimer peaks obtained from size distributions at each capillary volume as a function of capillary volumes. (D) Coverage of monomer and 





































































































In chapter 4.3 it will be demonstrated that gelatin passivated silica capillaries 
prevent adsorption of different immunoglobulins effectively. However, upon 
electrospraying IgM through such a gelatin passivated surface it was found, 
significant adsorption, and the adsorption-desorptin pattern is also significantly 
different from a bare surface as discussed here.  Firstly no monomer or dimer of IgM 
elution for ≈ 4 capillary volumes were observed, implying that in contrast to IgG, IgM 
has a greater affinity towards gelatin and that the kin tics of adsorption is not mass 
transport limited. This was followed by a sudden increase in monomer intensity 
(Figure 4.7A) that also corresponds to the appearance of dimers. The monomer 
intensity then decreased while the dimer intensity continued to monotonically increase 
till both reach a steady state at 11 capillary volumes significantly quicker than the 
previous case with the bare capillary. During desorpti n, as shown in Figure 4.7B, the 
concentration of dimers desorbing was higher than that of monomers, and indeed 
higher than dimers desorbing from IgM adsorbed to bare silica. Figure 4.7C shows the 
integrated concentrations divided into three domains: I where initially no protein 
eluting was seen to elute, followed by preferential expulsion of monomers, domain II 
(11 capillary volume onwards) where both monomer and dimers reached a steady 
state, and domain III (53 capillary volume onwards) when the protein was replaced 
with buffer. The increase in the monomer signal early on does not show any 
concomitant temporal variation in the dimer adsorpti n in Figure 4.7C thus one may 
qualitatively argue that the dimers were not expelling the monomers. It maybe that 
higher molecular weight species such as trimers, tetramers and pentamers that were 
present in small quantities (discussed later in chapter 5, Figure 5.1) were responsible 





the “Vroman effect” after the seminal work of Vroman in 1970s when it was shown 
that low molecular weight proteins would adsorb to a surface first but would 
subsequently be displaced by high molecular weight proteins [141, 142]. It is not clear 
as to why such an adsorption pattern is not seen duri g the adsorption of IgM to bare 
silica. Qualitatively, this may be because of differ ng affinities of IgM to bare silica 
and to gelatin surfaces. 
The maximum IgM monomer and dimer coverages are determined to be 0.49 ± 0.07 
mg/m2 and 2.65 ± 0.4 mg/m2 respectively, which is about a factor of five (for 
monomer) and two (for dimer) smaller than on a bare c pillary.  The amount of IgM 
monomers and dimers desorbed are 0.28 ± 0.2 mg/m2 and 0.39 ± 0.1 mg/m2, 
respectively, i.e. 57% of monomers and 17% of dimers. Thus it is found that IgM 
adsorption on a gelatin surface is significantly lower compared to a bare silica surface 
and desorption of both monomers and dimers is significa tly increased.  
There appear to be three major similarities for IgM adsorption to bare silica 
and gelatin coated silica: a) The amount of dimers adsorbed in both the cases is higher 
than monomers as seen in Figures 4.6D and 4.7D. This is not surprising since the 
dimer would have nominally twice as many antigen binding sites, b) the monomer and 
dimer mobilities sizes obtained during desorption are invariant of the two surfaces 
which may either imply that the two surfaces do not cause a significant change in the 
protein at least within the uncertainty of the instrument which in this regard is about ~ 
0.3 nm [15, 143], or that once the proteins desorb from the surfaces they return to 
their native state and c) the total protein eluting out is the same irrespective of the 
surface. The third similarity has an important consequence as discussed here. If IgM 
adsorption to bare silica and gelatin passivated surfaces would have continued, then 





distributions and not “equilibrium” size distributions. Because, these gas phase size 
distributions are same (implying the protein eluting s the same irrespective of surface 
type), thus it is likely, that IgM adsorption reached the same steady state for both the 
surfaces. Thus in all likelihood the recovery of the protein from both the surfaces is 
100% and thus “steady state” corresponds to “equilibrium”. 
It has been qualitatively pointed out earlier, by comparing Figure 4.6B against 
4.6A that dimers have a lower propensity to desorb from the surface. This can further 
be quantified and explored if one were to assume desorption to be a first order 
process, using the monomer and dimer concentration decay as a function of time 
during the buffer flush. The detailed analysis as provided above yields desorption rate 
constants for IgM monomer and dimer of 0.005 ± 0.001 min-1 and 0.0011 ± 0.0002 
min-1, respectively, from gelatin surface. On the other and for IgM desorption from 
bare silica is 0.004 ± 0.0025 min-1 and 0.00035 ± 0.00007 min-1 for monomers and 
dimers respectively. These values are well within te wide range of desorption rate 
constants (≈10-4 min-1 to ≈1 min-1) found in the literature [120, 144-146]. Clearly, 
there are two important inferences: the monomer desorbs faster than the dimer for 
both surfaces, and the propensity for both the monoers and dimers of IgM to stay 






Figure 4.7 (A) Size distributions of monomers and dimers of IgM as a function of capillary volumes during adsorption on a gelatin 
coated capillary surface. (B) Size distributions of monomers and dimers of IgM as a function of capillry volumes during desorption 
from the same gelatin coated capillary. (C) Integration of the monomer and dimer peaks obtained from size distributions at each capillary 
volume as a function of capillary volumes. (D) Coverage of monomer and dimers of IgM at the same conditi s as a function of 

































































































By selecting a multioligomeric protein, it was demonstrated that ES-DMA can quantify 
protein-adsorption for heterogenous protein mixtures. For IgM adsorption to bare silica it 
was found that IgM dimers a) adsorb at a rate faster than IgM monomers and b) have a 
lesser propensity to desorb compared to IgM monomers. Further, changing the nature of 
the ES surface showed significant variation of adsorpti n-desorption trends. For gelatin 
passivated surface it was found that Vroman effect was observed. For both the surface 
types, the desorption rate constants are consistent with literature at low shear implying 
shear does not affect the rate of desorption. 
4.3 Influence of protein adsorption-desorption to aggregate distribution 
4.3.1 Introduction 
One potentially confounding effect in accurately measuring the size distribution 
of protein oligomers by ES-DMA is the adsorption of the protein to the bare silica 
capillary. As demonstrated in the last two sections a d previously in literature [19, 30] 
there is compelling evidence that proteinds adsorb t  the glass capillary wall. To 
minimize these effects and for studies were aggregates were quantified measurements of 
protein size distributions were considered only after the adsorption-desorption process 
had reached steady-state. However, in these studies, it was assumed that the proteins 
desorbing from the capillary walls did not influenc the size distributions. Recent 
evidence suggests that proteins adsorbed to surfaces aggregate [147, 148]. Since these 





proteins may impact size distributions obtained with ES-DMA, an aspect that has never 
been studied before. 
To understand the effect of adsorbed proteins that desorb, the following approach 
is taken: Experiment I, involves obtaining size distributions of a protein, denoted A, as a 
function of time until the measured protein monomer signal reaches steady state (which is 
reached once the surface is saturated with protein A). In experiment II, another protein, 
denoted B, is used as a blocking agent for passivating  fresh silica capillary until surface 
saturation. In this case, the size distribution of pr tein B is obtained again as a function of 
time as in experiment I. The amount of protein B adsorbed on the surface can be 
estimated from the time taken for protein B’s size distributions to reach steady state and 
by correlating the gas phase counts obtained with the known liquid phase concentration 
of this protein at steady state. This determination is described in greater details in chapter 
4.1. In experiment III, protein A is electrosprayed through the capillary passivated with B 
and size distribution of A and its oligomers are measured and compared to results of the 






Figure 4.8: Approach taken to study the affect of aggregate distribution as a function of 
surface passivation.  
 
In this section, the size distributions of four different proteins, bovine serum 
albumin (BSA), polyclonal human immunoglobulin (hIgG), monoclonal human 
immunoglobulin (RmAb), bovine immunoglobulin M (IgM) are obtained with ES-DMA 
using bare and passivated capillaries thus allowing a systematic comparison of the effect 
of capillary passivation on the quantification of monomers and aggregates of proteins. 
For surface passivation  BSA [149-153] and gelatin [154, 155] were used  as blocking 
agents, each of which can form monolayers or multiple layers on a surface and hence 































End of Experiment II: Quantify coverage of protein B on silica surface
Experiment III
End of Experiment III : Quantify proportion of monomers, dimers etc of protein A
Bare silica passivated
with protein B






4.3.2 Materials and Methods 
 The sample preparation for this samples are already described in sections 4.1 and 
4.2. It should be pointed out that in all subsequent experiments in this chapter, upon 
insertion of the different samples into the ES, onewould need to wait about 4 minutes 
before starting to collect the data, since it would take a finite amount of time for any 
sample to traverse the full length of the capillary, different tubings and the DMA to 
eventually reach the CPC. Thus time t = 0 minutes refers to 4 minutes after sample 
insertion. The total monomer, dimer and trimer counts of the proteins were obtained by 
integrating the size distributions from 8 nm to 9.4nm, 9.6 nm to 11.4 nm, 11.6 nm to 
12.8 nm for RmAb and hIgG, 6 nm to 7.6 nm, 8 nm to 9.2 nm and from 9.4 nm to 10.2 
nm for BSA, and 14.4 nm to 16.4 nm, 18.2 nm to 20.4 nm and 20.6 nm to 22.8 nm for 
IgM. 
4.3.3 Results and Discussion 
4.3.3.1 Adsorption of BSA to passivate capillaries 
Sections 4.3.3.1 and 4.3.3.2 describe results corresponding to experiment II of Figure 4.8, 
where BSA and gelatin are used to passivate the capillary surface.  
 BSA has been widely used as a blocking agent to limit non-specific adsorption of 
proteins [149-153].  In this section, the protocol for passivating the ES capillaries with 
BSA  is described at pH conditions close to its isoelectric point (pI) of 4.8 [156]. At 
neutral conditions no significant variation in the size distribution was observed as a 





ES-DMA offers the opportunity to quantify the amount of BSA adsorbed as 
already described in Chapter 4.1.  For BSA passivation, ≈ 0.05 mg/mL of BSA at pH 4.8 
is electrosprayed for 1 hour (or approximately 32 capillary volumes) through a new 
capillary after its surface has been cleaned following the procedure outlined in Section 
2.2. In Figure 4.9A, no elution from the capillary is observed for the first 16 capillary 
volumes, after which the monomer and dimer counts icrease monotonically and reach 
steady state at ≈ 27 capillary volumes. The Y-axis has been offset slightly to show that 
BSA is not eluting at 16 capillary volumes. After about 60 minutes (32 capillary 
volumes) the protein sample was replaced with 20 mmol/L ammonium acetate at pH 7.0 
and the capillary flushed using this buffer while simultaneously monitoring the size 
distribution. Figure 4.9B displays mobility spectra during the flushing phase showing that 
the mobility size of monomers and dimers remained unchanged and that there was a 
monotonic decrease in the number density of desorbing monomers and dimers.  
Figure 4.9C shows the resulting calculated coverage of the BSA as a function of 
time. Region I in Figure 4.9C, corresponds to when there was no protein eluting, 
(represented by the dotted line), region II corresponds to when the protein was first 
observed eluting, and the concentration continued to increase, region III corresponds to 
steady state, and region IV corresponds to when the prot in was replaced with the pH 7.0 
buffer. The dotted line represents when no protein is eluting. The monomer, dimer and 
trimer peaks for each protein are assigned and labeled 1, 2 and 3, respectively, based on 







Figure 4.9: (A) Size distributions of monomers, dimers, and traces of trimers (not evident 
from this figure) of BSA eluting through the capillary as a function of capillary volumes. 
(B) Size distribution of the desorbing species as afunction of capillary volumes when the 
protein sample is replaced with buffer. (C) Coverag of BSA adsorbed and desorbed as a 
function of capillary volumes.  
 
The calculated coverage at steady state is determind to be 5.4 mg/m2 (region III). 
Assuming that BSA is spherical and using the measured diameter of 6.6 nm obtained by 
the ES-DMA, then the theoretical coverage of a monolayer is 3.2 mg/m2, which suggests 
that adsorption is multilayered. Such a multilayered adsorption scheme can be explained 
as follows [157]: first a layer of protein adsorbs to the surface and denatures, this 






























































































attracts a second layer of protein; as the layers build on top of each other, the interaction 
in between successive upper layers progressively weaken (as the extent of denaturation 
and exposure of hydrophobic residues are reduced) an  thus protein adsorption 
eventually stops.  The coverage obtained here falls within the range of previous studies of 
BSA adsorption under a variety of conditions where r ported coverage values range from 
1.2 mg/m2 to 10 mg/m2 [158-162]. After ≈ 30 capillary volumes of flushing, the amount 
of BSA remaining on the surface is estimated to be ≈ 2.8 mg/m2, which is close to the 
theoretical coverage of 3.2 mg/m2 for a monolayer. 
4.3.3.2 Adsorption of Gelatin to passivate capillaries 
In this section gelatin adsorption is quantified using ES-DMA.  The use of gelatin 
layers to passivate surfaces against protein adsorption has been previously reported [154, 
155]. In the current study, gelatin was deposited on glass capillary surfaces by 
electrospraying ≈ 31 capillary volumes of a gelatin solution through a freshly prepared 
capillary. The passivation process was also assessed using the DMA. Figure 4.10A shows 
the mobility distribution as a function of capillary volumes during the passivation. The 
size distributions are clearly wider than for the other proteins in this paper, and reflect the 
heterogeneity of gelatin. If the peak mobility is assumed to be 7 nm (Figure 4.10A), and 
assuming the protein to be an equivalent sphere, the theoretical maximum surface 







Figure 4.10: (A) Mobility distribution of 0.10 mg/mL gelatin in 20 mmol/L ammonium 
acetate at pH7. (B) The coverage of gelatin on fused silica as a function of time.  
 
 As described above for BSA, one can estimate the surface coverage of gelatin by 
monitoring the time course evolution of the gelatin signal.  Figure 4.10B plots the 
experimentally determined surface coverage as a function of capillary volume for a 
gelatin solution concentration of 0.1 mg/ml. Little g latin is observed initially (upto 5 
capillary volumes, domain I). Then the gelatin signal gradually increases and eventually 
reaches steady state (5 to 20 capillary volumes, domain II), after which there is no 
significant variation in the size distribution (within experimental variability) as shown in 
Figure 4.10A (domain III). At steady state the gelatin surface coverage is estimated to be 
4.2 mg/m2, which considering the theoretical estimate of 3.0mg/m2 for monolayer 
coverage, suggests a multilayer gelatin coating.  The value of 4.2 mg/m2 is comparable to 
coverages obtained for gelatin under different conditions using surface force apparatus, 
calorimetry and ellipsometry on different types of surfaces [163-167].  An interesting 
feature of gelatin adsorption is that it appears to be largely irreversible, because little 
























































not shown). It has been suggested that gelatin’s strong interaction with surfaces may be 
due to its ability to form a gel at room temperature by physical entanglement [168].  This 
behavior is in contrast to the other proteins examined (BSA, RmAb, hIgG and IgM) all of 
which show significant desorption from unpassivated (i.e. bare) capillaries. 
4.3.3.3 Effect of size distribution on passivated, partially passivated and unpassivated 
capillaries  
 For bare silica, i.e., for unpassivated surfaces it takes several capillary volumes 
(10 to 30) for BSA, hIgG, RmAb and IgM size distributions to reach steady state. When a 
capillary is passivated with BSA the number of capill ry volumes to reach steady state is 
reduced for hIgG, RmAb and IgM (5 to 20 capillary volumes). Although passivation by 
BSA reduces adsorption of these proteins, some nonspecific adsorption still occurs 
suggesting protein adsorption to the pre-adsorbed BSA layer thus a BSA passivated 
capillary will act as a partially passivated surface for hIgG, RmAb and IgM. In contrast, 
for a capillary passivated with gelatin, it is observed that hIgG and RmAb size 
distributions reach steady state immediately, while BSA and IgM take time before 
reaching steady state (5 to 10 capillary volumes). Therefore, one can conclude that the 
gelatin passivated capillary nearly completely prevents nonspecific adsorption of hIgG 
and RmAb, while less so for BSA and IgM, i.e. a gelatin passivated capillary is a 
completely passivated surface for hIgG and RmAb and a partially passivated surface for 
BSA and IgM.  
 Because the size distributions of RmAb, hIgG, IgM and BSA were obtained at 
steady state for unpassivated and gelatin passivated c pillaries, and for RmAb, hIgG and 





effect of capillary passivation on size distributions can be assessed, i.e. one can compare 
size distributions obtained in experiment I (Figure 4.8) with those obtained in experiment 
III (Figure 4.8).  Figure 4.11 plots dimer/monomer and trimer/monomer peak area ratios 
for steady state conditions for unpassivated, BSA passivated, and gel passivated 
capillaries. The uncertainties are from measurements made in triplicates. The different 
surfaces appear to have no effect on the observed dimer/monomer and trimer/monomer 
ratio. Thus, one can conclude that for the proteins a d the capillary surface passivation 
conditions examined here, surface passivation does n t alter size distributions measured 
under steady state condition relative to that obtained using a bare glass capillary (i.e. 
unpassivated capillary).It should be pointed out that t e dimer and trimers seen in these 
size distributions may not necessarily be intrinsic solution aggregates, as a portion of it 
may get created by the artificial induction of two or more monomers in the same ES 
droplet, which is also refered to as “droplet induced aggregation” which will be discussed 
in the next chapter. This is especially true for RmAb and hIgG as has been demonstrated 
later. However, in this section the objective is to systematically studying the difference in 
the distributions before and after passivation. If there was any difference in instrinsic 
aggregates because of desorbing proteins from unpassivated surfaces, then one would 
have also seen a difference in the observed distributions as well. The fact that such a 
difference in aggregate distribution is not seen for different proteins using passivated and 
unpassivated surfaces implies that the intrinsic solution aggregate proportions for the 






Figure 4.11: (A) Dimer to monomer and (B) trimer to monomer ratios of four different 
proteins on unpassivated, gelatin passivated and BSA passivated surfaces.  
 
It should be noted that RmAb and hIgG were observed to elute nearly 
immediately at several different concentrations from gelatin passivated capillaries 
implying little or no adsorption. These results indicate that protein recovery from a 
gelatin passivated surface is nearly ≈ 100 %. With an unpassivated or partially passivated 
surface the eluting monomer, dimer and trimer counts of proteins at steady state are 
found to be equal (within experimental variability) o the respective counts from a gelatin 
passivated surface or in other words steady state in an unpassivated surface also 
corresponds to equilibrium.   
There could be several possible scenarios for which unpassivated or partially 
passivated capillaries do not influence the size distributions. Proteins could be desorbing 
either as monomers or aggregates such as dimers, trimers etc., and could be desorbing in 
their native form or in denatured state [129, 130, 162]. Careful analysis of the mobility 
spectra between the desorption and adsorption experiments for all proteins indicate no 






















































level of the instrument resolution, 0.3 nm in mobility diameter [15, 143], there is no 
discernable changes in protein onformation. Further t  desorbing species were primarily 
monomers. This could either mean the proteins on the surface of the capillary elute as 
monomers or as dimers or larger aggregates that then dissociate to form monomers 
during passage through the capillary or the larger a gregates are irreversibly bound to the 
ES capillary surface and do not desorb at all. Given that the upper limit of the DMA 
range in its current configuration is 80 nm and that t e lower limit of detection is 109 
particles/mL, it is also possible that large aggregat s at low concentration desorb from the 
surface and pass undetected as well. Irrespective of the mechanism of desorption and the 
sizes of the desorbing aggregates, it is evident tha e desorbing proteins do not 
influence the aggregate distribution. 
4.3.3.4 Efficacy of gelatin passivation in repelling different protein monomers 
The strong passivating behavior of gelatin against RmAb and hIgG and the limits 
of the time resolution of the experiments conducted h re precludes one from determining 
if any adsorption at all is taking place; however, one can perform desorption 
measurements to estimate the efficacy of passivation.  In these experiments, protein is 
flowed through the capillary until the size distribution reaches steady state and then the 
capillary (unpassivated and gelatin passivated) is flushed with 20 mmol/L ammonium 
acetate buffer at pH 7.0. The temporal data for monomer desorption are presented in 
Figure 4.12 for both unpassivated and gelatin passiv ted surfaces.  
It is evident from Figure 4.12, that desorption of monomers observed from 
unpassivated capillaries is significantly higher than that seen for gelatin passivated 











=      (4.16) 
where Monomerpassivated and Monomerunpassivated are the desorbed total monomer counts 
from passivated and unpassivated capillaries at a time of when the buffer starts to elute 
(at 0 capillary volumes). A value of unity would then imply a perfectly passivating 
coating or proteins that are adsorbed irreversibly. For Figures 4.12A and 4.12B, data 
collection for the desorbing RmAb and hIgG from gelatin passivated surfaces were 
stopped after approximately ≈ 3 to 5 capillary volumes, since the amount of proteins 
desorbing by then was too little to be quantifiable with the ES-DMA.  
Table 4.2 presents the coating efficacy parameter,η, of gelatin for the proteins 
studied. The gelatin passivation seems to be especially effective in reducing adsorption of 
antibodies hIgG and RmAb. Gelatin has an isoelectric po nt (pI) of 4.7 to 5.3 [169] which 
is close to the pI of BSA (pH 4.8). At pH 7.0, both proteins are negatively charged and 
yet they show a propensity to adsorb, implying thatBSA’s affinity towards gelatin results 
from hydrophobic interactions [113, 156]. On the other hand, hIgG (pI 6.3-9.3) and 
RmAb (pI 8.5) are fairly neutral or positively charged at pH 7.0, and yet, gelatin which is 
negatively charged at this pH, repels both the immunoglobulins, the reasons for which are 
not clear. The pI of the IgM used here is unknown, so it was not possible to determine if 
the enhanced affinity is due to electrostatic effects or simply because IgM is ≈ five times 






Figure 4.12: Desorption of monomers of RmAb (A), hIgG (B), IgM (C) and BSA (D) for 
the gelatin passivated (solid circle, dotted line) and unpassivated capillaries (open square, 
solid line) at pH 7.0. 
 
Table 4.2. Comparison of efficacy of gelatin passivation for each of proteins 
Proteins η 
BSA  0.57 
hIgG  0.95 
RmAb  0.93 










































































































4.3.3.5 Stability of gelatin passivation 
The stability of gelatin passivation over three days was studied by electrospraying 
RmAb at 0.1 mg/mL at different times. It was found that the size distribution of RmAb 
reached steady state almost immediately upon sample introduction, indicating that the 
gelatin passivation was still intact. 
Buffers at pH 2.1 to pH 9.0 were flowed through theES and size distributions 
obtained with ES-DMA to determine if gelatin was desorbing from gelatin passivated 
capillaries. No evidence of gelatin desorption was found from pH 4.8 to pH 9.0 although 
the passivation became unstable under acidic conditi s (pH 2.1) and gelatin elution was 
detected by ES-DMA. Unfortunately gelatin desorption at pH 2.1 could not be quantified 
directly because the “Taylor cone” at the ES capillry tip was unstable at this pH for an 
initial period of time, which likely resulted from significant desorption of gelatin.  In 
addition, when RmAb solution (0.1 mg/mL solution, 20 mmoL/L ammonium acetate at 
pH 7.0) was flowed through a gelatin passivated capillary previously flushed with buffer 
at pH 2.1 for one hour a significant amount of RmAb was found to adsorb with an 
estimated coverage of ≈ 2.0 mg/m2. A coverage of ≈ 3.4 mg/m2 for RmAb on a 
unpassivated glass capillary surface was previously determined using ES-DMA (Chapter 
4.1). Thus, it is evident that acid treatment leads to a capillary surface with some exposed 
silica that act as sites for RmAb adsorption.  
4.3.4 Summary 
In this section size distributions of four proteins were systematically compared 
using passivated and unpassivated capillaries at ste dy state and it was found that size 





for the proteins examined in this study, protein adsorption does not influence aggregate 
distributions measured at steady state by ES-DMA. Although, size distributions of 
different proteins in this study were obtained using differential mobility analyzer, these 
findings apply to other techniques that use ES for aerosolization of proteins as well (e.g. 
mass spectrometry). A simple method of passivating capillaries with BSA and gelatin 
was presented a coverages of these proteins onto ES capillaries were also quantified in 
situ using the ES-DMA. Although in the ES-mass spectrometry community it is fairly 
common to passivate capillaries with polyethylene glycols (PEGs) [48] this is the first 
time that passivation for ES-DMA has been systematically explored. It was also found 
that gelatin passivated capillaries are effective in reducing non-specific adsorption of 
immunoglobulins and are stable upto about 3 days within a pH range of 4.8 to 9.0 
although gelatin desorption was observed at low pH (≈ 2.1). In this regard, PEGylation of 
ES capillaries (data not shown) with 5 kDa and 20 kDa silane PEGs was also undertaken 
but it was found that gelatin performs significantly better compared to these PEGs. In the 
future, the coating efficiency of gelatin (or other PEGs or proteins) against several other 
proteins can also be studied following the above approach.  
4.4. Protein Adsorption based Characterization: Preliminary results 
4.4.1 Introduction 
 In the above sections it was shown that several proteins tend to adsorb to the ES 
silica capillary. For a monomeric protein with high concentration disseminating the size 
distribution can often be problematic as the same ES droplet can harbor multiple 
monomers as will be demonstrated in the next chapter. To add further complexity to this 





proteins may also get encapsulated in the same droplet. Figure 4.13 below demonstrates 
this problem. Say there is a solution with a heterog neous mixture of three proteins X, Y 
and Z. While randomly sampling with ES two monomers of ay Protein X or Y or Z may 
get into the same droplet. If the concentration of all the heterogeneous proteins is known 
Poisson statistics can be employed to correct for this artifact. This is going to be 
discussed in further detail in the next chapter. However, in real protein systems, like cell 
extracts, the concentration of the different mixtures is often very high and unknown. 
Under such a scenario making sense of the size distribution obtained can be extremely 
difficult. One approach to overcome this problem is to intentionally adsorb the proteins to 
the ES columns and then characterize them during desorption as demonstrated below. 
 
Figure 4.13: (A) A colloidal solution with heterogenous mixture of Protein X, Y and Z. 












4.4.2 Materials and Methods 
Lyophilized Amelotin (Am) (concentration labeled 0.8 mg) was suspended in 800 
µL of 20 mmol/L ammonium actetate at pH 7.0 which produced a 1 mg/mL 
concentration in solution.  It was then diluted 10 times in the same buffer to obtain 0.1 
mg/mL sample concentration. A typical experiment conducted would be as follows: after 
incubating the ES capillary for ~ 1 hour with the above sample, size distributions would 
be obtained multiple times to ensure that protein adsorption had reached steady state. 
Then the sample was replaced with 20 mmol/L ammonium acetate buffer and size 
distributions were obtained every 6 minutes for theprotein desorbing from the ES 
capillary. 
4.4.3 Results and Discussion 
 
Figure 4.14: (A) Size distribution of 0.1 mg/mL of Am. (B) Size distribution of the same 
sample during desorption. 
 
 Figure 4.14A shows the size distribution of the Am sample at 0.1 mg/mL 
concentration after steady state. The Am protein has a molecular weight of 25 kDa and 
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the monomers, the sample was also expected to have larger aggregates although it was 
not clear what the size of these aggregates would be. Because of the situation explained 
in Figure 4.13, it was not possible to definitively characterize the sample based on the 
above size distribution. Instead desorption studies w re performed. Figure 4.14B shows 
the size distribution of the Am desorbing from the ES capillary upon eluting buffer 
through it. It shows four different peaks. The first peak at size < 4 nm appears to decrease 
quickly as a function of time implying this species has a low binding strength to the ES 
silica surface. As its size corresponds to < 20 kDa which is smaller than the Am 
monomer thus this species is probably smaller protein fragments. The second peak at ~ 5 
nm corresponds to the monomer of Am. Two more peaks are identified at ~ 7 nm and ~ 
8.5 nm that correspond to the trimers and tetramers of Am.  
4.4.4 Summary 
 Based on the example demonstrated above, it is evident that ES-DMA can be used 
for highly heterogeneous samples or for sample withhig  concentrations of proteins by 
first intentionally adsorbing the proteins to the ES silica capillary and then characterizing 
them while flushing buffer through the capillary. It should be pointed out that such a 
study intrinsically assumes that the monomers and lrger aggregates do not aggregate or 
dis-aggregate upon adsorption or during desorption  or from the surface. The 
experiments shown in this section were exploratory and further experiments need to be 







Chapter 5: ES ARTIFACTS: DROPLET INDUCED 
AGGREGATION 
5.1 Introduction 
Although the ES-DMA was primarily developed for size characterization, given 
the correlation between liquid phase and gas phase, it can also be used for quantification 
of bionanoparticles as discussed in chapter 3. Of the several classes of bionanoparticles, 
quantification of protein aggregates is perhaps of m st importance (chapter 3). A concern 
that has only been previously superficially addressed by ES-DMA users is whether the 
oligomer (or otherwise referred to as aggregate) distributions observed by ES-DMA 
reflects what is nascent to the liquid solution sampled, or is the analyzed oligomers an 
artifact of the ES process. It is reasonable to imag ne a situation in which during random 
sampling two or more analyte bionanoparticles occupy a volume encompassing what 
becomes an electrosprayed droplet (Figure 5.1). In this regard it should be pointed out 
that particles in liquid follow a Poisson distribution. Eventually as the ES droplet dries 
up, two or more of these particles would cluster toge her and would be detected as dimer 
or trimers by the DMA. As these dimers and trimers were not originally existing in the 
solution hence they are then artificially induced. In the rest of this dissertation this artifact 






Figure 5.1: (A) Distribution of particles in a collidal solution (B) Electrospray sampling 
may create artificially induced dimers or larger aggregates. 
 
Lenggoro et al. [170] and Pease t al. [19] used a semi-quantitative equation to 
provide an upper workable concentration above which the artifact described in Figure 5.1 
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Such an approach has some disadvantages. Firstly, it relies on total protein concentration 
of the sample. If the intrinsic aggregate (say dimers and above) population was more, 
then this effect would be considerably less. This will become evident from the examples 
provided in subsequent sections. Secondly, as it is an inequality it is only semi-
quantitative. Thirdly, it also poses a limit to the upper range of concentration of 
bionanoparticles. For example, for an ES droplet size of 140 nm the particle 





concentration has to be < 7×1014 particles/mL. In real cases, especially in the biopharma 
industry the protein concentrations range in ~ 1015 - 1016 particles/mL or more. 
 
This chapter is devoted to discussing an experimentally verified theory that will 
enable one to distinguish ES induced aggregates from intrinsic aggregates. This theory 
will eventually be applied in subsequent chapters as and when necessary. 
5.2 Materials and Methods 
5.2.1 Analytical Ultracentrifugation 
In the process of establishing the theory in context of ES-DMA, it would be necessary to 
validate it using at least one independent technique. In this study such a validation was 
performed using AUC. AUC is a versatile tool for determining hydrodynamic and 
thermodynamic properties of proteins [5]. AUC allows direct observation of 
sedimentation dynamics of proteins in solutions under the influence of centrifugal field 
without interaction with any substrate or matrix. The centrifugal force causes the 
depletion of protein particles at the meniscus and thus the concentration boundary moves 
towards the bottom with time. The material boundary position is recorded via absorbance 
measurement at regular radial intervals and time points within the sector shaped cell. The 
sedimentation coefficient for a macromolecule is related to molecular parameters via the 
Svedberg equation and thus size distributions can be obtained. AUC measurements were 
made using Beckman-Coulter XL-I Proteomelab (Brea, CA).  The temperature of the 
centrifuge chamber was equilibrated to 20 °C.  The ref rence cell was filled with a 
sample solution equivalent ammonium acetate buffer of matching molarity. 400 µL 





(3142.857 rad/s). Radial absorption measurements were recorded every 180 s at 280 nm 
wavelength with a radial position step size of 0.005 cm. The protein particles in the 
suspensions were subjected to a relative centrifugal orce (rcf, relative to gravity) ranging 
from 62384 g to 72245 g, depending on their position with respect to the rotor center in 
the sector shaped cell. The radial scans were then analyzed using the Continuous 
Sedimentation Coefficient Distribution method in SEDFIT [171, 172], fitting the baseline 
with a resolution of 200. Confidence level of 1σ was used while fitting the AUC data 
using SEDFIT. The peak values in the c(S) versus ‘S’ distributions were then converted 
to molecular weight using SEDFIT, correspondingly exhibiting the existence of 
monomers, dimers and trimers. The monomer and dimer concentrations for hIgG were 
determined by integrating from 6.3 to 7.8 Svedbergs and 9.4 Svedbergs to 11.6 
Svedbergs, respectively, while for IgM they were determined by integrating from 15.58 
to 25.12 Svedbergs and 29.15 to 42.21 Svedbergs.  
5.2.2 Sample preparation 
The methodology adopted for preparing proteins in this chapter have already been 
described in chapter 4. 
5.3 Results 
Using equation 5.1 one can ascertain the upper concentration for different 
proteins. Assuming that the ES droplet size is ~ 140 nm the corresponding upper limit of 
concentration is ~ 7×1014 particles/mL. Keeping this value in mind, one could take up 
two different examples, of 100 µg/mL hIgG (4.4×1014 particles/mL) and 100 µg/mL of 
IgM (6.4×1013particles/mL). Both these concentrations satisfy the above criterion and 





intrinsic aggregate population. Figure 5.2 compares the intrinsic dimer and monomer 
proportions obtained with ES-DMA and AUC for bovine IgM and hIgG, respectively. 
Integrating the area under the monomers and dimers using the two techniques it becomes 
evident that for IgM both techniques quantify almost the same amount of aggregates such 
that the dimer to monomer ratio is ~ 150% whereas the dimer to monomer proportions 
obtained for hIgG is ~ 35 % and ~ 10 % with ES-DMA and AUC, respectively. The 
subsequent sections describe how the differences between ES-DMA and AUC can be 
reconciled with the developed theory.  
 
Figure 5.2 (A) Size distribution of bovine IgM using ES-DMA. (B) Size distribution of 
bovine IgM using AUC. (C) Size distribution of hIgG using ES-DMA. (D) Size 





















































































































5.3.1 Intrinsic monomers 
Because the spatial distribution of analytes in soluti n is statistical, a theoretical 
treatment was developed based on probabilistic analysis. If a droplet generated at the tip 
of a capillary in ES is a random sample of the soluti n, and the particles in the solution 
areidentical and independent, the probability of k particles in a given droplet obeys a 










        (5.2)
 
where λ = VdCp, Vd is the droplet volume and Cp is the concentration of the analyte in 
solution and k is the order of aggregation. Here λ physically signifies number of particles 
per droplet. 
As mentioned previously in chapter 2 the droplet size is a function of size, i.e. it is not a 
specific value but rather a distribution, thus one ne ds to account for this distribution. For 
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Now if it is assumed that a solution only constitutes of monomers, then the Poisson 
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Assuming the average droplet volume to be ~ 140 nm, and for the known concentration 
of bovine IgM, the dimer to monomer ratio was determined to be 0.1, i.e if all particles 
were monomers there would be 5 % dimers that would be induced by the ES droplets for 
the given concentration. Because the proportion of dimers in Figure 5.2A were 
significantly greater this implies that this proporti n was intrinsic and also explains the 
reasons for similarity with AUC results. Following the same approach for hIgG, the 
dimer/monomer proportion comes out to be ~ 30% implying most dimers and droplet 
induced. Thus equation 5.6 above provides a semi-quantitative approach that helps one to 
decide how much effect “droplet induced aggregation” has. Naturally, one may wonder if 
there is a methodology that could be adopted to corre t for this artifact. This is described 
in the next section. 
5.3.2 Intrinsic monomers and dimers 
For reconciling the results obtained with ES-DMA and AUC for hIgG let it be assumed 
that there were monomers and dimers existing in the solution (based on the AUC data in 
Figure 5.2D). This is not an unreasonable assumption as AUC results in Figure 5.2B 
suggested so. 
A schematic description of how intrinsic and induced oligomers may be 
distributed within ES droplets is shown in Figure 5.3.  Consider there are Cp1 monomers 





are observed with probabilities P1, P2 and P3.  There is only one possible condition for 
observation of monomers; that is, only one monomer in a single droplet generated by ES 
has a probability of P1. For observed dimers, there are two possibilities. One is that two 
monomers are captured within a single droplet with probability P21, creating an induced 
dimer, and the other possibility is that there is one intrinsic dimer in a single droplet with 
probability P22. 
 
Figure 5.3. Physical representation of the probability distribution of induced and intrinsic 
aggregate distributions from electrospray. 
With this construct one can obtain the following two relationships: 
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Similarly for trimers, there are two situations, three monomers captured into a droplet 
with probability P31 or one monomer and one dimer captured within the same droplet 
with probability P32 as shown in Figure 5.3. Thus, 
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Likewise for tetramers, there are three situations, four monomers captured into a droplet 
with probability P41, or two dimers with the probability of P42 or two monomers and one 
dimer captured within the same droplet with probability P412. Thus, 
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Similarly for pentamers, considering probability of five pentamers, one monomer and 
two dimers or one dimer and three monomers: 
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Further now that there are monomers and dimers in solution the Poisson distribution 




















6i d pi d pi
V C D Cλ π= =        (5.12)                                                                                                             
Cpi is the number concentration of monomers in solution. 
The Poisson distributions of monomers and dimers are independent of each other. Thus: 
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Further combining 5.9, 5.13, 5.18, 5.19 and 5.20 it can be shown that: 
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Further for pentamers it can be shown following the same approach, 
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Following the same approach the proportion of larger induced aggregates can be 
determined.  
 Although this section laid down the equations thatcan be used for ascertaining the 
extent of droplet induced aggregation the next section discusses the approach that is 
required for correcting for this artifact. 
5.4 Discussion 
Although the objective of this chapter is to demonstrate and quantify droplet 
induced aggregation, it should emphasized that the methodology adapted here open up 
the avenue for measuring the absolute liquid phase number concentrations and the two 
are interlinked. A key feature of this statistical approach is that by measuring the relative 
oligomer mobility size distributions, one is able to work backwards to determine the 
absolute number concentration in solution. What is particularly attractive about this 





need for sample-specific calibration standards or detailed analysis of transport losses.  
For a solution constituting of monomers and dimers, there are many approaches one 
could take: 
Approach 1 
Recalling that in chapter 2 it was mentioned that one can use two different ES droplet 
volumes at two ES capillary pressure drops, if one were to obtain the size distribution of 
RmAb at both these capillary pressures, then one would btain equation 5.21 at both 
different pressure drops. Assuming equation 5.21 is at an arbitrary ES pressure of pES, 
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Then solving 5.21 and 5.25 simultaneously one can determine the absolute liquid phase 
number concentrations of monomers and dimers and thus determine the intrinsic 
monomer and dimer proportions. This approach will be again invoked in chapter 8 where 
Figure 5.2C and Figure 5.2D are going to be quantitatively discussed. It should be 
pointed out that this is a time consuming experiment as it needs the size distributions and 
droplet volumes to be obtained at two different dilutions.  
Approach 2 
If one were to assume that the dimers were covalent ggregates and would not be affected 
by dilution (irreversible aggregation), then one can dilute the solution to say 50% and 
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Then solving equation 5.21 and 5.26 simultaneously, Cp1 and Cp2 can be obtained. This 
also is a time consuming experiment as, like the approach 1, it needs size distributions 
and droplet volumes to be obtained at two different dilutions. 
Approach 3 
If the concentration of the solution (say by using UV-vis) is known then one can write: 
1 22p p pC C C= +            (5.27) 
Then solving equations 5.21 and 5.27 simultaneously, one can obtain Cp1 and Cp2. 
Approach 4 
The easiest approach is to combine equations 5.21 and 5.22 above simultaneously to 
obtain the intrinsic aggregates as this can be achieved by carrying out two experiments: 
one for size distribution and another for droplet volume. However, although theoretically 
possible it poses two challenges. If the concentration of the induced trimer is low then 
quantification may be inaccurate. Otherwise, if theconcentration of the solution is too 
high, then separation of trimers and larger aggregates from one another may be limited. 
This second limitation and other limitations of this mathematical approach is provided in 
detail in the next section. 
Although the same principle demonstrated in the last two sections can be applied to a 
solution with intrinsic monomers, dimers and trimers, one could imagine that the 





even more challenging because of certain experimental limitations as discussed in the 
next section. Thus developing such an approach was not been pursued.  
5.4.1 Limitations  
Although the above approach can be used for quantification of intrinsic 
aggregates or for correction of non-specific analyte aggregation, it has certain limitations 
that are mostly experimental.  
Firstly, it becomes difficult to use the above set of equations if the droplet size 
varies from one experiment to another. As the droplet size is usually determined by a 
separate experiment, any small fluctuation in the droplet size can also affect 
quantification. This is even more true for the larger induced aggregates as the dependence 
of these aggregates on the droplet size is more pronounced. For example, an uncertainty 
analysis on equation 5.22 above would show that a 10 % run to run variation in the ES 
droplet size would result in a 17% variation in the observed trimer to monomer ratio 
arbitarily assuming about 4×1014 particles/mL of monomers and 2×1013 particles/mL of 
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Secondly, the upper concentration regime would still be limited by the resolution 
of the DMA. For example, the size distribution of BSA is shown at a concentration of 0.1 
mg/mL (that corresponds to ~ 1015 particles/mL) using 2 mmol/L ammonium acetate that
generates a droplet size much larger than 140 nm at a DMA resolution of 25:1. 





5.4). For this size distribution because the separation between tetramers, pentamers and 
larger aggregates is not good, thus trying to quantify the induced aggregates would be 
difficult. Thus the resolution of the DMA also poses a restriction on the above approach 
for relatively higher concentrations of particles. 
 
Figure 5.4 Size distribution of BSA at 0.1 mg/mL using 2mmol/L ammonium acetate.  
Thirdly, this approach inherently requires induced aggregates. If the proportion of 
these induced aggregates is low or absent, then neither can one quantify the proportion of 
intrinsic aggregates nor can one use this approach for measuring the absolute number 
concentration. Often times the concentration of bionanoparticles can be low, and 
concentrating them for quantification may be undesirable. In such a case, a 
bionanoparticle can be quantified by calibrating the system with another bionanoparticle 
and then assuming the losses in the ES-DMA system to be the same for both. This 































Finally, the above analysis can be used for monodispersed samples. In several real 
applications, nanoparticles can be polydispersed and for such cases this methodology is 
difficult to implement. 
5.5 Summary 
 “Droplet induced aggregation” in the past had been tackled through semi 
quantitative approach. This chapter described how this artifact can be eliminated using 
Poisson statistics and a priori knowledge of the ES droplet size. The developed approach 
also allows one to determine the absolute liquid phase number concentration of different 
oligomers. There are certain experimental limitations to this approach that are also 
discussed in detail. In chapter 8 this methodology is going to be adopted to obtain 






Chapter 6: DMA ARTIFACTS: CONFORMATIONAL 
CHANGES OF LIGANDS UPON ADSORPTION TO 
NANOPARTICLES 
6.1 Introduction 
Gold - nanoparticles find regular use in the realm of nanotechnology because of 
its non-toxic nature, size dependent optical properties, high image contrast, high-yield 
synthesis and easiness in conjugation with other moieties for achieving desirable 
properties [173]. Amongst several moieties that are us d, conjugation with proteins is 
extremely important in the context of drug delivery. Protein adsorbed to a nanoparticle 
can act as a “corona” that then defines the identity of the nanoparticle-protein conjugate, 
allowing easy camouflaging and entry into the human body. At the later phase of its 
journey inside the body, the nanoparticle can be trigge ed to release the protein at 
affected region inside the body [174].  
Quantifying protein adsorption to different bionanoparticles is an important 
subclass of problems in the context of nanoparticles for drug delivery. The nature of the 
protein, its charge as well as the nature of the surface and its charge are important 
parameters that drive protein adsorption to bionanop rticles [173]. To gain an 
understanding of the relative importance of these factors several methods are used for 
quantification of the protein to the nanoparticles. A few techniques that are routinely used 
are: UV-vis [160], fluorescence spectroscopy [175], reflectometry [113], quartz crystal 
microbalance [176], surface plasmon resonance [177] and bicinchoninic assay [178]. As 





applications to quantifying protein adsorption to nanoparticles is electrospray-differential 
mobility analysis. Although primarily developed for measuring size of different 
bionanoparticles such as nanoparticles, viruses and proteins, it can also be used for 
quantifying ligand adsorption to another bionanoparticle. As this principle of ES-DMA is 
independent of material property hence it has been used for a variety of different 
nanoparticles [42, 65, 71, 72] that include nanoparticles-proteins, viruses-proteins, 
protein-proteins and viruses-quantum dots and is already discussed in great detail in 
Chapter 3. Thus although this chapter is going to focus only on protein adsorbing to 
nanoparticles, the principles employed here may not be limited to such a case. Keeping 
this in mind, any bionanoparticle adsorbing to an anlyte is defined as a ligand. 
 There are two different approaches that are regularly used for quantifying ligand 
adsorbed to nanoparticles as already discussed in Chapter 3. One is the area based 
approach (referred to as AB approach, henceforth, equation 3.2) and another is volume 
based approach (referred to as VB approach, henceforth, equation 3.3). Both approaches 
significantly deviate from each other. This is evident from the results assimilated in Table 
3.2 of chapter 3. One of the most significant disadvantages of both these equations is that 
it is assumed that the protein does not change in conformation upon adsorption to the 
surface. Such an assumption is highly protein specific. Whether a protein will change in 
conformation after adsorption would depend on several factors such as: size of the 
nanoparticle, type of protein and the relative charges on the protein and the surface. 
Comparing case 1 and case 2 in Figure 6.1, it is evident a situation might arise when a 
ligand adsorbs to a nanoparticle, changes its conformation and forms multiple layers. In 





equal to a single layer of protein without any signif cant conformational changes (case 1). 
Conversely, if a protein adsorbs and denatures substantially which results in a significant 
increase in the size of the conjugate, the number of ligand adsorbed per nanoparticle 
would be over predicted by ES-DMA. Secondly, mobility diameters of bionanoparticles 
determined can often be instrument specific. As the equations 3.2 and 3.3 rely on the 
mobility diameter of the ligand, any inaccurate determination of its size would also affect 
the quantification as well. 
 
Figure 6.1: Mobility increase does not take into account changes in conformation changes 
of protein upon adsorption to a nanoparticle. 
  
Thus, measuring the mass is a more accurate approach f r quantifying ligand 
adsorption using ES-DMA. As DMA cannot directly provide a measure of mass, hence it 
is necessary to invoke another gas phase technique. The technique chosen in this context 
is called aerosol particle mass analyzer (APM). APM size selects particles by the balance 
of electrical and centrifugal forces [179]. It constitutes of two concentric rods much like 
the DMA and particles are selected based on the balance of drag and electrical forces. 
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Here mparticle
 is the mass of the particle, nparticle is the charge on the particles, e is the 
elementary charge, VAPM is the corresponding APM voltage, ω is the rotations speed of 
the APM, r2 and r1 are the outer and inner radius of the APM cylinder, ra is the average of 
r1 and r2. 
 It can be easily hyphenated with DMAs to measure mass of particles preselected 
by the DMA as has been demonstrated before [78]. In pri ciple, depending on the 
resolution of the APM it can also be used to measure the mass of ligand adsorbed to 
nanoparticles and thus eliminates the shortcoming of the ES-DMA that may arise because 
of configuration changes in the protein. 
The objective of this chapter is to demonstrate that DMA-APM can be used in 
tandem to quantify ligand adsorption to nanoparticles. This is demonstrated with two 
model examples: gold nanoparticles to bovine serum albumin at variable concentrations 






6.2 Materials and Methods 
6.2.1 Sample preparation 
Thirty nanometer citrate stabilized gold nanoparticles were acquired from Ted pella 
Inc. Bovine serum albumin was acquired from Sigma Aldrich and suspended in 2 
mmol/L ammonium acetate buffer at pH 7.0 prepared by adding about 0.077 gm of 
ammonium acetate to 500 mL of deionized water and then by adding about 10 µL of 
ammonium hydroxide to adjust the pH. Subsequently BSA was added to the citrate 
stabilized gold such that the concentration of BSA would be 2 µmmol/L, 5 µmmol/L, 10 
µmmol/L, 20 µmmol/L, 50 µmmol/L and 100 µmmol/L, resp ctively. The volume of 
these samples were 500 µL. These samples are then allowed to sit at 4 0C overnight and 
then spun down for 10 minutes at 10 krpm each after which about 485 µL of the 
supernatant would be removed and replaced with 2 mmol/L ammonium acetate buffer. 
This step was subsequently repeated two times to remov  the excess protein. The 
unconjugated sample was only centrifuged once, as otherwise multiple centrifugations 
would aggregate the sample.  
About 35 µL of 60 nm polystyrene latex beads (NIST SRM 1963) were added to 965 
µL of 2 mmol/L ammonium acetate buffer to which dialyzed RmAb suspended in 2 
mmol/L ammonium acetate buffer (pH varied) would be added such that the total protein 
concentration in the solution would be 1 mg/mL. Four s ch samples were prepared at pH 
values of 5.0, 7.0, 8.5 and 9.0. The methodology adapted for dialyzing the RmAb 
samples is available elsewhere. The samples would then be allowed to incubate overnight 
at room temperature. As the density of PSL is almost equal to that of water, the excess 





proteins getting encapsulated in the same droplet with the conjugate and thus creating 
non-specific adsorption to the conjugate (as mentioned in chapter 5). This artifact is a 
function of the concentration of the free protein in solution, the ES droplet size and the 
concentrations of the conjugates in solution. By measuring the size distributions of the 
prepared samples at different dilutions no observable difference in mobility size were 
found for the PSL-RmAb conjugates implying that the effect of this artifact was 
negligible (data not shown). It should be pointed out that such an artifact was 
insignificant even more so for the Au-BSA samples as the excess protein was removed 
through centrifugation.  
6.2.2 ES-DMA-APM  
A 40 µm capillary (TSI Inc 3900126) was used in theES (TSI Inc 3480). The ES 
chamber pressure was maintained at 3.7 PSI. The aerosolized nanoparticles were carried 
from the ES towards the DMA using a supplement of 1 L/min of air and 0.2 L/min of 
CO2 (referred to as the polydispersed flow henceforth). T e DMA was operated with a 
polydispersed flow rate of 1.2 L/min and sheath flow of 3 L/min. The CPC was operated 
at a high flow mode of 1.5 L/min. A step size of 1 nm was used for obtaining each size 
distribution. The APM (Model 3600, Kanomax, Japan) was operated at 4500 RPM for all 
samples and the aerosol flow in and out of it was mintained at 1.5 L/min.  
The methodology adapted for quantification using DMA-APM is demonstrated in 
Figure 6.2 below. At first a size distribution of the bare sample (say Au or PSL) would be 
obtained by varying the DMA voltage which can be correlated to the mobility size and 
thus would give a gas phase size distribution. Then the peak mobility size of this 





Kaleidograph.  This is shown in step 1 of Figure 6.2. Then the DMA voltage would be 
fixed at the value that corresponds to the peak mobility size and the APM voltage would 
then be varied at conditions mentioned above to obtain a plot of voltage versus gas phase 
concentration. This distribution would be obtained by increasing the voltage in steps of 2 
V from 8 V to 30 V for the PSL and PSL-RmAb samples and in steps of 1 V from 22 V 
to 40 V for the AuNP and AuNP-BSA samples and obtaining the gas phase counts at 
each of the voltages for about 30 to 60 s. The aerosol counts thus obtained would be first 
averaged at each respective APM voltage and thus a volt ge corresponding to mass and 
gas phase distribution would be obtained. This distribution would then be again fit 
through a Gaussian to determine the mass of the peak size. This step would then be 
repeated for the conjugates to obtain the mass of the peak size of the conjugate (Step 3). 
Then, for the known surface area of the bare nanoparticle, the coverage can be 






Figure 6.2: The different steps involved that eventually provides the number of ligands 
adsorbed/nanoparticle using a DMA-APM system. 
 
6.3 Results and Discussion 
Using the approach outlined in the previous section, the amount of protein 
adsorbed was calculated for AuNP-BSA samples as a function of increasing BSA 
concentration. The results obtained with DMA-APM are shown in Figure 6.3 below. It is 
seen that the coverage of BSA to increase with concentration. This trend has been 
consistently seen with several other proteins on different surfaces as discussed in chapter 
4.1. At low concentrations, adsorption-desorption at the nanoparticle surface reaches a 
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surface. At higher concentrations, proteins reach the surface of the nanoparticle faster 
thus allowing less time for proteins to spread. Concomitantly the nanoparticle surface 
area available for protein adsorption is more. This explains the increase in BSA 
adsorption as a function of concentration. Strikingly, the values obtained with DMA-
APM are in excellent agreement with coverages of BSA obtained on planar Au surface 
using QCM-D. This agreement of results between ES-DMA and QCM-D also implies 
that the adsorption coverage for 30 nm nanoparticle and planar Au is the same. This is 
not unreasonable as Teichroeb et al found that coverages are independent of particle size 
from ~ 30 nm onwards. 
Using the AB and VB approaches one could also determin  the coverages. Using 
either of the approaches requires the mobility diameter of BSA which can vary from 6.7 
nm to 7.1 nm [11, 180]. Assuming the later value and k owing the average mobility 
diameters of the bare nanoparticles and the conjugates llows quantification of the 
ligands and are plotted in Figure 6.3 below. Comparing the values obtained APM with 
those obtained by using equation 3.2 and 3.3 it is evident that: a) the AB approach fairs 
poorly and consistently underreports compared to VB approach and b) the volume based 
approach works fairly well at low concentrations and starts to under report the amount of 
ligand adsorbed significantly at larger concentrations of BSA. The agreement at low 
concentrations for the VB approach is probably because at lower concentrations of added 
BSA, the protein probably takes an expanded conformation closer to the assumed value 
of 7.1 nm. As already mentioned this is not surprising as others have also reported that 
different proteins can take expanded conformations at lower concentrations. As the 





conformation.  For such a case the VB approach can still be used to better fit the coverage 
obtained by DMA-APM and QCM-D by assuming a lower value of ligand diameter, 
although it would then need to be determined by other orthogonal techniques.  
 
Figure 6.3: Coverages of BSA on 30 nm AuNP as a functio  of concentration obtained 
with DMA-APM (square-black), on planar Au surface obtained with QCM-D (diamond-
red), using VB approach (circle-purple) and AB approach (triangle-green).    
 
Knowing the dimensions of BSA (5.5x5.5x9 nm3 [181]) allows one could 
estimate if the adsorption is monolayered. Depending o  side-on (foot print area 5.5x5.5 
nm2) or end-on adsorption (5.5x9 nm2) the coverage would be 2.2 mg/m2 or 3.6 mg/m2, 
respectively, under the simplest conditions (i.e. neglecting electrostatic repulsions, solute 
effects etc). As the maximum coverage lies in betwen these values, it is reasonable to 
infer that the adsorption of BSA to the Au nanoparticles is monolayered and is a 
























As a second application the coverages of RmAb on NIST SRM PSLs were also 
studied. As the pI’s can vary significantly for different IgGs, thus for conveniently 
comparing the DMA-APM data with the selected literau e, all the pH values have been 
offset with respect to the pI of the respective IgG. For example, the adsorption coverage 
of IgG 2B shown in Figure 6.4A below has an isoelectric point of ~ 5.0 and the pH values 
at which it was studied [182] were pH 4, 4.5, 5, 6, 6.5, 7 and 8 . It is offset in a way such 
that its isoelectric point appears at 0 units in Figure 6.4A below. Similarly, IgG 7B 
(mouse IgG type 1), Mab-1 (mouse IgG type 1) and RmAb (human IgG type 1) had pIs 
of ~ 5.5, ~ 5.4 and ~ 8.5, respectively. IgG 2B andIgG 7B were adsorbed to negatively 
charged 501 nm PSLs [159] and Mab-1 was adsorbed to negatively charged 297 nm PSLs 
[183]. From Figure 6.4A it is evident that the adsorpti n of RmAb reaches a maximum at 
the pI and decreases significantly away from the pI. Based on the results obtained with 
other immunoglobulins IgG 2B,  IgG 7B and Mab -1 it is evident that the dome shaped 
adsorption pattern for RmAb corroborates with studied conducted on other monoclonal 
IgGs with different techniques. Further, the adsorpti n pattern of RmAb on silica as a 
function of pH in 20 mM ammonium acetate buffer has been studied previously as 
discussed in chapter 4.1.  It is evident that amount of RmAb adsorbed to silica was 
considerably smaller in that study. Others have also reported increased adsorptions at 
lower ionic strengths [106, 112, 118]. Thus it is evid nt that the results obtained with ES-
DMA-APM is consistent with literature [113, 144, 182, 183] and implies that 
electrostatic forces (between protein-protein and protein-sorbent) play the most dominant 





Based on the dimensions of an immunoglobulin, the maxi um monolayered 
theoretical coverage that could be obtained is 3.8 mg/m2. Further, considering 
electrostatic effects, this could be as low as 2.1 mg/m2 [184].  The experimental 
maximum coverage obtained with DMA-APM is higher, suggesting multilayered 
adsorption. Quantifying the amount adsorbed with DMA-APM also enables comparisons 
with values predicted by VB and AB approaches. Consistent, with the observations 
discussed for BSA adsorbed to Au NPs, it is found the AB approach under-reports 
significantly at all pH values whereas VB appears to corroborate well with DMA-APM at 





Figure 6.4: (A) RmAb adsorbed to on negatively charged 60 nm PSL (NIST SRM 1964) 
quantified with DMA-APM (square, black) and comparisons with literature: IgG 2B 
(mouse IgG type 1) (triangle, green), IgG 7B (mouse IgG type 1) (circle, purple) and 
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different pH values obtained using DMA-APM (square-black), and predictions based on 
VB (circle-purple) and AB approach (triangle-green). 
 
It should be pointed out that the DMA-APM in the context of ligand 
quantification also has certain limitations imposed by the resolution and lower limit of 
detection of the APM.  Such examples are: a) NPs that are very heavy (say 100 nm 
AuNPs) or have a broad mass distribution for a fixed mobility size (the relative 
percentage increase in mass after protein adsorption can often be < 0.2 % which is the 
lower limit of detection for the APM), b) Bionanoparticles that are light (say 10 nm or 20 
nm PSLs or 5 nm gold nanoparticles or different protein complexes cannot be quantified 
as the mass is below the detection limit) or c) light weight polyethylene glycols and self 
assembled monolayers (as the relative increase in mass after ligand adsorption can be 
small). Such limitations can however be eliminated with higher resolution APMs. 
6.4 Summary 
 By integrating an aerosol mass analyzer with the conventional ES-DMA, a new 
methodology for quantifying ligand adsorption to bionanoparticles was developed that 
allows for accurate quantification and eliminates the intrinsic sensitivity issues with 
DMA. This also permits systematic investigations of the area based and volume based 
approaches that are available for quantification using ES-DMA. This investigation 
suggested that both volume based and area based approaches are not accurate as ligands 







Chapter 7: APPLICATIONS: VIRUSES 
7.1 Introduction 
Common tests used to identify the concentration andcomposition of viruses 
includes transmission electron microscopy (TEM), scanning electron microscope (SEM), 
analytical ultracentrifugation and dynamic light scattering. Although each of these 
methods possesses particular strengths for evaluating viral products, they all have 
disadvantages. Some of these disadvantages were alrady discussed in chapter 1. In the 
context of characterizing viruses, resolving particles that are close in size is an important 
criteria, as viral degradation often leads to mixtures of intact and partially degraded 
viruses that can differ in diameter by 10 nm or less which are difficult to distinguish with 
TEM and DLS (because of lack of contrast between the proteins and TEM grids and 
because of the intrinsic principles of operation of DLS, respectively).  
ES-DMA can be potentially used for analysis in biomanufacturing environments 
(e.g. evaluation of gene therapy produces, vaccines for routine lot release, etc.) where 
relatively concentrated solutions of particles 20 nm to 200 nm in size are measured. The 
advantages of ES-DMA for characterizing vaccines include its ability to provide a direct 
read-out of particle size distributions, to measure rapidly statistically significant 
populations of nanoparticles, and to detect changes in nanoparticle diameter as small as 
0.3 nm, far below the size of the smallest viruses [15, 143]. In addition, viruses can be 
identified based on particle size, thereby ruling out contaminating adventitious agents 
unless they are of the same size. Size measurement by ES-DMA also does not rely on 
chemical specificity between the host (say a bacteria) and the virus. Given these salient 





decision making in biomanufacturing environments. However, before ES-DMA can be 
accepted as a tool it requires to demonstrate that it meets the ICH Q2 principles first 
which is the objective of this chapter. 
7.2 Materials and Methods  
7.2.1 Test article preparation 
 Phage PP7 and its host Pseudomonas aeruginosa were obtained from the ATCC 
(Manassas, VA; accession numbers 15692-B4 and 15692).  Coliphage PR772 and host E. 
coli strain K-12 J-53-1 were obtained from the Félix d’Hérelle Reference Center for 
Bacterial Viruses (Université Laval, Québec, Canada).  These bacteriophage models were 
used instead of actual mammalian viruses because they can be easily grown to high titer 
and can be prepared and studied under BSL1 conditios.  Stocks were prepared by CsCl 
gradient ultracentrifugation methods, and live intact phages were enumerated by plaque 
assays using their respective hosts, as described els where [37, 185].  The phages were 
then dialyzed into 2.0 mmol/L ammonium acetate, pH 7.4, in preparation for the 
electrospray. Studies showed that short term storage (≈ months) in this buffer system did 
not significantly impact phage infectivity (results not shown). For PR772 the dialyzed 
sample at an initial concentration of 1.5×1012 plaque forming units/mL (pfu/mL) was 
diluted to prepare a serial dilution of 4×, 10× 50×, 500× and 5000× and have been 
henceforth referred to as PR772a, PR772b, PR772c, PR772d and PR772e, respectively. 
For PP7, dialysis a parent stock resulted in an initial concentration of 2.5×1013pfu/mL. 
Then a fifty times dilution from the above stock was prepared from which serial dilutions 
of 2×, 5×, 50×, 500× and 1000× were prepared and have been henceforth referred to as 





Analysis in this chapter was limited to viral particles in solutions in which 
nonvolatile salts, surfactants, or other materials present in formulation buffers had largely 
been removed. The presence of these species were found to cause clogging of 
electrospray capillaries, destabilizating the electrospray and resulting in noisy size 
distributions. Other factors that affect the stability of the electrospray include capillary 
diameter, ionic strength outside of a specific conductivity window, and protein or buffer 
species that affect the surface tension. 
To create partially degraded test samples, dialyzed PR772 and PP7 samples were 
placed in 1.5 mL protein low binding centrifuge vials (Eppendorf North, Westbury, NY, 
USA, #022431081) and heated using a BLOK heater (Labline Instruments Inc, Melrose 
Park, IL, USA, #2003) to temperatures from 50 oC to 80 oC. The samples were heated 
within 2 minutes to the desired temperature, and maintained within ± 1.0 oC as measured 
by a type K thermocouple (Omega, Stamford, Connecticut, USA) inserted directly into 
sample vials via holes punctured through their caps. After 30 minutes the samples were 
removed from the BLOK heater. Control samples for comparison were held at ambient 
temperature (25 oC) for 30 minutes. 
For infectivity assays, dilutions of the virus stocks and heat treated samples were 
prepared and added to mid-log-phase host and liquefied top agar, which was spread over 
tryptic soy agar plates. 
7.2.2 Buffer Preparation 
The protocol for buffer preparation for ES-DMA was same as that already 





7.2.3 Gold nanoparticles Preparation 
 For quantitative number concentration calibration f the ES-DMA, gold 
nanoparticle reference standards were used. One milliliter aliquots of as received 20 nm 
and 60 nm Ted Pella gold initially at particle conce trations of 7.0×1011 particles/mL and 
2.6×1010 particles/mL were centrifuged for 20 minutes and 10 minutes, respectively, at 
13,200 rpm which were subsequently concentrated to prepare stock concentrations of 
3.4×1012 particles/mL and 2.6×1011 particles/mL for 20 nm and 60 nm samples 
respectively. Two different sizes were selected because the sensitivity of ES-DMA 
depends on size, with sensitivity increasing with particle size. Serial dilutions of 2, 4, 8, 
16, 32, and 64 times for the 20 nm and 2, 4, 8, and 16 times for 60 nm were then prepared 
from this stock.  
7.2.4 ES-DMA operation and data analysis 
 The ES was operated under the same conditions as described in chapter 2.6. A 25 
µm capillary was used. The DMA was operated with a sheath flow of 30 L/min for PP7 
or 10 L/min for PR772. By stepping through different lectric fields, a size distribution 
was obtained, in increments of 0.2 nm. The CPC was operated in the high flow mode as 
described in chapter 2.6.   
 Gold nanoparticles (Ted Pella) prepared in ammonium acetate buffer or 60 nm 
polystyrene latex particles (NIST SRM® 1963) were used as system suitability standards 
to confirm operation of the instrumentation [15, 78143]. 
7.2.5 Gold calibration approach 
In order to correlate gas phase concentration with liquid phase, Cole et al., [39] 





determine the concentration of virus particles.  The ratio of particles in solution and 
signal intensity from the DMA gave the response function of the DMA system.  The 
response function was then used to obtain virus concentration in solution. Virus 
concentration values determined this way were found to be in good agreement with 
amino acid analysis [39].  A similar protocol was ued in this article to determine 
concentrations of PP7 and PR772.  
Two different gold nanoparticles sizes of known concentrations were selected; 
nominally 20 nm and 60 nm, to approximate particles lo e in size to PP7 and PR772.  
Serial dilutions of 20 nm citrate stabilized Ted Pella gold nanoparticles, as mentioned in 
section 2.3, were created to obtain a response function for the ES-DMA of 6.21×10-8 ± 
4.6×10-9 (particles/cm3)/(particles/mL) for PP7 where the response functio is defined as 
the ratio of the concentration measured in gas phase using ES-DMA and the actual 
particle concentration in solution. Similarly using 60 nm particles, a response function of 
9.15×10-8 ± 8.0×10-9 (particles/cm3)/(particles/mL) for PR772 was obtained. The 
difference in response functions for PP7 and PR772 was likely due to different ES-DMA 
settings and operational parameters used (e.g. particle size dependent diffusional losses).  
7.2.6 TEM Characterization 
TEM analysis employed a standard negative staining procedure performed by JFE 
Enterprise (Brookeville, MD). Briefly, a drop of 0.01% of BSA was placed on a 
formvar/carbon coated grid and wicked off with filter paper. Then 2.0 µL of the virus was 
applied on the coated grid and allowed to air-dry. The grid was washed with distilled 





grid, allowed to stain for 30 seconds, wicked off and then allowed to air dry again before 
TEM imaging. 
7.3 Results  
 Like any assay, ICH Q2 should be used to validate ES-DMA for any particular 
application, e.g., testing particle size distributions of vaccines or gene therapy vectors. 
According to ICH Q2, “the objective of validation of an analytical procedure is to 
demonstrate that it is suitable for its intended purpose.” This guidance recommends 
evaluation of a quantitative assay along seven lines of inquiry; namely specificity, 
linearity, range, accuracy, precision, robustness, sy tem suitability, limit of detection 
(LoD) and limit of quantitation (LoQ). In the remainder of this chapter, the phages were 
considered as though they were the models for industrially relevant virus preparations of 
interest and the performance of ES-DMA was evaluated s a quantitative assay relative to 
ICH Q2 criteria to measure the viral analyte present in the sample.     
7.3.1 Specificity 
Demonstration of specificity confirms the ability of an assay to distinguish the 
species of interest within a sample from extraneous material or closely related species 
such as contaminating adventitious viruses.  ICH Q2 states that specificity must “assess 
unequivocally the analyte in the presence of components … including impurities, 
degradants, matrix, etc.” [44]. 
ES-DMA can differentiate intact virus particles from impurities associated with 
degradation products, e.g., capsids that are partially or completely degraded.  To model 
such impurities, virus particles were thermally degraded for 30 minutes at temperatures 





and PP7 before and after thermal treatment (Figure 7.1).  ES-DMA size distributions for 
PR772 (Figure 7.1A) showed two peaks corresponding to degraded viruses (≈ 50nm) at 
70oC and intact viruses (≈ 60 nm) at ambient temperature and 60 oC. The full size 
distribution (Figure 7.1A) also included a third peak at ≈ 8.0 nm which was assigned to 
P3 trimers based on Bacher et al’s [11] molecular weight correlation.  Larger structures 
that were likely aggregates of the capsid proteins also appeared between 10 nm and 20 
nm and increased in intensity with increasing incubation temperatures. The specificity of 
ES-DMA was confirmed by comparing ES-DMA size distributions to TEM micrographs. 
The TEM micrographs showed a similar trend of intact particles at ambient conditions, 
partially degraded particles at 60 oC and then completely degraded particles at 70 oC with 
predominantly intact virus particles (Figure 7.1B) and degraded particles (Fig. 7.1C and 
Figure 7.1D). Some particles of size 100 nm to 200 nm were seen (Fig. 7.1D) but 
possibly were below the limit of detection of the ES-DMA, for only a few were found in 
the TEM micrographs. 
The ES-DMA size distribution of PP7 (Figure 7.1E) showed putatively intact 
virus particles (≈23 nm) and degraded capsid proteins or their aggregates at smaller sizes 
(≈10 nm) that increased in concentration with incubation temperature. Similarly, the 
TEM micrographs, at ambient conditions showed no difference from sample heated at 
60oC (Figure 7.1F); however, in contrast to ES-DMA data, there was little evidence of 
degraded capsids proteins. Nevertheless, the agreement confirmed ES-DMA’s ability to 








Figure 7.1: (A) ES-DMA size distributions for PR772 and TEM images of PR772 (B) 
untreated and heated for 30 minutes to (C) 60oC and (D) 70oC. (E) ES-DMA size 
distributions for PP7 and TEM images of PP7 (F) untreated and (G) heated for 30 
minutes to 60oC. 
  
7.3.2 Precision, Linearity and Accuracy 
The linearity, accuracy and precision of ES-DMA for measuring the concentration 
of virus particles were determined. Five different dilutions each of PP7 and PR772 were 
prepared and their concentrations were determined by a plaque-based assay and ES-
DMA. For virus particle concentration measurement, the PP7 peak included counts from 
21.0 nm through 26.8 nm and the PR772 peak included counts from 55.0 nm to 67.8 nm. 
The mean mobility diameter of PR772 and PP7 were det rmined to be 62.1 nm ± 0.4 nm 
PP7 at 25 oC
100 nm
PP7 at 60 oC
100 nm
PR772 at 25 oC
200 nm
PR772 at 60 oC
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and 23.8 ± 0.3 nm respectively for size distributions obtained in triplicate.  All linearity 
studies were performed using the same capillary to ule out any differences arising from 
different capillaries. ES-DMA gas phase number density as a function of solution 
concentration of PR772 and PP7 was plotted over a solution concentration range from 
4.48×109 particles/mL to 5.15×1012 particles/mL and 1.12×1010 particles/mL to 9.9×1012 
particles/mL for PR772 and PP7, respectively (Figure 7.2).  The linear fits were 
log10(N)=0.9774 log10(C)-5.6782 with R
2= 0.9995(denoted by long blue dash) for PR772 
and log10(N)=1.09 log10(C)-6.1662 (denoted by short purple dash) with R
2=0.9993 for 
PP7. The linear fits for 60 nm and 20 nm Au were log10(N)=0.9425 log10(C)+7.2533 with 
R2= 0.9989 and log10(N)=0.9439 log10(C)+7.4424 with R
2=0.9996 respectively.  R2 
values in excess of 0.99 for both the cases indicated that the fit was good. The error bars 
in the Figure 7.2, if not visually apparent, were smaller than the symbols and were from 
samples run in triplicate. The long (blue) and short (purple) dashed lines guide the eyes. 
ES-DMA characterizes two properties of particles: size and number concentration.  
The accuracy of ES-DMA for determination of size were stablished for spherical 
and nearly spherical particles elsewhere [15, 143]. Accuracy of ES-DMA for 
determination of concentration can be established usually by comparing results with 
another orthogonal technique although methods are not always directly comparable as 







Figure 7.2: ES-DMA aerosol number density, N, versus olution concentration, C, for 
PP7 and PR772.  
 
To relate ES-DMA counts to concentration of virus particles in solution, ES-
DMA was calibrated by analyzing gold nanoparticles of known concentration as already 
discussed. The absolute liquid phase virus concentration was also determined by ES-
DMA (column 4, Table 7.1).  Particle measurements were 11-15 fold (PR772) and 22-42 
fold (PP7) greater than their infectivity (Table 7.1), showing that these preparations were 































































PR772a 3.75×1011 471700±96400 5.15×1012 14 
PR772b 1.5×1011 154400±5100 1.69×1012 11 
PR772c 3.00×1010 38300±2300 4.18×1011 14 
PR772d 3.00×109 2504±200 4.13×1010 14 
PR772e 3.00×108 400±110 4.48×109 15 
PP7a 2.50×1011 614800±7300 9.90×1012 40 
PP7b 1.00×1011 258500±6600 4.16×1012 42 
PP7c 1.00×1010 23700±330 3.81×1011 38 
PP7d 1.00×109 1700±110 2.69×1010 27 
PP7e 5.00×108 700±20 1.12×1010 22 
*Samples run at least in duplicate 
In order to compare the inter-day precision with intra-day precision, samples 
PR772c and PP7b were measured repeatedly on an individual day to determine the 
repeatability and across several days to measure the intermediate precision. The data was 
found to fall within relatively narrow bands (Table 7.2). It was observed that for both PP7 
and PR772 the intra-day variations were smaller than e inter-day variation, as is typical 
for precision studies. The larger inter-day variation was expected because over this time 





sheath flow and the CPC) and restarted which may have c used modest differences in 
flow rates or may have affected the performance of the DMA or the CPC. In addition, the 
effect of changing capillaries was also studied, an issue addressed in greater detail in 
section 7.3.5.  














Repeatability PR772c 38300 2300 0.064 6.0 
Repeatability PP7b 269300 13500 0.050 4.8 
Intermediate precision PR772c 33270 6950 0.209 17.5 
Intermediate precision PP7b 265200 17400 0.065 5.5 
Capillary variation PR772c 29920 3200 0.107 11.0 
Capillary variation PP7b 271140 34750 0.128 13.1 
*http://www.itl.nist.gov/div898/handbook/prc/section1/prc14.htm 
** Calculations done at 90% confidence level for samples run in triplicate 
7.3.3 Detection and Quantitation Limits 
 The limits of detection and quantitation were determined using the signal-to-noise 
method indicated in ICH Q2. First, the CPC baseline was determined by electrospraying 
ammonium acetate buffer through a capillary and by o taining size distributions of this 
control buffer from 2 nm to 45 nm for PP7 or 2 nm to 75 nm for PR772.  Then, the 
baseline where PP7 (21 nm to 26.8 nm) and PR772 (55 nm to 68 nm) would appear were 





in triplicate and the uncertainty in CPC counts in the baseline was determined to be 45 
particles/cc ± 14 particles/cc and 7 particles/cc ± 2 particles/cc for the measured size 
range of PP7 and PR772, respectively (data not shown).  This then corresponded to the 
noise in gas phase.  Then by multiplying the average of the gas phase noise with the 
average response functions of 20 nm and 60 nm Au nanoparticles respectively, the 
corresponding noise in liquid phase was determined for PP7 and PR772.  Further, since 
ICH Q2 specifications for LoD require a signal-to-nise ratio of 3:1, the liquid phase 
noise was multiplied by three to obtain LoDs of 7.3×108 particles/mL for PP7 and 
2.3×108 particles/mL for PR772 respectively. Expressing these values as plaque assay 
LoDs (pfu/ml) yielded 2.3×107 pfu/mL (assuming particle:infectivity ratio of ≈ 32) and 
1.7×107 pfu/mL (assuming particle:infectivity ratio ≈ 14)  for PP7 and PR772, 
respectively.  These values were distinctly higher than the LoD of approximately 106 
infectious virus/mL determined by Hogan, et al. [14] for bacteriophage viruses although 
they did not report a baseline uncertainty.  
 The limit of quantitation (LoQ) was determined using a similar signal-to-noise 
method.  For the LoQ, all steps were similar to that described for LoD except the last one 
where the liquid phase noise in the above data was multiplied by ten instead of three as 
per ICHQ2, resulting in LoQs of 2.5×109 particles/mL and 7.5×108 particles/mL for PP7 
and PR772, respectively. Expressing the concentration in terms of pfu/mL, the LoQ were 
determined to be 7.7×107 pfu/mL and 5.6×107 pfu/mL for PP7 and PR772 respectively.  
7.3.4 Range 
 ICH Q2 also requires a determination of the dynamic range of the instrument.  





upper limit of 106 particles/cm3 (in the aerosol phase), but any highly concentrated 
solution can always be diluted to reduce the concentration to the linear region of the 
instrument.  Thus, the upper range can be defined by the highest particle titer in a test 
particle.  
7.3.5 Robustness  
For ES-DMA the primary factors that influence size and concentrations are 
ambient temperature variations; fluctuations of the gas flow in the electrospray, DMA 
and CPC; performance of the neutralizer; and variation in capillaries. ICH Q2 calls for 
investigation of such parameters under the rubric of robustness. Ambient temperature 
variations may influence the gas flows in the ES, the DMA as well as the CPC.  The 
performance of the DMA depends on the relative rates of a carrier gas in the DMA and 
the analyte carrying gas that arrives from the ES. Any changes in these flows can cause 
apparent changes in size and concentration of the particles of interest. Further, inside the 
CPC, particles are counted by condensing butanol vapors on them, which are also highly 
sensitive to temperature. Additionally, the flow rates may also vary slightly over time 
even without temperature changes. Each change may cause variation in counts and size 
obtained by ES-DMA assay over several hours on the same day or over several days as 
has been addressed under the rubric of “repeatability” and “intermediate precision”. 
Further, the neutralizing source used for charge reduction (Po – 210) had a half-life of 
138 days and produced enough alpha radiation to neutralize the ionized partices for 
several months.  Had the experiments been conducted ov r several years, the charging 
efficiency would have varied in this time frame. This would result in less singly charged 





efficiency of the neutralizer would reduce. Since all experiments were carried out in a 
time frame (seven days) much smaller than the half-life of the source, hence the source 
would not have a significant effect on the results. Capillaries in the electrospray, another 
robustness parameter, often need to be changed because of clogging from either very 
large impurities (micron sized) in the solution or from deposition of particles on the 
electrospray tip with time, which affects ES-DMA con entration measurements.  To 
study this variation, the PP7 and PR772 samples were k pt the same and size 
distributions of these samples were obtained using three different capillaries on the same 
day.  In this regard, the PP7 and PR772 samples had concentrations of 4.2×1012 
particles/mL and 4.2×1011 particles/mL, respectively. For PP7 and PR772 the mean 
diameters obtained were 23.7 nm ± 0.1 nm and 61.9 nm ± 0.3 nm in conjunction with 
linearity studies, which implied that changing the capillaries did not affect the size.  
However, concentrations determined by the ES-DMA were found to vary with change of 
capillaries (last two rows, Table 7.2). These variations were found to be comparable to 
the intermediate precision, i.e. changing capillaries on one day had as much effect as did 
other day-to-day factors (such as flow and temperature fluctuations). 
7.4. Discussion and Summary 
Manufacturers routinely characterize vaccines and gene delivery products when 
releasing lots or performing stability studies.  Determining the purity of final product and 
assessing concentration at various stages of product pro essing are of paramount interest. 
While techniques such as TEM and dynamic light scattering can be used, drawbacks 
include long analysis times (TEM), skewing of size for multimodal distributions 





characterization techniques such as antigen detection and nucleic acid detection and 
amplification are also popular but they either require specific antibodies or high 
concentrations [186].  Also, plaque-forming assays cannot distinguish between a single 
virus or an aggregate of several viruses which could potentially disassociate upon 
administration to humans and cause an over dose [187].  MS is gaining popularity for 
characterization [188], but has been primarily applied to analysis of proteins of viruses 
[189, 190] and rarely for entire capsids because of their large sizes (> 1 MDa) resulting in 
high m/z ratios [191].  But, as mentioned in chapter 3, MS spectra can be complex and 
size distributions can be difficult to interpret because of multiple charging of particles.  
In contrast, ES-DMA is a near real time method that operates at atmospheric 
pressure, and can resolve the whole size distribution from capsid proteins to the whole 
virus as has been demonstrated in section 7.3.1.  ES-DMA can achieve this objective by 
correlating identity with size.  Thomas et al., [35] has shown that the components of 
mixtures of very similar sized viruses can be distinguished based on size by ES-DMA. 
For example, they differentiated MS2 from RYMV based on a 4.3 nm size difference. 
Even though a database correlating size with identity has not yet been assembled using 
ES-DMA yet, a broad range of viruses can be distinguished based on their distinct 
mobility diameters as discussed in the introduction.   
It is possible that two or more viruses may overlap in size such as MS2 and PP7 
or HRV and GD7, making positive identification and complete discrimination difficult 
despite the subnanometer resolution of ES-DMA.  However, in the case of industrial 
virus production, risk mitigating factors, such as stock characterization and adventitious 





To make the ES-DMA conducive to biomanufacturing, ES-DMA was evaluated 
in the context of ICH Q2.  The ratio of particles/mL to pfu/mL for a given virus remained 
approximately constant as a function of decreasing virus concentration (Table 7.1).  This 
suggested that the ES-DMA behaved linearly for the concentration range examined.  
However, the ES-DMA and plaque assay data did not yield the same counts (Table 7.1), 
which implied that not all phage particles were infectious such that a direct comparison to 
infectivity data led to a 10 to 40 fold disparity in the measured values, a common 
observation in virology when comparing the infectivity assay to methods that physically 
count particles [192, 193].  This discrepancy betwen the plaque assay and the ES-DMA 
measured concentrations presumably involves several factors.  ES-DMA is a physical 
measurement and counts all virus particles whether “live” or “dead”, while the plaque 
assay is infectivity count.  To be infectious, a phage must land on the bacteria, penetrate 
the cell membrane, take over the cellular machinery, and then make copies of itself and 
finally lyse the bacteria.  Each of these processes has an efficiency of less than 100% thus 
a 1:1 particle to infectivity ratio is rarely achieved for any type of virion.  This also 
explains why the LoDs and LoQs had different limits depending on whether they were 
expressed with respect to particles/mL or pfu/mL.  The plot of linearity (Figure 7.2) 
showed that the data did not extrapolate through the origin, an observation consistent 
with that of Hogan, et al., [14] for MS2, T2, and T4 viruses suggesting possible 
variability in the plaque assay measurements or differences in depositional losses that 
arise from particles sticking to surfaces (with smaller particles showing a greater 
propensity to stick because Brownian diffusion is more) which may be size and species 





linearity at concentrations below ≈ 1010 particles/mL perhaps because of imprecision at 
the LoD. 
Concentration measurements with ES-DMA yielded an uncertainty of ≈ 10-20% 
(obtained by dividing the standard deviation with the average in Table 7.2), a value close 
to that reported in a previous study [39] and slight y lower than that of the virus 
infectivity assay, which has an uncertainty of up to ≈ 30% (unpublished observations, 
FDA). Additional advantages of ES-DMA compared to infectivity assays include faster 
analysis time (minutes compared to a day for plaque assay) and that the genetic sequence 
of the virus or a viral host is not required for analysis.    
The LoD was found to be size dependent.  As indicated by Hinds et al. [24], 
deposition losses due to particle diffusion increase strongly as the particle size decreases.   
These losses may occur in the neutralizer, DMA, entrance to the CPC, or all the 
intermediate connective tubings.  Therefore, it is unsurprising that the LoD for PP7 
would modestly exceed that for PR772 solely due to diffusion deposition losses. 
In summary, as the first step towards potential industry use and acceptance, ES-
DMA was examined as a tool for vaccine and gene therapy product characterization in 
the context of ICH Q2 guidelines. The ES-DMA characterizes both “alive” or inactivated 
viruses, potentially tracks their degradation, and can resolve aggregated species. Further 
ES-DMA is rapid, non-biologically based quantitative assay, effective for non-enveloped 
viruses, with a lower detection limit of ≈ 109 particles/mL, and was found to meet the 






CHAPTER 8: APPLICATIONS: PROTEINS 
8.1 Introduction 
Detection and characterization of protein aggregates in formulations is of prime 
importance to the biopharmaceutical industry [194-16]. A concentration-size chart 
summarizing the most commonly used methods for sizing aggregates is presented in 
Figure 8.1 [197, 198]. The solid and dashed lines represent boundaries for constant mass 
of protein particles assuming a spherical density of 1 gm/cc. 
Because protein aggregates span a wide range of sizes, and quantification of 
aggregates depends on the technique employed, there is no one analytical tool that can 
measure all classes of aggregates [3, 199, 200], and multiple methods are typically used 
for cross validation [5, 197, 199]. The objective of this paper is to evaluate electrospray – 
differential mobility analysis (ES-DMA) as another method to add to the suite of protein 
aggregate characterization tools.  
The current configuration of the ES-DMA used in this d ssertation, can characterize 
particles from approximately 3 nm up to approximately 150 nm spherical equivalent 
diameters. From prior work it has been determined that he lower limit of detection of 
ES-DMA is in picomolar range [14, 19, 30, 201]. While, the upper limit of concentration 
till recently, has been limited by the inability to differentiate between intrinsic aggregates, 
from aggregates formed from different oligomers residing in the same ES droplet,  it was 
demonstrated in chapter 5 that such an artifact can be eliminated.  As shown by Figure 
8.1, ES-DMA, size exclusion chromatography (SEC), analytical ultra-centrifugation 









Figure 8.1: The concentration and size landscape of the most popular characterization 
tools namely size exclusion chromatography (SEC), analytical ultra-centrifuge (AUC) 
and field-flow fractionation (FFF). (Adapted and modified from [198] )  
In this study using SEC with ES-DMA two proteins, a monoclonal antibody 
therapeutic of the IgG1 class, Rituxamab® (RmAb) and  polyclonal human antibody 
(hIgG) are characterized. The proteins are systematically heat stressed, to promote the 













































8.2 Sample Preparation 
8.2.1 Protein Sample Preparation 
RmAb and hIgG samples were prepared by the same procedure as outlined in 
chapter 4. All samples were subsequently diluted to concentrations of about 0.1 mg/mL 
in 20 mmol/L ammonium acetate buffer at pH 7 for analysis with ES-DMA and SEC. 
This diluted concentration was not verified by UV/vis spectrometer as it was below the 
limit of quantitation of the instrument in this chapter. Samples that were not heat treated 
were used as controls. Aggregate formation was accelerat d by subjecting samples to 70 
oC for 30, 60, 90, and 120 minutes for RmAb and for 10, 20, 30, 60, 90 and 120 minutes 
for IgG to monitor the time evolution of the aggregate formation. The heat incubated 
samples were preserved in the refrigerator at 4 oC before analysis. Because the heat 
treated samples showed evidence of large aggregates that could potentially clog up 
electrospray capillaries and size exclusion columns, hence the samples were filtered using 
0.22 µm filters (Millex GV – Catalogue #: SLGV004SL) prio to characterization.  
8.2.2 Size Exclusion Chromatography (SEC)  
SEC was performed with a Agilent 1200 system using a TSK 3000 gel filtration 
column at ambient temperature. Using 20 mmol/L ammonium acetate buffer in the SEC 
column caused the IgGs to adsorb to the SEC column and no protein would elute for 
several hours. Thus 100 mmol/L potassium  phosphate at pH 7.0 along with 300 mmol/L 
sodium chloride was used as reported in other studies [184, 202]. The injection volume 





concentration of the protein injected and recovered w re below the limit of quantitation 
of the UV/vis spectrometer used in this study hence the recovery could not be calculated 
for hIgG and RmAb. However, several steps were taken, that qualitatively suggest that 
protein adsorption (esp. the monomers) to the SEC column was low. Before running the 
actual heat treated samples for analysis the columns were pretreated with heat incubated 
samples (t = 30 minutes sample for hIgG and t = 60 minutes for RmAb) three times 
(approximately 30 minutes each). SEC chromatograms obtained for these samples did not 
show any difference from run to run. Further, after inishing all experiments for the day, 
the column would be flushed with buffer (100 mmol/L potassium  phosphate at pH 7.0 
along with 300 mmol/L sodium chloride) for 1.5 hours followed by a 10% methanol 
wash during which only nominal protein would desorb f om the column, implying 
nominal adsorption to the column. For quantitative analysis it was also assumed that the 
recovery of monomers at different incubation times stay the same for the proteins. 
The dimers and monomers were quantified by integrating from elution time of 
14.33 minutes to 20.81 minutes and 11.62 minutes to 14.32 minutes respectively. The 
fractional percentages of dimers were determined by first integrating the area under the 
monomer and dimer peaks at that particular incubation time, and then dividing dimer 
peak area by the monomer peak area at the same incubation time. The background noise 
for the SEC was determined by integrating the area under the monomer and dimer peaks 
after running 20 mmol/L ammonium acetate buffer in triplicates. The respective average 






The voltage and current measured in the ES unit were approximately in between 1.6 
kV to 1.8 kV and – 170 nA to – 180 nA, respectively, for all samples. To achieve 
sufficient resolution from the DMA, the ratio of sheath-to-aerosol flow rates within the 
DMA was set to 25, which provides a theoretical resolution of ~0.4 nm for the antibodies. 
Under these conditions, data were collected with a voltage scanning step size of 0.2 nm 
and a dwell time of 10 seconds from 2 nm to 45 nm, i.e. it would take approximately 36 
minutes to obtain each ES-DMA size distribution, comparable to SEC experiment. The 
ES capillary was passivated using gelatin following a  approach outlined in chapter 4.3. 
From the size distribution (number concentration vs. size) the area under the 
monomer, dimer, trimer, tetramer and pentamer peaks were determined by integrating 
from 7.8 nm to 9.8nm, 10.0 nm to 11.6 nm, 11.8 nm to 13.0 nm, 13.2 nm to 13.8 nm and 
14.0 nm to 14.8 nm, respectively. Oligomers were identified by an empirical correlation, 
between mobility diameter and molecular weight that is discussed in greater detail later. 
The average background noise in ES-DMA under the mono er, dimer, trimer, tetramer 
and pentamer peaks was found to be 241 particles/cm3, 125 particles/cm3, 54 
particles/cm3, 23 particles/cm3 and 18 particles/cm3 respectively. 
About 20 µLto 30 µL aliquots of samples were for used for analysis, but only 2 – 
3 µL was consumed during the course of an experiment, i.e. the sample volume 
requirement of ES-DMA is significantly less compared to SEC.   
The reader should note that the signal produced by the ES-DMA can be material 
dependent. Similar observations have been made by the mass spectrometry community 





correcting for ES artifacts) can reflect the intrinsic levels of aggregates of different 
particles in solution, or in other words, ES-DMA can be used for determining absolute 
liquid phase concentrations irrespective of material property [102, 103]. 
8.3 Results and Discussion 
8.3.1 Size distributions obtained with ES-DMA 
 Figure 8.2A shows the size distributions of the RmAb obtained by ES-DMA for 
unstressed (t= 0 minutes) sample and samples that were incubated at 70 oC for increasing 
incubation times. For peak identification the correlation from Bacher et al [11]between 
mobility size (d) and molecular weight (MW) expressd in kDa: 
2 3MW = - 22.033 + 9.83 d - 1.247d  + 0.228 d        (8.1) 
Using this correlation, the monomer, dimer, trimer, t tramer and pentamer peaks for IgG 
with a molecular weight of 150 kDa should appear at 9.3 nm, 11.7 nm, 13.4 nm, 14.7 nm 
and 15.8 nm, respectively. This correlation was specific to their experimental set-up and 
operating conditions, and can vary up to 1 nm for different DMAs [64]. In this work the 
monomer, dimer, trimer, tetramer and pentamer peak appeared at 8.8nm, 10.8nm, 
12.6nm, 13.4nm and 14.4 nm, respectively, in reasonble agreement with the predicted 
values. Pease t al. [19] have also shown that the sizes of IgG oligomers as measured by 
the ES-DMA are in excellent agreement with the structural dimensions obtained from 
protein crystallographic database. Thus oligomer peaks from ES-DMA size distributions 
can be identified with a high degree of confidence. B sides these, there are three peaks 
that are characterized at sizes 3.6 nm, 6.2 nm and 7.6 nm. The proportion of these peaks 
are insignificant (<< 1 %) compared to all other peaks and correspond to the non-volatile 





monomers of RmAb (not intrinsic to the solution, produced during neutralization in the 
gas phase), and dimers of F-ab fragments of RmAb, respectively.  
The size distributions in Figure 8.2A, show a decreasing trend for monomers 
(labeled 1), dimers (labeled 2) and trimers (labeled 3) with increasing incubation time, 
while the tetramers (labeled 4) and pentamers (labeled 5) increase initially (t = 30 
minutes and t = 60 minutes), but subsequently decrease at later times. While larger 
oligomers are clearly evident in the spectra the resolution is insufficient to make a 
definitive assignment. The maximum intensity of theaggregates for the sample incubated 
for 120 minutes appear at mobility diameter of 19 nm to 20 nm.  Assuming Bacher’s 
correlation the molecular weight at this mobility diameter corresponds to approximately 
1300 kDa to 1500 kDa i.e. the most of these aggregates are probably enneamers (9-mers) 
and decamers (10-mers) of RmAb.  
Figure 8.2B shows the size distributions for hIgG where the oligomers are again 
identified using Bacher’s correlation.  Like RmAb, the monomers (labeled 1), dimers 
(labeled 2) and trimers (labeled 3) decrease with incubation, however, unlike RmAb, the 
larger aggregates do not increase with incubation time. The size distribution also shows 
two smaller peaks (<< 1% compared to other peaks) at 6.2 nm and 7.8 nm which 
correspond to the doubly charged monomers (not intrinsic to the solution, produced 
during neutralization in the gas phase) and dimers of F-ab fragments, respectively. It is 
possible that larger aggregates of RmAb and hIgG (> 50 nm) form with increasing 
incubation time at concentrations below the limit of detection of ES-DMA.  In fact, at 
longer incubation times, visible precipitation was observed for both proteins. Flow 





ranging in size from 4 µm to 100 µm for both RmAb and hIgG (data not shown). For both 
the Figures 8.2A and 8.2B the normalization has been done with respect to the area under 
the monomer peak at t = 0 minutes. All distributions are at an ES capillary pressure drop 
of 3.7 PSI. Size distributions obtained at 3.0 PSI pressure have not been shown but show 
similar trend.  
 
 
Figure 8.2(A) Size distribution of RmAb for increasing incubation times at 70 oC. The 
inset shows a magnification of different aggregates s a function of incubation time. (B) 
Size distribution of IgG prepared at different incubation times at 70 oC.  
Because of “droplet induced aggregation” introduced in chapter 5, the data obtained 
with ES-DMA needs to be corrected. For simplicity i is being assumed that only 
monomers and dimers exist in the solution. This is a reasonable assumption based on 
previous findings using other aggregate characterization techniques [103, 184, 202] and 
by using SEC, as discussed in the next section, for IgG and RmAb. In all such cases, the 
proportion of the intrinsic trimers was negligible (< 1%).  Then equations 5.21 and 5.25 















monomer and dimer concentrations. The percentage of the intrinsic dimers determined 
following this approach is discussed later. 
The larger aggregates, as measured by the ES-DMA, are quantified and plotted as a 
percentage of all oligomers present at each incubation time in Figure 8.3 below. It is 
evident that for RmAb the proportion of tetramers and larger oligomers increases as a 
function of incubation time (Figure 8.3A) whereas for IgG the proportion remains 
constant (Figure 8.3B). The percentages have been dtermined by first integrating the 
area under the respective oligomer (trimer, tetrame and pentamer) peak at the each 
incubation time divided by the integrated area under th  monomer + 2×dimer + 3×trimer 
+ 4×tetramer + 5×pentamer peak. 
 
 
Figure 8.3 (A) Percentages of the trimers, tetramers and pentamers of RmAb and (B) IgG 








































8.3.2 SEC Chromatograms 
 
Figure 8.4 (A) Chromatograms of RmAb obtained with the SEC for heat treated samples 
at increasing incubation times at 70 oC. The inset shows a magnification of the aggregate 
region (B) Chromatograms of hIgG obtained with the SEC for heat treated samples at 
different incubation times at 70 oC.  
Figure 8.4A shows SEC chromatograms of RmAb for inceasing incubation times 
at 70 oC. In SEC larger aggregates will elute first, so the last peak is assigned to the 
monomer. Little evidence of dimers and trimers in the = 0 minutes and t = 30 minutes 
samples are seen. Larger aggregates appear after t=60 minutes that increase in intensity 
with incubation time. Figure 8.4B shows SEC chromatograms of hIgG. The mode of the 
monomer peak for both RmAb and hIgG are at approximately 16.3 minutes, but the full 
width at half max for hIgG is approximately 5.43 minutes compared to only 
approximately 1.38 minutes for RmAb implying that hIgG interacts with the SEC column 
longer. Evidence for larger aggregates are observed, for short incubation periods, but 
drop below the background after 10 min of incubation. The fact that the monomer peak is 
dropping, with no observation of higher aggregates at long incubation times would 







(dimers, trimers etc). In Figure 8.4, for both RmAb and hIgG, the acetate peak elutes first 
(before 20 minutes) in all samples and has not beenshown for clarity. Also, for both the 
plots (A) and (B) the normalization has been done with respect to the area under the 
monomer peak at t = 0 minutes. 
8.3.3 Comparison of ES-DMA with SEC 
Table 8.1, compares the dimer proportions obtained by SEC and ES-DMA (before 
and after correcting for “droplet induced aggregates”) for RmAb and hIgG. The standard 
error bars are calculated from measurements on three samples. For columns 2, 4, 5 and 7 
of Table 8.1 the dimer to monomer proportions have be n determined by dividing the 
area under dimer peaks with the area under the monoer peaks at that incubation time. 
For columns 3 and 6, the dimer to monomer ratio represents Cp2/Cp1 determined after 
using equations 5.21 and 5.25 to solve for Cp1 and Cp2 respectively. It is evident from the 
ES-DMA results that a major proportion of the dimers detected were droplet induced. 
Even after correction for “droplet induced aggregats”, it was found that ES-DMA 
indicates a higher fraction of dimers than SEC at t = 0 minutes. In order to understand the 
possible sources for the discrepancy in between these two techniques AUC was used to 
quantify the dimer to monomer proportions for the t = 0 minute samples; the 
dimer/monomer ratio for RmAb and hIgG were determined to be 4.8%±0.8% [103] and 
11.7%±1.9%, respectively (for hIgG refer Chapter 5). Thus the dimer to monomer ratio 
obtained using AUC and ES-DMA appear to be the same nd slightly greater than SEC. 
Out of the three techniques, the error bars in the dimer percentage measurement of ES-
DMA is highest perhaps because of the variability in the measurement of ES droplet 





for the heat incubated samples using AUC, as the dimer and other oligomer proportions 
in these samples were below the limit of detection of the AUC, but, as evident from Table 
8.1, for all heat incubated samples the dimer to monomer proportion obtained with ES-
DMA was greater than SEC (except hIgG at t = 0 minute for which the dimer/monomer 
proportion obtained with ES-DMA and SEC are comparable). There are several possible 
reasons for these differences. Firstly, both in ES-DMA and SEC protein is subject to 
shear forces, which could potentially induce aggregation or alternatively break small 
oligomers apart. Secondly, high salt concentrations n the mobile phase of the SEC are 
used to minimize adsorption of protein, but it is known that high salt concentrations can 
also break up aggregates [5]. Thirdly, prior work by others has indicated that dimers may 
preferentially absorb in the SEC column [200, 204]. Inaccuracies can also arise in 
determining the dimer/monomer ratio using the ES-DMA.  There could be two sources 
for this: a) as mentioned in chapter 5 the correction for “droplet induced aggregation” 
requires the droplet volumes of the ES and any inaccur y in these measurements can 
propagate in the determination of the dimers/monomer ratio and b) for RmAb it was 
initially assumed there are monomers and dimers in solution, however, with increasing 
incubation time (after 60 minutes) there was evidence of trimers, tetramers and larger 
aggregates that are intrinsic to the solution (Figure 8.3A) which was not accounted for in 










Table 8.1. Dimer/Monomer ratio for ES-DMA before and after correcting for “droplet 
induced aggregates” and SEC at different incubation times at 70 oC.  























0 33.0 ± 2.0 5.0 ± 2.0 1.0 ± 0.4 37.0 ± 5.0 12.0 ± 6.0 7.0 ± 2.0 
10 - - - 25.0 ± 1.0 7.0 ± 2.0 4.0 ± 2.0 
20 - - - 18.0 ± 2.0 7.0 ± 2.0 ND2 
30 27.0 ± 2.0 5.0 ± 2.0 2.0 ± 0.1 16.0 ± 2.0 8.0 ± 4.0 ND2 
60 15.0 ± 1.0 2.0 ± 1.0 ND1 13.0 ± 2.0 7.0 ± 2.0 ND2 
90 11.0 ± 2.0 3.0 ± 2.0 ND1 11.0 ± 1.0 6.0 ± 2.0 ND2 
120 6.0 ± 1.0 2.0 ± 1.0 ND1 9.0 ± 2.0 4.0 ± 2.0 ND2 
 
ND1 (not determined) For these samples the SEC was not able to resolve the dimers from 
the larger aggregates hence the dimers were not quan ified  
ND2 (not determined) The signal-to-noise ratio for the dimers for these samples were less 
than 3 
 
Based on the signal to noise (S/N) ratio of the monomers and larger aggregates for the 
different samples obtained with SEC and ES-DMA the detection limits for these two 
methods were compared. For ES-DMA, considering RmAb sample at t = 120 minutes the 
monomer, dimer, trimer, tetramer and pentamer average counts were 158961 





corrected for droplet-induced artifacts), 13467 particles/cm3, 18780 particles/cm3 and 
25913 particles/cm3, respectively. Comparing these values to the background noise 
(provided in materials and methods section) it is evident that the S/N ratio was 2 to 3 
orders of magnitude higher than the background noise. On the other hand for the same 
sample the average monomer counts obtained with SEC was 5342 arbitrary units, and 
thus the monomer S/N ratio was ~ 10 (the background noise for SEC monomers is 
provided in materials and methods section) whereas the S/N ratio for dimer was < 3.  
Thus, ES-DMA appears to have a lower limit of detection.  
 
Figure 8.5: (A) Normalized monomer counts for RmAb as a function of incubation time 
at 70 oC obtained with SEC and ES-DMA (after correcting for “droplet induced 
aggregation”). (B) Normalized monomer counts for hIgG as a function of incubation time 
70 oC obtained with SEC and ES-DMA (after correcting for “droplet induced 
aggregation”).  
Despite the differences in the dimer fractions, there appears to be good agreement  in 
the relative amount of  monomer decay between ES-DMA and SEC, as can be seen in the 
normalized monomer plots of RmAb (Figure 8.5A) and hIgG (Figure 8.5B) as a function 































































normalization has been done with respect to the total area under the monomer peak at t = 
0 minutes. For ES-DMA the normalization has been doe with respect to the absolute 
monomer concentration at t=0 minutes. 




                  (8.2)
 
where C is the concentration of the monomer in the liquid phase at time t, k is the rate 
constant, and n is the reaction order.  
For n=1, assuming Co is the initial monomer concentration, the concentration of 




C kt= −             (8.3) 
For n ≠ 1, the general rate equation can be solved to get: 





− −= − −              (8.4) 
Further 1nokC
− can be replaced with an apparent rate constant k', such that 





− ′= − −                 (8.5) 
For IgGs a wide range of reaction orders have been proposed, n = 1.0 [205, 206], 1.2 
[207], 1.5 [208, 209], 2.0 [210, 211] or 2.5 [212]. The order of the reaction is typically 
determined by fitting the experimental data using different reaction orders, and assigning 





The reaction-order fitting results are presented in Table 8.2. In the case of RmAb it 
was found that both ES-DMA and SEC indicated a reaction order of approximately unity. 
Physically, this may either imply that the aggregation process is unfolding limited or 
occurs via monomer addition to oligomers [213]. Despite being completely different 
techniques, the difference in the decay rate constants are within 5% of each other and in 
good agreement with those reported previously [211, 4] for the temperature range, 55 
oC to 70 oC.  
Table 8.2. Rate constants and R2 values obtained for RmAb and IgG using ES-DMA and 
SEC by fitting different reaction orders.  
RmAb hIgG 
ES-DMA SEC ES-DMA SEC 
n k' (min-1) R2 k' (min-1) R2 k' (min-1) R2 k' (min-1) R2 
1 0.0073a 0.97 0.0069a 0.99 0.0096 0.84 0.0083 0.84 
1.2 0.0210 0.94 0.0175 0.98 0.0235 0.89 0.0230 0.90 
1.5 0.0292 0.88 0.0226 0.96 0.0316 0.95 0.0304 0.97 
2 0.0540 0.77 0.0364 0.88 0.0549b 0.99 0.0517b 0.99 
2.5 0.1095 0.66 0.0625 0.79 0.1023 0.98 0.0939 0.96 
3 0.2430 0.57 0.1137 0.71 0.2024 0.95 0.1809 0.91 
a The uncertainty in rate constant measurement for ES-DMA and SEC were determined 
to be ±0.001 min-1 and ±0.0016 min-1, respectively, based on measurements on three 
samples. 
b The uncertainty in rate constant measurement for ES-DMA and SEC were determined 
to be ±0.003 min-1 and ±0.011 min-1, respectively, based on measurements on three 
samples. 
For hIgG, a second order reaction yielded the best fit for both SEC and ES-DMA. 





depletion. The apparent rate constant k' obtained for hIgG is in good agreement with 
values obtained elsewhere [207, 210, 215] at 65 oC to 70 oC. In addition, the rate 
constants obtained by both methods agree well, differing by only ≈ 6%.  
8.4 Summary 
Using two heat incubated IgGs the ability of ES-DMA and SEC to characterize 
oligomers were compared. Results of this study indicated that ES-DMA can be a useful 
method for monitoring protein stability and for characterizing protein aggregates and its 
capabilites are at par and in some cases (e.g., resolution, detection limit) better than those 
of SEC.  ES-DMA observes a higher fraction of dimers, and due to its inherent higher 
resolving power, and lower limit of detection was able to characterize the larger 
oligomers that were not apparent in SEC at the concentrations used in this chapter (≤ 0.1 
mg/mL). In addition ES-DMA generally has shorter analysis time and lower sample 
volume requirements than SEC. Although ES-DMA has certain constrains as discussed in 
chapter 3, it is anticipated that the above demonstration will make it a popular process 






CHAPTER 9: APPLICATIONS: NANOPARTICLE-
PROTEIN COMPLEXES 
The objective of this chapter is two-fold: i) to demonstrate that ES-DMA can be 
used to monitor nanoparticle-protein conjugate (or otherwise also referred to as complex) 
stability and ii) to demonstrate through an explorat ry experiment that ES-DMA can also 
be used for glycan analysis. 
9.1. Nanoparticle-protein conjugate stability 
9.1.1 Introduction 
The importance of nanoparticle-protein conjugates was already established in 
chapter 6. One desirable property of conjugates is that they should be very stable [173]. If 
not stable, conjugates may aggregate and these aggrgates can appear in sizes spanning 
from few nanometers to several micrometers. This size range is within the operational 
range of both dynamic light scattering (DLS) and transmission electron microscopy 
(TEM) and thus both these techniques are routinely used for monitoring conjugate 
stability [20, 67, 100, 173]. However, each of these techniques has certain disadvantages. 
For example in DLS, the scattered light intensity scales as the sixth power of the 
hydrodynamic diameter of particles, thus although it is sensitive to aggregation, it fails to 
provide multimodal size distributions for highly polydispersed systems. Further, it is 
difficult to correlate intensity obtained with DLS to the liquid phase concentration of 
particles. TEM on the other hand is expensive and time consuming. The objective of this 
chapter is to demonstrate that ES-DMA can also be routinely used for monitoring 





9.1.2 Materials and Methods 
9.1.2.1 Sample preparation 
Ammonium acetate, a volatile buffer, at a concentration of 2 mmol/L, was 
prepared in 0.5 L volumes by adding 0.077 g of ammonium acetate and the pH was 
increased to 9.4 by adding about 250 µL of ammonium hydroxide. Polyclonal human IgG 
(Sigma Aldrich, isoelectric point pH 4.8 – 9.3) was suspended in the above mentioned 
buffer at pH 9.4 to prepare a protein solution of cncentration 1 mg/mL. These pH and 
IgG concentrations were intentionally chosen as it was found that choosing a lower pH or 
significantly lower concentration of IgG causes signif cantly more gold-nanoparticle-
protein conjugate monomer loss as a function of centrifugation.  
Commercial Tedpella 30 nm gold nanoparticles were tak n in 450 µL aliquots to 
which about 2 µL of ammonium hydroxide was added to increase the pH to ~ 10 after 
which 50 µL of 1 mg/mL IgG solution was then added an  then allowed to interact for 
0.5 hours (Figure 9.1B). This sample will be referred to as 0× AuNP-IgG henceforth. For 
removing the excess protein, another aliquot was centrifuged for 10 minutes at 10,000 
rpm (Figure 9.1C), then 450 µL of the supernatant replaced with 450 µL ammonium 
acetate buffer at pH 9.4 (Figure 9.1D and 9.1E). This sample will be referred to as 1× 
AuNP-IgG. Likewise, steps c to e were repeated to prepare samples that were centrifuged 
twice and thrice and will be referred to as 2× AuNP-IgG and 3× AuNP-IgG respectively. 
Control protein solutions were also prepared which involved centrifuging the samples 




Figure 9.1: Demonstrates the steps involved in preparation of AuNP
and e will be refered to as 0× Au NP
Step e, c to e are repeated to prepare 2× Au NP
 
9.1.2.2 ES-DMA operation
 A 40 µm capillary with an outer diameter of 150 
used to electrospray the conjugates and AuNP samples as it is difficult to achieve stable 
Taylor Cone with 25 µm capillary while using low ionic strength solutions
The ES chamber pressure was maintained at 3.7 PSI. The DMA was operated at 10 L/min 
and the CPC was operated at high flow mode (1.5 L/min).
 As mentioned in chapter 5, one of the artifacts of using the ES is if the 
concentration of particles
(say > 100 nm) then two or more particles (conjugates in this context) can get 
encapsulated in the same ES droplet and appear as “d oplet induced aggregates”.  For this 
particular study, the concentration of the AuNPs was 2×10
manufacturer), i.e., it was low enough such that “droplet induced aggregation” did not 
play any dominant role. It should be pointed out that this rationale applies to the bare 
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µm and length of 24 cm was 
 




 (~ 2 mmol/L). 





AuNP particles as well as the conjugate samples since this artifact is independent of 
material property. 
9.1.2.3 TEM 
A JEOL 2100 TEM was used for obtaining micrographs of the AuNP, IgG and 
AuNP-IgG conjugates in the size range of 10 nm to ~5 µm. About 3 – 5 µL of sample 
volume would be applied on ultrathin carbon film on a 400 mesh copper grids (Ted Pella 
Inc.). The samples would then be dried in a vacuum chamber (Thermo Scientific)  for ~ 2 
hours and then stored in the refrigerator at 4 oC prior to analysis. 
9.1.2.4 Fluid Imaging  
FLOWCAM (Fluid Imaging Technologies Inc.) [216] was used for for 
determining size distributions of conjugate aggregat s in the size range of 4 µm to 50 µm. 
A 10X Olympus lens was used for taking images of the aggregates. The flow cell used 
had a cell depth of 100 µm and width of 2000 µm. The solution of interest was pumped 
through the flow cell at the rate of 0.05 mL/min. For the given cell dimensions, this rate 
were fast enough to eliminate the possibility of capturing the image of same aggregate 
multiple times. A particle segmentation threshold was defined with dark pixels of 8.0 and 
light pixels of 6.0. These parameters were used to differentiate particles from the 
background. The distance to nearest aggregate neighbor was selected as 3 µm to 
eliminate the possibility of counting smaller aggregates within larger ones. An auto 
image rate of 10 frames/sec was selected. Usually a solution would be run until 5000 
particles had been imaged which ensured repeatable and good statistical data. Increasing 





9.1.3 Results and Discussion 
The conjugate samples were centrifuged upto three tim s and their stability was 
monitored and compared against the uncentrifuged conjugate as well as bare gold 
nanoparticles using DLS, ES-DMA, TEM and FLOWCAM. Figure 9.2A shows the 
hydrodynamic diameter of the bare gold and conjugates samples as a function of 
centrifugation. The bare AuNP appeared at size 35.3nm in reasonable agreement with 
the labeled size of 33.2 nm of the parent stock solution. After addition of IgG and 
subsequent incubation for 30 minutes, the size increases to 52.0 nm implying successful 
conjugation of AuNP with IgG. The 17 nm increase with the DLS is more than the 10 nm 
size of IgG and seems to indicates that IgG forms multiple layers on AuNP surface. In 
order to accurately quantify the number of layers of IgG adsorbed a fluorometer was 
used. For a typical IgG the projected side, end and frontal areas are 53 nm2, 68 nm2 and 
94 nm2 respectively. This implies that depending on the conformation of IgG, upon 
adsorption about 40 to 70 IgG monomers can adsorb to a single 33 nm AuNP to form a 
complete monolayer. The results with fluorometer suggested that about 140±40 IgG 
monomers adsorbed per AuNP (i.e. 2 to 3 layers depending on conformation). This could 
either imply that IgG undergoes significant structural change upon adsorption to the 
AuNP so that the surface can accommodate more monomers than the theoretical 
estimates above or that IgG adsorbs to form multiple layers on to AuNP. As already 
discussed, DLS results appear to suggest the later. Such multilayered adsorption of 
proteins to AuNPs or planar surfaces has also been observed before as already mentioned 





 Upon centrifuging the conjugate samples, the hydrodynamic diameter was found 
to increase almost linearly as shown in Figure 9.2A. The error bars are from 
measurements on three samples and if not visually apparent are smaller than the symbols 
used. This can either imply that more IgG is adsorbing to the AuNP as a function of 
centrifugation or that centrifugation is creating agregates that is biasing the DLS 
hydrodynamic diameter to larger sizes as has been rported in previous studies [20, 66, 
67]. The former explanation is unlikely, as with each centrifugation step significant IgG 
was removed from the solution and was replaced withbuffer (for example, after 1st 
centrifuge about 10% free IgG is left in solution, after 2nd centrifuge about 1% free IgG is 
left in solution and so on), which means that the amount of free IgG left in the solution 
after each centrifugation step is lesser so the likelihood of more protein adsorbing to the 
AuNP is also reduced. Further, there is further evid nce with ES-DMA, TEM and 
FLOWCAM that supports the samples were indeed aggregating and is discussed below. 
 Figure 9.2B shows size distributions of the bare AuNP samples and the 
conjugated samples as a function of centrifugation usi g ES-DMA. Like DLS, the ES-
DMA for AuNP-IgG 0X shows an increase in mobility size compared to the bare AuNP 
sample implying successful conjugation.  The increase in size with the ES-DMA is just 
about 7 nm from 33 nm to 40 nm. This is a factor of two lower than the increase seen in 
DLS. This contradiction is not unreasonable as DMA is a gas phase technique and the 
measurements are not done under the same hydrated conditions unlike DLS. In fact, a 
systematic comparison of size measurements obtained with DLS and DMA previously 
has shown that mobility size increase measured for ligands adsorbed to nanoparticles 





increase of mobility size obtained for AuNP-IgG-0X sample can also be used for 
quantifying the amount of protein adsorbed per NP. However, ES-DMA can under-report 
protein adsorbed especially for multilayered protein adsorption to NP, as has already 
been discussed in Chapter 6 and was thus not used in this study for quantifying the 
proteins adsorbed.  
From the size distributions of centrifuged samples in Figure 9.2B, it is evident 
that unlike DLS, the mobility size of the conjugate monomers stayed the same with 
subsequent centrifugations although the monomer counts decreased along with the 
appearance of small quantities of aggregates at sizes ~ 50 nm and ~ 60 nm. It has been 
shown using ES-DMA, that dimers of particles appear at size ~ 1.26 times that of the 
monomer while trimers appear at size ~ 1.5 times that of the monomers [217]. Based on 
this information, the aggregates at ~ 50 nm and ~ 60 nm are identified to be dimers and 
trimers of the conjugates. For quantifying the extent of aggregation, one can integrate the 
area under the monomer, dimer and trimer peaks and plot them as a function of 
centrifugation (Figure 9.2C). It is evident from Figure 9.2C that the total monomer 
concentration decreases to ~ 50 % whereas the average mobility diameter remains 
invariant of centrifugation. The decrease of monomers and concomitant increase of larger 
aggregates appears to qualitatively explain the increase in hydrodynamic size obtained 
with DLS. Although trimers are the largest aggregats seen with ES-DMA, there could 
also be larger aggregates existing in the solution that were not detected by ES-DMA 
because they were below the detection limit of the instrument, which in this regard is 109 





and thrice, aggregates were visually confirmed as well. In order to characterize and 
validate the existence of larger aggregates TEM was used.  
 Figure 9.2: (A) The hydrodynamic diameter  of AuNP (not centrifuged) and AuNP-IgG 
samples as a function of centrifugation. (B) ES-DMA size distributions of the same 
samples. (C) The total gas phase counts (primary Y-axis) of monomers, dimers and 
trimers and mobility diameter (secondary Y-axis) as a function of centrifugation. 
 
 Figure 9.3A shows 0× AuNP-IgG conjugate sample as seen under the TEM. The 
commercial AuNP solution had non-volatile citrate salt that dried up on the TEM grids 
and created background with dark patches making it difficult to discern the 
monodispersed AuNP-IgG conjugates. The fact that these dark patches indeed are from 
























































































































































buffer) and IgG samples (in acetate buffer). AuNP samples clearly had the same 
characteristic as Figure 9.3A (data not shown) while such dark patches were not evident 
from IgG samples in acetate buffer (data not shown). Upon zooming up of Figure 9.3A 
the conjugates become visible (Figure 9.3D) and appe r to be monodispersed. Further 
zooming even upto 10 nm (data not shown) does not sh w any evidence of protein 
adsorbed to the conjugates. This is not surprising, as it is known from studies in literature 
[173], proteins adsorbed to nanoparticles are often times not clearly evident even with 
high resolution TEM, although independent evidence from DLS, ES-DMA and 
fluorometer suggests otherwise. Figures 9.3B and 9.3C clearly showed a mixture of 
conjugates monomers along with structures that ranged in size from few hundred 
nanometers to more than a micrometer. A zoom up of one of these larger structures 
(Figure 9.3E) confirmed that these structures were made up of individual AuNP-IgG 
conjugates and were thus aggregates of these conjugates. Usually AuNP aggregates (that 
are not functionalized) fuse at the grain boundary [143], whereas the individual AuNP 
particles in these aggregates appear to be slightly apart from neighbouring AuNP 
particles. This implies that these individual units were AuNP-IgG particles and not bare 
AuNP particles. This aggregation also appears to explain the conjugate monomer loss 








Figure 9.3: TEM images of (A) AuNP-IgG 0X, the black dots represet the individual 
AuNP-IgG conjugates, the dark grey color patches ar from citrate, and the light grey 
color is from the carbon background of TEM grids, (B) AuNP-IgG 1X, (C) AuNP-IgG 
3X, (D) zoom up AuNP-IgG 0X (also showing patches of dark grey citrate background 
along with light gray carbon background) and (E) zoom up AuNP-IgG 1X.  
  
From the TEM data, it would be possible to obtain multi odal size distribution 
over the size range of a few nanometers to several micrometers. However, such a task 
would be extremely time consuming to the extent thait would be impractical from the 
industrial perspective to use it. On the other hand, FLOWCAM which is fairly 
inexpensive (~ $20k USD) can provide size distributions of micrometer sized particles in 














FLOWCAM constitutes of a flow cell (Figure 9.4A) through which the sample passes at 
a known flow rate. As the aggregates pass through they are counted and photographed. 
For a known sample analysis time (usually 3 to 5 minutes, but can be longer for better 
statistics if aggregate concentration is low), the aggregate concentration can be 
determined. The photographed images are then analyzed and the equivalent spherical 
diameter of particles determined. Figure 9.4B shows some of aggregates that were 
photographed for the AuNP-IgG 3X sample. As seen in Figure 9.4B some aggregates 
appear to be spherical, while others appear fibrillar. Thus, even for the same sample, the 
morphological characteristics for the aggregates can widely vary. Most particles shown in 
the Figure 9.4B were greater than 10 µm although majority of the aggregates in solution 
were less than 10 µm as is evident from the size distributions obtained from FLOWCAM 
(Figure 9.4C). As the smaller aggregates were closer to the lower size limit of the 
instrument (4 µm) their morphological characteristics were not clear from the 
photographs. It should be pointed out that no difference was found in the characteristics 
of the aggregates for different samples (0X to 3X). In Figure 9.4B some aggregates are in 
better focus of the objective lens of the camera and thus appear to have sharper edges 
compared to others. The end result of analysis is a size distribution of the sample of 
interest in the size range of 4 µm to 100 µm (or larger). Figure 9.4C shows such size 
distributions for the conjugate samples (AuNP-IgG 0X to AuNP-IgG 3X) along with an 
AuNP control sample which has very little aggregates. The FLOWCAM used in this 
study is not set up to distinguish protein particulates biophysically (such as fluorescence) 
from other aggregates. Thus it is not evident from the data if these aggregates were 





samples were subjected to the same centrifugal stress as the conjugate samples and size 
distributions were obtained with the FLOWCAM subsequ ntly. This way, one could 
compare the extent of aggregation for these samples with that of the conjugates by 
integrating the area under the size distributions. Figure 9.4D plots the integrated size 
distributions for IgG and AuNP-IgG centrifuged different number of times (from 0 to 3 
times).  It is evident that the IgG samples do not aggregate significantly under centrifugal 
stress while the conjugates do, thus implying these aggregates must be conjugates. This is 
in conjunction with the decrease of monomers of conjugates seen with ES-DMA (Figure 
9.2B) and the increase of Au-NP conjugates seen with TEM (Figure 9.3B, 9.3C).  
One can attempt to quantitatively reconcile the increase in the aggregates with 
FLOWCAM with the decrease in the conjugate monomers with ES-DMA. Because the 
concentration of the AuNP particles in solution were known, the gas phase counts 
obtained with ES-DMA could be, in principle, correlated with liquid phase concentration 
and thus ES-DMA can be used to determine the total volume loss in the liquid phase 
because of monomer loss. Similarly, as the aggregate sizes and their concentrations are 
known, the FLOWCAM can be used to determine the total volume increase because of 
aggregate formation. Following this approach, it was found that the increase in volume 
with FLOWCAM was 10 fold more than what is expected based on ES-DMA results. ES-
DMA has been successfully used for correlating the liquid phase concentrations with the 
gas phase on several occasions before as demonstrated in Chapters 4, 7 and 8, thus this 10 
fold offset is not because ES-DMA but rather FLOWCAM. Fluid imaging methods such 
as FLOWCAM is relatively new and size distributions and aggregate sizes obtained with 





flow rates, c) lenses used etc. even if the instrument is operated within the recommended 
settings of the manuals. Such variations are surprising as this technique is fairly new and 
more research is currently underway for understanding these above effects better [218]. 
Thus, at this point the FLOWCAM results can only be regarded semi-quantitatively until 
a better understanding of these factors are thoroughly understood.  
 
 
Figure 9.4: (A) Simplified schematic of the internal constituents of a FLOWCAM. (B) 
Photographs of different conjugate aggregates for AuNP-IgG 3X sample. (C) Size 
distribution of centrifuged samples and of the contr l AuNP. (D) The integration of size 
distributions obtained with FLOWCAM for the AuNP-IgG conjugate and IgG samples as 

































































































 AuNP-IgG conjugate aggregates were intentionally produced by centrifugation 
and were then characterized using ES-DMA, DLS, TEM and FLOWCAM. ES-DMA can 
provide more quantitative information about conjugate stability compared to DLS and is 
significantly quicker than TEM. FLOWCAM, a fluid imaging method was also explored 
in this context and although the results were in qualitative agreement with ES-DMA, 
DLS and TEM, it was not quantitative enough to close the volume balance. 
9.2 Glycan Analysis: Preliminary results 
9.2.1 Introduction 
 The majority of approved protein therapeutics posses  some type of glycans 
which are sugar molecules covalently attached to the protein. There can be significant 
heterogeneity in the type of glycans carried the same protein which can concomitantly 
affect the safety and efficacy of a drug [219, 220]. Thus glycans are usually 
comprehensibly characterized by enzymatic deglycosylation followed by 
chromatographic [219] and/or mass spectrometric techniques [221]. Although these 
methods provide rigorous characterization of glycan structure, they can be time 
consuming and expensive, and require highly trained personnel.  In contrast, lectin based 
assays, in principle, are simple, inexpensive, and rapid alternative for monitoring 
identifying glycans [222]. In such an approach, a protein X with a glycan Z is incubated 
with gold nanoparticles. Then a lectin Y is added that is capable of identifying glycan Z. 





conjugate and also may adsorb to other AUNP-X conjugates thus creating a network of 
aggregates. The schematics of the approach is shown in Figure 9.5.  
 
Figure 9.5: Schematics of a lectin based assay for identifying glycans. 
9.2.2 Materials and Methods 
Concanavalin A, was purchased from Vector Laboratories and used without 
further purification. Ribonuclease B (RNase B, from bovine pancreas, >80 %), sodium 
chloride (99.9 %), manganese chloride tetrahydrate (99.99 %), calcium chloride dihydrate 
(98 %), 4-(2-hydroxyethyl) piperazine-1-ethanesulfonic acid (HEPES, 99.5 %), and 
indium foil (99.99 %) were purchased from Sigma-Aldrich and used as received.  Citrate-
stabilized gold nanoparticles (average diameter ≈10 nm) were purchased from Ted Pella. 
The manufacturer reported concentration is 5.7 x 1012 particles/mL.  Lectin and bovine 
serum albumin solutions were prepared to the desired concentrations by dissolving in 
HEPES buffered saline, HBS (pH 7.4, 150 mmol/L NaCl, 0.01 mol/L HEPES, 1 mmol/L 
Au



















Ca2+, 1 mmol/L Mn2+). Type I water (UV treated; 18 MΩ-cm; 0.2 micrometer final filter) 
was used for all solution preparations. 
To prepare protein-modified gold nanoparticles, the protein was first dissolved in 
water at a concentration of 1 mg/mL.  The pH of the as received 10 nm gold nanoparticle 
solution was raised to ≈10 with 0.1 mol/L NaOH (measured by EMD colorpHast pH test 
strips). Protein solution was added to the gold nanop rticle solution at a volume ratio of 
1:10. The solution was mixed and allowed to incubate at room temperature for at least 30 
min before analysis or use.  
9.2.3 Results and discussion 
 In the context of Figure 9.5, protein X is RnaseB, and the lectin that recognizes 
the glycan mannose (Z in Figure 9.5) of RnaseB is ConA. Figure 9.6 shows size 
distribution of 10 nm Au and its peak mobility appears at ~ 11 nm in conjunction with 
previous findings. After adsorption with RnaseB it shows an increase in size by about 2 
nm. It also shows small fractions of dimers at ~ 17 nm. These dimers of the conjugates 
were probably induced during centrifugation of the sample. After adsorption of ConA to 
this sample, a wide distribution is obtained and its in ensity is clearly much less than the 
Au and Au-RnaseB conjugates and is thus plotted with a seconday axis. In this regard, 
the Au-RnaseB-ConA sample has been normalized with respect to the Au-RnaseB 
sample. This wide distribution is indicative of an ggregating sample which was also 






Figure 9.6: Size distributions of Au, Au-RnaseB and Au-RnaseB-ConA. 
9.2.4 Summary 
The above example thus qualitative demonstrates that ES-DMA can be used for 
monitoring lectin bindings to glycans. Further, expriments need to be conducted for 
quantitative measurements. However, there are several challenges that may hamper its 
application in this area. For example, the above analysis is rather qualitative because of 
the rapid decay of the concentration of AuNP-RnaseB-ConA conjugates. If the rate of 
aggregation was slower, then indeed ES-DMA could be used used to obtain mechanistic 
information about the aggregation. Another issue that might hinder ES-DMA’s usage in 
this area is that usually the lectin binding chemistry is carried out in high concentrations 
of non-volatile buffers which is not electrosprayable. This poses two challenges: i) 
change of buffer might affect the kinetics and ii) buffer exchange typically is time 
consuming (several minutes if centrifuged, several hours without centrifugation) and the 






































Chapter 10: CONCLUSIONS 
This chapter briefly describes the intellectual contributions and the anticipated benefits 
because of the research conducted in the context of this dissertation. It also identifies the 
directions of future research.  
10.1 Intellectual Contributions and Anticipated Benefits 
As it is difficult to disseminate the contributions from the resultant benefits hence they 
are hereby being discussed together. It should also be pointed out that this list is not 
necessarily in the order of importance.  
1. Review of ES-DMA: Chapter 3 provides the first comprehensive literature review of 
all applications of the ES-DMA since its development in the context of bionanoparticles.  
As a peer reviewer noted: “I have followed the subject reviewed from its very beginning 
as an interesting curiosity, and was pleasantly surprised to learn from this review that it is 
in its way to making some impact.” This work has since been accepted for publication at 
Trends in Biotechnology and is tentatively scheduled to appear in the May, 2012 issue 
[224]. The author anticipates, given the wide audience of this journal and given the wide 
variety of information that can be extracted by using ES-DMAs, it will become a popular 
tool in the near future. 
2. Adsorption-Desorption of proteins to ES surface and its effects: Protein adsorption 
has been a nuisance that has bothered the ES community for about three decades. The 
author demonstrated, that by simply correlating the liquid phase concentrations with gas 
phase ES-DMA can be used to quantify the protein adsorbed and desorbed. As one of the 
peer reviewers pointed out: “The systematic study undertaken of the phenomenon is of 





studies.” The reviewer in this case was referring to section 4.1 which was published in 
Langmuir [144]. Section 4.2 extended this to oligomeric proteins. Because the shear rates 
inside ES capillaries are comparable to that inside human blood vessels, thus it also 
makes ES-DMA the one of the few tools that can be used at such high shear. Given the 
ease with which surfaces can be modified (as shown in section 4.3, published in Journal 
of Colloids and Interface Sciences [180]) the author anticipates that ES-DMA can 
become a powerful tool that can be eventually impleent by the biopharma and food 
industry for studying adsorption-desorption of complex heterogeneous proteins on 
surface-modified ES capillaries. Section 4.3 also ameliorates the concern that protein 
desorbing from silica capillaries do not influence aggregate distributions. This essentially 
implies that prior publication that had been carried out without passivating capillaries 
were accurate in the context of quantification of aggregates. 
3. Validated ES-DMA in the context of ICH-Q2: Although ES-DMA has been in use 
for more than 15 years it has been mostly limited to research labs. This in part was 
because no systematic study was available in the context of ICH-Q2. In essence a 
technique needs to be “validated” by demonstrating that it meets the stringent criterion 
set by ICH. In view of that, a systematic study was undertaken to demonstrate that ES-
DMA does indeed meet ICH’s criteria. As one peer reviewer commented “it looks quite 
systematic and can be served as a solid validation of ES-DMA for practical usage.” This 
work (Chapter 7) was published in Journal of Virological Methods [201]. The assays that 
are currently used for viral characterization and concentration measurements are 
extremely time consuming (order of hours and days, respectively). ES-DMA on the other 





biomanufacturing. Thus the author anticipates that as i has been validated, ES-DMA can 
become an important process analytical tool in the near future. 
4. Characterization of Protein Aggregates: Chapter 8 determines that ES-DMA has a 
better resolution and lower limit of detection compared to the industrial workhorse - SEC 
and yet shows excellent agreement with SEC in monitori g monomer stability. Given 
that ES-DMA is also quicker than SEC and requires significantly less sample volume, it 
is only a matter of time before it is accepted by the biopharma industry as an at-line 
process for streamlining manufacturing and also for improving the quality of drug 
products. As the editor of the Journal of Pharmaceutical sciences pointed out this “… 
manuscript contains original and significant new findings …”. In this case he was 
referring to data presented in Chapter 8. This work is already published in the above 
mentioned journal [225]. 
5. Droplet Induced Aggregation: The probability of two or more particles residing in 
the same ES droplet and producing an artificial dimer has been long thought to be an 
issue with ES units. However, no experimental methodology was available to eliminate 
this artifact. The author assisted Mingdong Li, who is currently a graduate student under 
Prof. Michael R. Zachariah in developing a methodolgy that eliminates this artifact. The 
work described in Chapter 5 is published in Aerosol Science and Technology [103] and 
Langmuir [102]. This approach depends substantially on the accuracy of the ES droplet 
volume determined. Unfortunately, current capillaries that are produced by commercial 
companies such as TSI and New Objective do not produce ES droplet volumes that have 
low variability and hence the applicability of the approach is currently limited. However, 





that “droplet induced aggregates” can be corrected for during data analysis. 
Concomitantly, this may increase the current upper limit of particle concentration that is 
currently used with ES-DMA systems. 
6. Quantifying Ligand Adsorption to Nanoparticles: Although traditionally DMA-
APM has been used for obtaining mass of very large ggregates (of the order of 100 nm) 
this is the first application of ES-DMA-APM for quantifying liquid phase protein 
adsorption to nanoparticles. Obtaining the mobility size using DMA and then the mass 
using DMA-APM can be useful in understanding the orientations of proteins after 
adsorption. Thus in the near future ES-DMA-APM can prove to be an useful tool in this 
context at least in the research labs.  
7. Increased the Library of Bionanoparticles Characterized: In the past 15 years ES-
DMA has been used to characterize a variety of nanop rticles. The author increased this 
library by characterizing more than 50 different bionanoparticles. In order to make this 
dissertation a coherent story it was beyond the scope t  include all particles characterized. 
However, Figure 10.1 provides a glimpse of the most important nanoparticles 
characterized by the author. The letters within parenthesis stand for: P – published, U – 








Figure 10.1: List of most important bionanoparticles characterized from Jan, 2008 to Feb, 
2012. 
 
10.2 Future Research 
 Usually lab-driven research and industry-driven research take separate paths. 
Keeping that in mind, this section provides the potential future directions of research in 
each of these categories. As far as the industry is concerned there are at least two 
frontiers: 
1. Automation of Sample Analysis: Much like current industrial ES-MS units and LC-
MS units, the entire process from sample insertion to data analysis could automated by 
incorporating the transfer functions of the different ES-DMA components (chapter 2) 
(currently implemented in TSI Inc. built units) as well by integrating “droplet induced 
aggregation” theory (chapter 5).  
2. High-throughput Analysis and Lowering Limit of Detection of ES units: Another 
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capillary systems that could potentially enable high throughput analysis. Further, design 
modifications in ES units could also be made to lower the limit of detection. 
In the context of lab research there are several areas that require further 
investigation. They are listed as follows: 
1. Adsorption Based Analysis for proteins: The affinity of most proteins to ES silica 
capillary can be harnessed to characterize complex heterogeneous protein mixtures. This 
is demonstrated with an example in section 4.4. 
2. Glycan Analysis: One approach of identifying different glycans in a protein is a lectin 
based approach, whereby addition of the right lectin to a glycoprotein solution causes 
aggregates to form that can then be characterized. Given the excellent resolution of ES-
DMA and the first analysis time, it could potentially be used to understand the 
aggregation mechanisms of such aggregation. This is di cussed in greater detail in 9.2. 
3. Structural changes of proteins (esp. non globular proteins) inside the ES-DMA: 
Although this was pointed out in Chapter 3, pursuing this study would require multiple 
spectroscopic techniques such as circular dichroism (CD), Fourier transform infrared 
spectroscopy (FTIR) etc. Because such techniques require large quantities of protein, it 
would require very long (several hours) of sample colle tion time at the end of the ES-
DMA unit to pursue such a study.  
4. Do the proteins retain any water post DMA: Although it is presumed that the ES 
droplet completely dries up, there is yet to be any experiment proof in the context of ES-
DMA to validate this.   
5. Proteins produce different signal outputs compared to nanoparticles: It is 





compared to inorganic nanoparticles (such as gold or sucrose). This is seen in ES-MS too, 
but given that the charging mechanism of ES-neutralizer is presumably material 
independent, such a material dependent response is unexpected and definitely requires 
further research.  
6. Better capillary passivations to reduce protein adsorption: It was shown in chapter 
4 that gelatin is able to significantly reduce immunoglobulin adsorption. However, 
gelatin fairs poorly against other proteins. Thus it would be interesting to investigate 
other types of passivations to reduce protein adsorption to ES capillaries. 
 Finally, the author anticipates that in the coming decade the popularity of ES-
DMA would continue to increase exponentially and will continue to provide answers to 








APPENDIX A: CFD simulations of a modified DMA design 
 
A.1. Introduction 
The objective of this project was to explore a new DMA design that could be 
implemented for increasing the electric field exerted on particles passing through DMA 
using CFD. This description is being provided in the appendix section as it is unrelated to 
the dissertation and yet is of sufficient importance for proper documentation. In this 
context, for spherical particles because of their isotropic nature, the electric field (low or 
high) does not influence the mobility inside the DMA. However, non-spherical particles 
may orient differently especially at high electric f elds thus producing a electric field 
dependent mobility which can then be used to extract the shape information of the 
particle [226]. As mentioned earlier, it is beyond the scope of this dissertation to discuss 
such non-spherical particles. This particular project was undertaken to assist a graduate 
student Mingdong Li working under Prof. Zachariah for his own dissertation related 
work.  
CFD simulations on DMAs are extremely rare in litera u e [227, 228]. This study 
undertaken here was the first of its kind using FLUENT (commercial CFD simulation 
software). 
A.2 Design and Preprocessing 
Traditionally DMAs manufactured by TSI have 10 mm spacing in between the 
outer (R2) and inner DMA (R1) electrodes. A DMA was selected that had the design 
dimensions as shown in Figure A1 below. In this figure all dimensions are in millimeter. 





should stay laminar. Further for concentric cylinders the diameter needs to be redefined 
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where 2 22 1( )A R Rπ= − and 2 1 2 12 2 2( )P R R R Rπ π= + + − .  
 
Figure A1: The original DMA design. 
Substituting, the respective dimensions and using 10 L/min as the sheath flow, it 
appears from Figure A2 below, that the Reynolds number only increases marginally with 
decrease in inner and outer electrode spacing (the inner electrode is fixed at 9.48 mm). 
This is because although the velocity increases with reduction in spacing, the hydraulic 
diameter also decreases causing only a small increase in the Reynolds number. Further, 

















cylinder this critical value would then be 1000 as the critical Reynolds number in a 
concentric cylinder is half of that in cylindrical tubes [230]. As the theoretically predicted 
Reynolds number is significantly less than this critical value thus one may conclude that 
the flow will remain laminar even if the gap between the electrodes is reduced to as low 
as 2 mm (Figure A2). 
 
Figure A2: Increase in Reynolds number with decrease in spacing between inner and 
outer electrodes. 
 
The spacing was arbitrarily chosen to be 3 mm such that for the same voltage, the 
electric field on a particle would be ~ 3 times more. This reduction in gap was achieved 
by inserting two inserts labeled 1 and 2 in Figure A3. Of these inserts, insert 1 makes a 
300 angle with the horizontal.  Further the entrance of the aerosol flow where it mixes 
with the sheath flow (shown in Figure A4) was reduced to 1/10th of this spacing to reduce 



























penetration of the electric field further upstream of aerosol flow may affect the mobility 
size (by exerting electrical forces on the particle before it can relax to sheath flow).  
 
Figure A3: The modified DMA design. 
A.2.1 GAMBIT 
 For creating the computational domain GAMBIT 2.4.6 was used. Quadrilateral 
meshes were arbitrarily selected with a spacing of 0.01 for the entire computational 
geometry and was significantly better resolved compared to previous literature [227, 
228]. Ideally, further optimization of the mesh size could be done by optimizing the 
solution obtained and the time taken for convergence of residuals. Such a comprehensive 
approach was however not undertaken as these simulations were merely exploratory. 
After creating the mesh the boundaries were labeled and the type of boundary conditions 
defined (Figure A4). For aerosol and sheath flow velocity inlet conditions were used. For 
the outlet, outlet boundary condition was used. Theinterior was chosen to be a fluid. The 
rest of the boundaries were defined as walls. Althoug  the aerosol flow actually enters at 




















surface (implemented in FLUENT). After defining the boundary conditions, the file was 
exported as a 2-D *.msh file. 
 
Figure A4: Computational domain and boundary conditions. 
A.2.2 FLUENT 
FLUENT 6.3 (2D-dp) was used for solving the flow. It should be pointed out that 
for simplicity, the electric field inside the DMA was not considered. After importing the 
data the scale was set to mm (note that GAMBIT does not have any scales and works 
with arbitrary numbers). The geometry was defined to be axi-symmetric and the flow was 
defined to be steady and laminar. The aerosol velocity was assumed to be 0.01 m/sec 
(corresponds to 0.3 L/min) and the sheath flow was defined to be 0.8 m/sec (corresponds 
to 10 L/min). Air was chosen as the working fluid and the pressure in the computational 
domain was defined as atmospheric. All other conditions such as convergence criterion, 
pressure-velocity couplings, relaxation factors etc. were left unaltered.  
A.3 Results and Discussion  
 For most boundary conditions (different aerosol and sheath flow velocities) the 















virtual computing lab services. Figure A5A and A5B shows the velocity contours and 
magnitudes respectively. It is difficult to interpret this data without carefully investigating 
locally, especially at the confluence of the aerosol and sheath flows. One of the issues 
that need to be accommodated during designing is whether the flow velocities of sheath 
and aerosol match at the junction where the aerosol enters the DMA. This is of great 
importance as any substantial mismatch could create local flow perturbations. One way 
of investigating this mismatch is to create several sections near the confluence of the 
aerosol and sheath flow and then monitor the magnitude of the axial and radial velocities. 
From Figures A5C and A5D it appears based on 8 different sections that were created in 
this above mentioned region that the axial velocity of the aerosol flow matches very well 
with sheath flow. These sections with respect to the computation domain are labeled in 
the inset of both A5C and A5D. At the exact region where the aerosol flow enters the 
DMA, there is some radial velocity. This is unavoidable but can be reduced further by 
reducing the angle of entry by redesigning the insert 1. As mentioned before the angle of 
entry of insert 1 is 300. Had this been lesser then the radial velocity could have been 
reduced. However, as the modifications were made to a pre-existing DMA, this 
redesigning would have required substantially more changes in the DMA that would have 
been logistically difficult. Hence this design modification was not pursued. Physically, 
this implies that some aerosol particles that enter th  DMA would actually cover certain 
distance radially which might consequently affect the determined mobility for such 
particles. However, it should be noted that the above design is currently producing 
reproducibly good results experimentally (not discussed) implying the above issue is not 







Figure A5: (A) Velocity contours and (B) velocity vectors in the computational domain. Magnitude of axial (C) and radial 
velocities (D) at 8 different sections. 
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 Modifications were first made to an already existing DMA design to reduce 
the spacing between the electrodes. It was found that decreasing the spacing only 
marginally increases the Reynolds number. Further, exploratory simulations were 
carried out on this modified DMA design with reduced inner and outer electrode 
spacing of 3 mm. For simplicity the electric field inside the DMA was not coupled 
with the flow. By investigating the region where the aerosol flow meets the sheath 
flow it was found that the axial velocity components of aerosol flow at 0.3 L/min 
matches very well with the sheath flow of 10 L/min. Thus, this design should work 
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